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Abstract
The primary focus of this thesis is the development of a digital microflu-
idic based system with integrated microelectrode biosensors, designed
for the analysis of human brain microdialysate in the intensive care unit.
The main aim is to measure the neurochemical eﬀects of spreading de-
polarisations (SD waves), which have been shown to be detrimental to
the injured human brain.
A combined electrode was developed containing working electrodes in the
range of 25 to 125 µM, a reference electrode and an auxiliary electrode,
within a needle of outer diameter 300 to 500 µm. Glucose, lactate and
ATP biosensors were developed with detection limits of 2 to 10 µM and
response times of under 10 seconds.
A digital microfluidic system was designed to segment the dialysate at
a microdialysis probe outlet, thereby eliminating Taylor dispersion and
reducing the time lag between the sample leaving the brain and analysis.
Diﬀerent designs are discussed for the manipulation of droplets for opti-
mal analysis, thus creating a microfluidic toolkit. The analysis chamber
was analysed mathematically, the optimal placement of electrodes found
and the sensor performance assessed on-chip.
The on-chip glucose biosensor was used in vivo in a translational pilot
study. The biosensor performance was validated against rapid sampling
microdialysis with excellent results. The glucose biosensors successfully
monitored concentration changes, in response to stimulations, in the
range of 10 to 400 µM. The data shows that during a SD wave, there
is a time delay between the increase in potassium and the decrease in
glucose, due to the uncoupling of blood flow and metabolism. For the
first time, the microfluidic system was used in the intensive care unit,
monitoring brain injury patients at the bedside.
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Chapter 1
Introduction
1.1 The Human Brain
The human brain is a complex organ, which actively controls most bodily functions.
It is similar in structure to that of other mammals, however when comparing to body
size, the human brain is three times larger (1). The brain regulates and monitors
the body’s actions and functions by receiving sensory information via nerve inputs
and processes them using many diﬀerent representations, before giving a response.
Diﬀerent areas of the brain are responsible for diﬀerent functions, for example the
brain stem regulates autonomous functions such as the heart beat, the basal gan-
glia controls motor output, the cerebellum is used for coordinated movement, the
hippocampus for memory and the neocortex brings the signals together and pro-
cesses them, giving rise to personalities and consciousness. The locations of these
brain areas are indicated in figure 1.1. Damage to the brain can have devastating
consequences. The most severe is death however, brain injury can have more subtle
eﬀects. The most common brain injury is caused by a hit on the head and the exter-
nal forces involved are most likely to aﬀect the neocortex. Therefore, the processing
and the response to external stimuli can change and the personality of the patient
can become very obsessive or violent. Whilst there is no obvious disability, this can
have a very debilitating eﬀect on the patient and their family.
There are two main components of the brain: white and grey matter. White
matter forms the main bulk of the deeper parts of the brain and is composed of
myelinated axons. Therefore it can quickly transmit messages to diﬀerent parts of
the brain and to other organs. Grey matter is the area of the brain which processes
information. It is composed of neuronal cell bodies and glial cells known as astro-
cytes. The brain is protected both by the skull, which in humans is more than 1 cm
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Figure 1.1: Structure of the human brain
Sagittal view of the human brain. Image created using MRI. The brain stem is responsible for au-
tonomous functions, the cerebellum for movement and the cortex for personality and consciousness.
The hippocampus is not visible on this mid-line sector.
thick and is cushioned by cerebral spinal fluid (CSF). CSF provides mechanical sup-
port so that the brain is not aﬀected by its own weight and acts as a cushion against
jolts and injuries (2). The brain is also protected from large molecules and bacteria
by the blood brain barrier (BBB). The BBB separates the circulating blood and the
extracellular fluid of the brain and is crucial for correct neuronal function (3). It is
present along the capillaries and consists of tight junctions which seal together the
endothelial cells. The tight junctions restrict the passage of water soluble molecules,
and protects the brain from infection and from fluctuations in the composition of
fluids in the rest of the body, by forcing molecules to travel via the trans-cellular
route across the BBB (4). The BBB also protects molecules that are released by
cells in the brain from being washed away in the blood stream, allowing for complex
pathways to occur.
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1.1.1 Neurons
Neurons have a distinctive structure, as shown in figure 1.2, and form networks,
in which information is relayed electrically and chemically. Neurons process in-
formation uni-directionally along their length via electrical action potentials (AP)
and transmit information to other cells via chemical release at their terminus (5).
Dendrites relay electrochemical information from other neurons to the soma, or cell
body, and the axons transmit the information away from the soma to other neu-
rons. A neuron only has one axon however it can branch many times and innervate
multiple parts of the brain.
Figure 1.2: Structure of a neuron
The schematic shows two neurons. The soma (cell body), dendrites and axons are indicated. The
synapse is the junction which connected an axon of one neuron to the dendrite of another neuron.
Schwann cells form the myelin sheath which increase the conduction of electrical messages.
The junction whereby one neuron communicates with another is known as a
synapse. A synapse is a specialised junction over which the chemical signal is passed
and is shown in figure 1.3. A synapse allows the electrical signal to be converted
into a chemical signal, which is passed between neurons (6). The AP propagates
along membranes by sodium and potassium channels sequentially depolarising lo-
cal segments of the membrane, until it reaches the presynaptic terminal. Here, the
depolarisation causes voltage-gated calcium channels to open. Calcium floods into
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the cells, which triggers synaptic vesicles to dock onto the membrane. The contents
(neurotransmitters) are released via a process known as exocytosis. The neurotrans-
mitters diﬀuse across the synaptic cleft (5 - 50 nm (7)) and some bind to receptor
molecules (ligand-gated ion channels) on the postsynaptic cell. This changes the
local transmembrane potential causing an AP in the dendrite (8). The generation
of the AP depends not only on the receptor stimulation but also on the immediate
chemical environment of the postsynaptic cell. Re-uptake pumps may actively pump
the excess neurotransmitter back into the cells to prepare the synapse for future stim-
ulations. A poison derived from a puﬀerfish, known as tetrodotoxin (TTX), locally
blocks APs by inhibiting voltage-gated sodium channels and therefore preventing
membrane depolarisation (9).
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Figure 1.3: Schematic of a synapse
A schematic showing the structure of the junction between two neurons. An AP from the axon
stimulates chemical release of neurotransmitters into the synaptic cleft. These diﬀuse across the
gap to the postsynaptic receptors on the dendrite. An AP is then triggered in the second neuron.
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1.1.2 Astrocytes
Astrocytes have multiple functions and constitute over 50% of the cell mass of the
brain (10). Previously, they were thought to provide only physical support and to
perform house-keeping duties for the neurons. This idea originated from the fact
that they are electrically non-excitable and therefore could not play a role in signal
transmission (11). This has since been challenged and it is now known that their
function goes beyond general house-keeping. Astrocytes are indeed involved in reg-
ulating the local environment by maintaining ion and pH homeostasis, delivering
glucose eﬃciently, providing nutrition and removing neuronal waste products (11).
However, it is now also thought that they can directly regulate neurons and aﬀect
their ability to form a synaptic network (11). During embryogenesis they provide
molecules that modify the growth of the neuron. Additionally, within the cerebellum
and the hippocampus they can form myelin and participate in signal transmission.
Astrocytes are star shaped glial cells, which are crucial for clearance of the main
excitatory neurotransmitter glutamate from the synaptic cleft, preventing a neuro-
toxic build up. They also couple this glutamatergic activity to the local supply of
energy in the form of glucose and lactate (12).
Spatial Organisation
Astrocytes and neurons are the two main cells of the grey matter. Figure 1.4
shows the spatial organisation of the astrocytes and neurons in the cortex (11).
The blood vessels are outlined by the astrocytic end feet which form gap junctions
to the endothelial cells. This forms a partial barrier (part of the BBB), which
regulates the transmission of water-soluble molecules from the blood to the brain
via active transport (13). The gap junctions allow for rapid communication between
the astrocyte and the neuron and allow small molecules, such as glucose and lactate,
as well as ions to move freely through the network that the astrocytes create (10).
1.1.3 Brain Metabolism
The brain consumes 20% of the energy used by the body even though it represents
just 2% of the human body mass (12, 14). Much of the energy required is used
for processing information in the form of APs, and more specifically in the re-
establishment of ionic gradients post-AP. This is a high energy task, which requires
more oxygen and glucose to be taken from the blood for use in metabolism. Glucose
can be incorporated into various lipids and proteins and can produce metabolic
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Figure 1.4: Spatial organisation of astrocytes and neurons in the cortex
Neurons are labeled with antibody to microtubule-associated protein 2 (MAP-2; blue), whereas
astrocytes are expressing enhanced green-fluorescent protein (eGFP; yellow). A small vessel is
outlined by eGFP-positive astrocytic end feet. Image taken from (11)
intermediates. It is the precursor for several neurotransmitters such as GABA,
glutamate and acetylcholine. The delivery of metabolic substrates by the blood, is
tightly linked to diﬀerent brain processes, which have diﬀerent metabolic demands.
Metabolism is usually described as three processes: glycolysis, the citric acid cycle
and oxidative phosphorylation.
Glycolysis is the pathway which converts glucose into pyruvate and occurs in
both aerobic and anaerobic metabolic pathways. In anaerobic conditions, pyruvate
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can be converted to lactate. In aerobic conditions, pyruvate is passed into the
mitochondria where the citric acid cycle occurs. The products are passed to the
membrane where various protein complexes generate ATP by a sequence of redox
reactions. A simplified overview of this process is shown in figure 1.5.
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Figure 1.5: Summary of the key metabolites involved in metabolism
Oxygen and glucose are provided by the blood vessels. Glucose is converted to pyruvate during
glycolysis. In the absence of oxygen, lactate is formed. In the presence of oxygen, metabolism
follows the citric acid cycle and oxidative phosphorylation occurs.
Energy resources stored within astrocytes are in the form of glycogen, which
is eﬀectively a type of glucose polymer, however these stores are limited. These
glycogen stores are small and the supply of the metabolic substrates (glucose and
oxygen) from the blood, is tightly coupled to demand. During periods of higher
activity, local blood flow increases. This is known as neurovascular coupling and
is the basis of many common imaging methods for brain activity. Initially it was
thought that the glycogen was an energy source, for use when glucose was unavail-
able. However, it has a high turnover rate even when glucose levels are normal, and
there is a body of evidence which suggests that glycogen may also play a role in
normal brain metabolism (10, 12, 15).
Although glucose is overwhelmingly thought of as being the main energy source
for cells, there are many examples of studies showing that lactate is produced and
used during aerobic respiration (16, 17, 18, 19), thus supporting a publication in
1953, which stated that in vitro brain tissue can utilise lactate to respire (20). Mea-
surements from astrocytes showed that these cells produced lactate from glucose dur-
ing hypoxic events and that lactate increased during neuronal stimulation (15, 21).
An astrocyte-neuron shuttle system has been postulated by many (22, 23, 24, 25)
and proved a controversial topic of much discussion (26, 27). In this hypothesis,
astrocytes produce lactate from pyruvate and release it into the extracellular fluid.
Lactate is then taken up by the neurons and possibly used as a fuel for oxidative
metabolism to re-polarise the cell (28).
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1.2 The Injured Brain
Traumatic brain injury (TBI) has recently been described as a silent epidemic by
the Lancet Neurology journal (29). In the UK, an estimated 238,000 people suﬀer
a TBI each year (30). When compared to breast cancer, which for example has an
incidence of approximately 120,000 people annually, the awareness of TBI is very low.
Interruption of cerebral blood flow for 10 seconds can result in loss of consciousness
and cell damage (31) and after 20 second electrical activity ceases (32). Impairment
of the local energy state and of homeostasis develops within minutes and after 5-10
minutes, irreversible cell damage is likely to arise (31). When the tissue is injured,
blood vessels are damaged and it has a higher energy demand. It is the combination
of these eﬀects that means that the local metabolic demands are often not met.
This results in an increase in lactate concentration and a fall in pH. A simplified
overview of the key pathways involved is shown in figure 1.6. The majority of head
injury’s are caused by impacts to the head. This causes local haematoma (bleeding)
and swelling. As the brain is a closed box, this increases the pressure in the brain
tissue which will most likely result in the breakdown of the local blood supply to
damaged tissue. Perfusion to the injured area can be supplied by collateral blood
vessels but when this is required long-term, it is often insuﬃcient. Treatment may
include increasing blood pressure to push blood through swollen brain tissue, or
removing part of the skull to allow the tissue to swell freely. Patient outcome in
these cases is hard to predict.
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Figure 1.6: Key pathways involved during injury
The neuron, astrocyte and blood flow are tightly coupled. When the tissue becomes injured if one
part of the pathway is aﬀected, it can silence the neuron. This means it can no longer communicate
and the viability of the cell is aﬀected due to demands on metabolism. A stroke can aﬀect the
blood flow by occlusion of vessels. Poisons (toxic chemicals released from neighbouring cells) can
directly aﬀect the metabolism.
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1.2.1 Focal and Global Ischemia
As discussed, injured brain tissue often becomes ischemic (33). In this case, there is
insuﬃcient blood flow to meet the metabolic demands of the tissue and the extra-
cellular fluid can contain high levels of irritant chemicals released from the nearby
dead or dying tissue. There are two types of brain ischemia: focal and global. Fo-
cal ischemia occurs when there is a localised reduction in blood flow to a specific
brain region, normally due to a blood clot. Global ischemia aﬀects the whole brain
and the blood supply is limited to all regions. This is most commonly caused by
cardiac arrest. Ischemia can cause a variety of symptoms, including lack of sight,
loss of coordination or slurred speech, depending upon which area of the brain is
aﬀected. These symptoms may only last seconds but can also be permanent if the
tissue becomes irreversibly damaged (34).
1.2.2 Primary and Secondary Injury
Primary and secondary injury is used to classify processes that occur during brain
injury. Primary injury refers to the initial damage and is the physical result of
the trauma. It is irreversible and often occurs before the paramedics arrive at
the scene. TBI may take many forms including intracerebral haemorrhage (ICH)
where haemorrhage occurs in the brain tissue, subarachnoid haemorrhage (SAH)
where blood collects between the arachnoid membrane and the pia mater, cerebral
contusion which is a bruise in the brain tissue, and axonal injury which results
from rapid acceleration or deceleration of the brain causing lesions in the axons and
neuronal death.
Secondary injury refers to the gradual decline of penumbral tissue surrounding
the ischemic core (the primary injury site) and may involve an array of cellular
processes triggered by the trauma. Secondary injury can develop slowly over days,
often whilst the patient is being monitored in intensive care. This type of injury
is a large contributing factor in brain damage and death. Approximately 40% of
TBI patients deteriorate days after the initial injury (35). Secondary injuries can
include ischemia, cerebral hypoxia, cerebral edema (swelling of the brain cells), raised
intracranial pressure and neurovascular edema (leakage of the blood plasma into the
brain).
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1.2.3 Spreading Depolarisation
A spreading depolarisation (SD) is a mass depolarisation of neuronal and glial cells.
SDs self-propagate along the cortex surface, like a wave. The depression of the
electrical signal, first described by Leao in 1944 (36), coincides with a large increase
in extracellular potassium as the neuronal cells depolarise, an increase in blood flow
and changes in metabolism (37). The resting potential of a cell is -70 mV and when
a threshold of -50 mV is reached, the cell is said to be depolarised. Depolarisation is
caused by an influx of cations, for example sodium or calcium. As a result, there is an
eﬄux of potassium into the extracellular space and an influx of chloride ions into the
cells. To recover from the depolarisation, the initial intracellular and extracellular
ionic gradients must be re-established. This in turn, imposes a high demand for
energy (38) and hence challenges the local delivery of glucose and oxygen to the
brain. Figure 1.7 shows the mechanisms of a spreading depolarisation in a neuron
(39).
SDs have been shown to spontaneously occur in the injured human brain (40, 41,
42). During brain injury and ischemia, the extracellular glucose concentration has
been shown to decrease and the concentration of lactate to increase (43, 44). The
accumulation of lactate in the extracellular fluid may cause acidosis which could
have a deleterious eﬀect (32). The number of depolarisations and the clustering of
these events, is associated with the growth of the infarct area (45, 46, 47) and the
secondary damage in the injured human brain (48, 49, 50). A schematic is shown in
figure 1.8, which is taken from (51). Whilst SDs may occur in the healthy human
brain, for example during a migraine with aura, there is unlikely to be damage to
the cortex if cerebral perfusion is normal (40).
Clinically, the patient outcome several days after the initial brain injury is charac-
terised by a set of covariates recorded on admission, such as age, pupil abnormalities,
level of hypoxia and motor score. However, a study by Murray et al showed that
these commonly used covariates only explain 30% of the variance in TBI outcome
(52). Results obtained by the Co-Operative Study on Brain Injury Depolarisations
(COSBID) group, suggest that the number and frequency of spreading depolari-
sations are a better indicator of patient outcome than any of the currently used
factors. Therefore the technology described in this thesis is aimed at characterising
these waves chemically.
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Figure 1.7: Swollen neuron during an SD
In the top diagram a healthy brain cell is shown. In the bottom diagram a swollen cell during a SD
is shown. If the influx of sodium and calcium is more than the outflux of potassium, there is a near-
complete loss of electrochemical energy, passive ion distribution across the membrane, intracellular
hyper-osmolality with cellular swelling and distortion of dendritic spines and extracellular hypo-
osmolality with extracellular volume (ECV) shrinkage. The hallmark of this process is near-
complete sustained depolarisation from ∼70 to ∼10 mV. (39)
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Figure 1.8: Brain injury
Schematic of brain injury taken from (51). Delayed cerebral ischemia may result from a complex
chain of events. SDs could precipitate brain damage by imposing additional metabolic stress on
the energy-depleted brain and by worsening the oxygen and glucose deficits.
1.2.4 Monitoring the Injured Human Brain
The underlying pathophysiological mechanisms of an injured brain are complex. At
present there are a variety of methods that are used in hospitals to monitor the
injured brain. Computerised tomography (CT) and functional magnetic resonance
imaging (fMRI), can provide useful information by constructing an image of the
brain, however it does not provide continuous or bedside monitoring. In fact, most
TBI patients have at best two CT scans and no MRI scans during a five day stay
in the intensive care ward. There are a variety of methods to monitor brain injury
at the bedside which can include intracranial pressure (ICP), changes in brain oxy-
genation using jugulous venous oxygen saturations or a LICOX probe, brain tissue
monitoring via microdialysis, brain electrical activity using electroencephalogram
(EEG) or electrocorticography (ECoG) and cerebral hydrodynamics using transcra-
nial doppler flowmetry and near infrared spectroscopy.
To investigate the underlying mechanisms of brain injury, and specifically spread-
ing depolarisations, the electrical and chemical signals should be identified. During
the SD event, the tissue is under sustained depolarisation and hence the electrical
activity is suppressed due to the neurons being unable to fire (39). Monitoring this
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suppression and identifying SD waves, will aid in the assessment of the health of
at-risk tissue. It has also been shown that the local glucose and lactate concentra-
tions have a clear response to an SD wave (53). Glucose has been shown to decrease
and local lactate levels to increase. These molecules are also associated with energy
metabolism in the tissue and may help identify underlying pathways, which lead to
tissue deterioration. Therefore, simultaneously monitoring glucose and lactate, as
well as electrical activity, will provide further assessment of the health of the tissue.
37
1. INTRODUCTION
1.3 Neurochemical Analysis
We have had the opportunity to work with clinicians at King’s College Hospital,
London, to monitor at the bedside of brain injury patients on the intensive care
ward. During surgery, a microdialysis probe, ECoG strip electrode and ICP probe
are implanted into the at-risk tissue during surgery allowing the recording of neuro-
chemical changes, brain electrical activity and brain pressure respectively.
Microdialysis sampling coupled with ex vivo analysis is one of two main ap-
proaches to neurochemical analysis, the other being the implantation of a biosensor
directly into the tissue for in vivo analysis. An overview of each method will now
be given.
1.3.1 Microdialysis
Microdialysis (MD) was originally used to measure the neurotransmitter concentra-
tions within the rat brain in 1974 by Ungerstedt and Pycock (54) and was first used
in the human brain in 1990 (55). It is now used in a wide variety of experiments in
animals (44, 56) and in human studies (53, 57).
Technique
Microdialysis is a popular method of tissue sensing and uses a semi-permeable
membrane to mimic a blood capillary, as shown in figure 1.9. A MD probe consists of
a double lumen concentric tube. Buﬀer that is ionically similar to the extracellular
fluid of the tissue, is steadily perfused through the inner tube to the tip of the probe
and flows back via the outer tube. At the tip there is a membrane with a molecular
weight cut oﬀ that can range from 5kDa to 100kDa. This prevents large molecules
and cells from entering the dialysate sample. Small molecules, that can diﬀuse across
the membrane, follow their concentration gradients into the probe. The analyte of
interest is collected in the dialysate that emerges at the outlet of the probe for ex
vivo analysis.
Recovery
Microdialysis is a sampling tool and the amount of analyte that diﬀuses across
the semi-permeable membrane into the dialysate, is dependent upon a variety of
factors. Recovery (R) can be calculated using equation 1.1.
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Figure 1.9: Principle of microdialysis
A diagram showing the main principles of microdialysis. Solution flows in through the inner tube
and washes over the tip. The tip is a semi-permeable membrane allowing small molecules to diﬀuse
from the tissue into flowing solution. This flow is then carried out of the tissue by the outer tube
for analysis. Image from CMA Microdialysis.
R(%) =
Cout
Cext
× 100 (1.1)
Cout is the concentration of analyte at the probe outlet and Cext is the in vivo
analyte concentration. Probe recovery is dependent upon the length of the probe
membrane, the external diameter and thickness of the membrane, the perfusion
flow rates, the temperature and pH, along with the shape and charge of the analyte.
Diﬀusion through the extracellular space, in vivo cellular re-uptake and capillary
exchange between the tissue and blood can also aﬀect recovery (58).
Calibration and quantification methods of in vivo recovery are controversial, as
in vivo recovery is dependent on both active and passive eﬀects (7, 59, 60). These
include active uptake and release processes, tortuous diﬀusion paths and excluded
volumes (where the cells take up space through which the molecules cannot pass).
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The concentration gradients in vivo are therefore not principally across the mem-
brane but across the tissue. This is indicated in figure 1.10 which is adapted from
(61). In general, in vivo recovery is lower than in vitro recovery, and in vitro recov-
ery should not be used to estimate tissue levels. Tissue levels can be estimated using
a no-net-flux (NNF) experiment (7, 62). However, in humans this is not possible
and true concentrations are estimated by setting the in vivo recovery to 100%. This
is achieved by using long membrane lengths and low perfusion flow rates (61).
Detection Method
Analysing neurochemical samples requires high sensitivity and time resolution.
The sensitivity of the detection method must allow accurate assessment of concen-
trations within the physiological range and be able to detect small variations in fast
concentration changes. This can be done in a wide variety of ways including optical,
electrochemical methods and separation techniques such as mass spectrometry or
electrophoresis. Currently, neurochemical analysis on the clinical ward is achieved
by combining a microdialysis probe with electrochemical detection.
1.3.2 Rapid Sampling Microdialysis
Classical microdialysis involves hourly sample collection followed by batch-wise anal-
ysis using separation techniques, such as HPLC, electrophoresis and mass spectrom-
etry. This has a number of drawbacks within a clinical setting. The low flow rates
involved means that a long time is required to collect a large enough volume of
dialysate for analysis. Hence, there is a low temporal resolution, due to hourly col-
lection of samples. This has been greatly improved with on-line techniques, such as
rapid sampling microdialysis (rsMD), which allows for the collection of samples ev-
ery 30-60 seconds using flow injection analysis (FIA) (63). Results from both animal
(44, 56, 64) and human brain studies (53, 57, 63) indicate that rapid, large changes
in neurochemicals occur on these timescales, which can only be recorded by this
sampling technique. Therefore, separation techniques such as mass spectrometry
or electrophoresis are not ideal for on-line monitoring. The small sample volumes
require not only a fast but also a sensitive technique as the samples contain a small
number of molecules. By flowing more quickly, the fall in probe recovery with higher
flow rates, challenges sensitivity.
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Figure 1.10: Recovery of microdialysis probes in vitro and in vivo
In in vitro recovery the dialysate concentration is limited by the diﬀusive flux across the membrane
and internal flow rate. In in vivo recovery there are passive eﬀects such as excluded volumes and
tortuous diﬀusion paths and active eﬀects such as cellular uptake and release rate to the local
extracellular fluid concentration. Adapted from (61).
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1.3.3 Implanted Biosensors
An alternative to MD sampling is to implant a biosensor directly into the tissue.
Microelectrodes are often employed due to the fast time responses and small sizes,
10 ms and 10 s of µm3 respectively (7).
Electroactive Neurochemicals
A small number of neurochemicals are inherently electroactive, the most impor-
tant being the neurotransmitter dopamine. Changes in the dopamine concentration
at the 100’s of nM level, can be detected by fast cyclic voltammetry at carbon fibre
electrodes (65). The high voltage scan rates that are used, give both sensitivity and
selectivity, as only the kinetics of dopamine oxidation are fast enough for detection.
Non-electroactive Neurochemicals
For non-electroactive neurochemicals, biosensors are used. A biosensor consists
of two parts: a molecular recognition component, such as an enzyme, and a signal
transducer, for example an electrode. Typically, biosensors operate amperometri-
cally at a constant potential, so a given analyte concentration gives an oxidation
flux of the enzyme that is reflected in the current produced by the electrode. This
has very good sensitivity. When fabricating a biosensor, the enzymes need to be in
close conjunction with the electrode to provide good sensitivity and stability of the
biosensor.
Interference
The basal levels of glucose and lactate in the brain have been recorded using
implanted biosensors, to be 300 and 100 µmolL−1 respectively (43, 62). The big
problem for biosensors studying neurochemicals is interference from other molecules,
which may also be present in the sample solution. There are more than 200 neu-
roactive compounds within the brain (7) and this places a strong requirement for
selectivity on any chemical sensor. As many biosensors are operated with a large
overpotential, interference from other electroactive species, such as the oxidation
of ascorbic acid, is a major problem for measuring glucose and lactate levels in the
brain. The concentration of ascorbic acid in the brain is typically 250 to 400 µmolL−1
(66), and hence the current produced by ascorbate can obscure any signal from the
analyte of interest. Diﬀerent approaches to improve selectivity include adding an
enzyme filter layer with ascorbate oxidase, as well as using size- and charge-selective
polymer films (43). Selectivity can also be achieved by using a sentinel electrode
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where the electrodes are self-referencing. Gerhardt developed a glutamate electrode
using microfabrication techniques, which had two recording sites, only one contain-
ing glutamate oxidase (67). A simple subtraction calculation eliminates background
eﬀects and interferences from unwanted molecules.
Calibration
Similar to a MD probe, in vivo calibration is a challenge due to tortuous diﬀu-
sion paths. The majority of groups rely on post experiment calibration. However,
neurotransmitters and other proteins may foul the electrode surface, reducing the
performance of the biosensor over time. Therefore the calibration of the sensor once
it has been removed from the tissue may not be representative of the sensor at
the time of recording. These are major challenges and need to be considered when
applying biosensors to an in vivo environment.
1.3.4 Comparison of Microdialysis and in vivo Biosensors
The two main approaches to neurochemical analysis will now be compared in terms
of important criteria for accurate and reliable measurements.
Damage
Many neuroanalytical animal studies involve using an in vivo sensor to target
specific regions of the brain. This is achieved with great accuracy due to their small
size. The damage caused upon implantation of a microelectrode is less than that of
implanting a MD probe (68, 69), and due to the lower consumption of molecules,
sensors do not aﬀect the local dynamics of the environment as much as a MD probe
could do. Both an in vivo sensor and a MD probe are invasive and the extent of
damage occurring upon implantation into the tissue depends upon the dimensions,
material sterility, and the perfusion fluid (7). The tracks of a microelectrode and
a MD probe, 7 days after initial implantation are shown in figure 1.11 (taken from
(69)). It is clear to see that the MD probe (figure 1.11b) causes much more damage
to the surrounding tissue than an implanted microelectrode sensor (same position
in figure 1.11a).
Blood flow and glucose metabolism decrease immediately after implantation but
given time this does recover (7). Initial damage from implantation may result in
disruption to the blood brain barrier however resealing usually occurs within 1-2
h. Implantation can next initiate an acute inflammatory response, where cells and
proteins of the immune system migrate to the sensor or probe and release reactive
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Figure 1.11: Damage upon implantation of a microelectrode and a MD probe
Microelectrode and MD probe placements verified with cresyl violet staining, 7 days following
implantation. A: a minor track produced by the microelectrode. B: a pronounced track produced
by the MD probe. Taken from (69)
oxygen species and enzymes that adsorb to the surface and lower sensitivity. The
acute immune response can last up to three days, and the formation of a fibrotic
capsule can block the sensor oﬀ from the environment. Use of biomolecules as the
molecular recognition element may also induce an immune mediated response, as
can the texture of the sensor. Fouling of the sensor or probe is due to reversible
or irreversible protein adsorption onto the sensor surface. This conditioning layer
endures and mediates all further interactions that occur at the surface (70). To
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eliminate the eﬀect of fouling, diﬀerent polymers applied to the biosensor have been
tested for compatibility (64, 71, 72) and a sentinel electrode is often employed (73).
Infection also creates a huge problem when inserting probes or sensors directly
into the tissue. Foreign body reactions of the tissue to the biomaterial of the sensor
can aﬀect the recordings (71). Kelly Drew found that implanting a MD probe into a
tissue caused up to 1.4 mm of damage surrounding the probe using light and electron
microscopy (74). Adrian Michael reported that the damage caused by a microsensor
is too small to be detected with a light microscope (75). The diﬀerence was put
down to the significant size diﬀerence, however, it was mainly due to infection, as
the microdialysis probe had been in the tissue for several months.
Sensitivity
Although implanted sensors have great sensitivity, they are often hindered by
noise. As discussed, the sensors are sensitive to other chemicals in the tissue, al-
though much has been done to exclude the interference signals. At very low con-
centration levels, the signal of the analyte can disappear into the background noise,
at which point not much can be done to improve it. Due to the nature of MD
sampling, it can be coupled to many other analytical techniques such as HPLC,
mass spectrometry or electrophoresis. This allows the collection of samples, which
increases the volume analysed, and hence the number of molecules. This improves
the sensitivity of the assay and allows multiple neurochemicals to be measured.
Time Resolution
The time resolution of microdialysis is often poor. Classical microdialysis in-
volves the hourly collection of samples. Here, the fast neurochemical changes cannot
be identified, only the overall trend. This has been improved upon by rsMD, which
analyses samples every 30-60 seconds on-line. However, it still does not compare to
the sub-second time resolution of an implanted sensor.
Spatial Resolution
MD has a spatial resolution of 100 µm3 (7). This is clearly much larger than
individual synapses, so MD levels reflect the responses within a local brain area.
Microelectrodes often see hot-spots and can have a spatial resolution down to 10
µm3 (7).
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Calibration
There is no good method for calibrating in vivo in either microdialysis or im-
planted sensors. The MD probe is dependent upon the recovery of molecules across
the membrane and the surrounding tissue. As the MD probe causes more damage
than an implanted sensor, the local tissue environment may change over time and
have an eﬀect on the recovery rates of the probe. Calibrating an implanted sensor is
also diﬃcult. Many rely upon an ex vivo calibration after the experiment, however
issues of fouling and interference from unexpected or unknown molecules may aﬀect
the interpretation of such a calibration.
Human Use
In human studies an in vivo sensor cannot be directly implanted into the brain
due to compatibility issues. The biosensors contain many substances (enzyme, im-
mobilising films etc.), which may be toxic and immunogenic. These molecules must
be proven to cause no adverse reaction in the tissue before use, which is a diﬃcult
task. Therefore, many use a microdialysis probe, as it is already FDA approved and
is easily sterilised. To date, no implantable sensor has been approved for clinical
use. Examples of sensors designed for monitoring the human brain include carbon
fibre monitoring of dopamine (76, 77), and biosensors for glutamate sensing (78),
proving that this method is exceptionally diﬃcult to implement.
1.3.5 A New Paradigm for Microdialysis
At present, for clinical monitoring we are restricted to using microdialysis. With
on-line microdialysis, the only format to give higher time resolution, there is often
a significant length (typically 1 m) of low volume connection tubing. At the low
flow rates used in microdialysis, this length results in a time lag between dialysate
leaving the brain and analysis, typically ten minutes. The flow rate is limited due to
pressure upon the membrane and is set at a compromising flow rate (between time
lag and recovery) of 2 µLmin−1 in the intensive care unit. A major problem is Taylor
dispersion, (79) which acts in continuous flows and is described in more detail in
chapter 6. Dispersion of molecules reduces the signal amplitude and broadens the
signal of transient changes, increasing the diﬃculty of analysis. The microdialysis
equipment and particularly the associated analysis instrumentation, is not suitable
for mounting on the animal or patient. The clinical rsMD system is described in
detail in chapter 2 and within clinical use, it is placed on a trolley behind the patients
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bed. Miniaturisation of the system would be preferable and may lead to a wearable
device that allows monitoring of patients not only at the bedside but as they recover
and begin to move around.
Whilst rsMD had improved the time resolution from classical microdialysis, a
continuous measurement of concentration levels would increase the time resolution
further. The small volumes involved with using microdialysis must be analysed
accurately and with an easily measurable output. The use of microelectrode-based
biosensors allows a fast response time with great sensitivity in the physiological
range within these small sample volumes. Coupling biosensors to microdialysis
would therefore be of great advantage, allowing rapid changes in metabolites to
be seen. This method would be highly translational between animal and clinical
studies, as biosensors could be combined with microdialysis to analyse the dialysate
continuously for several days due to the ability to frequently calibrate the biosensors
ex vivo. In this thesis, glucose and lactate biosensors have been combined with
microdialysis.
A method to address all of these problems could be the implementation of a mi-
crofluidic platform. Lab-On-Chip (LOC) devices aim to miniaturise a full chemical
laboratory onto a small device. Within the device all the manipulations and chem-
ical reactions for appropriate analysis takes place. This idea was first introduced
by miniaturising chemical electrophoresis onto a chip (80). Here, the channels were
micromachined using microphotolithographic techniques and samples were injected,
separated and detected on-chip.
The flexibility of design and usefulness in many diﬀerent areas, from pharma-
ceuticals and biotechnology, to defence and agriculture, has enabled microfluidics
to become very successful. Continuous flow microfluidic platforms have had great
success in use for kinetic studies (81, 82), on-chip polymerase chain reaction (PCR)
(83, 84, 85), diagnostics (86, 87) and cell studies (88, 89) due to the inherent advan-
tages of very small sample volumes, faster analysis times and low cost.
The aim in this thesis is to use a microfluidic chip, not only to miniaturise the
system, but also to remove many problems facing microdialysis users. Namely, those
caused by the long connection tubing that is often required: Taylor dispersion and
long time delays before analysis. More information on microfluidics can be found in
chapter 5.
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1.4 Outline of Thesis
The current clinical analysis system, rapid sampling microdialysis (rsMD), is de-
scribed in detail together with common methods and materials in chapter 2.
To improve the time resolution, a microelectrode-based biosensor is proposed
which will allow for continuous analysis of the microdialysate. The development
of small, integrated electrochemical cells using microelectrodes for the placement
within small flow channels is discussed in detail in chapter 3. Using these electrodes,
key biosensors, such as glucose, lactate and ATP, are fabricated. The performance
of the biosensors is discussed in chapter 4.
Digital microfluidics has been developed for use with a microdialysis probe to
eliminate the Taylor dispersion seen in the long lengths of connection tubing nec-
essary in a clinical ward. Chapter 5 discusses the implementation of a microfluidic
toolkit. This starts with a T Junction, which is used to generate droplets of mi-
crodialysate in oil. The droplets are transferred to a second microfluidic chip for
analysis. Digital microfluidics reduces the time lag (the time taken for the sample to
leave the probe in the brain and reach the analysis system) by using a fast flowing
oil stream and propelling the droplets to the analysis. This not only allows real time
analysis of the microdialysate but has the added advantage of allowing the perfu-
sion rate to be lowered, which in turn increases the recovery of the probe, without
aﬀecting the time lag. Further manipulations of droplets, such as dosing with stan-
dards and enzymes, are also discussed. Placement of electrodes within an analysis
chamber, designed to collect droplets and remove the oil, and the performance of
biosensors on-chip is described in chapter 6.
In chapter 7, the microfluidic system is tested in a pilot animal study using a
glucose biosensor in continuous flow. Here the glucose biosensor is validated against
rsMD glucose levels. Models of ischemia were used to investigate brain physiology in
a translational study and laser speckle was used to monitor blood flow whilst glucose,
lactate and potassium levels were also measured. Finally, the thesis ends with proof
of concept clinical data and a discussion about implementation and validation of the
microfluidic system in the clinical ward.
48
Chapter 2
Methods & Materials
2.1 Electrochemistry
Electrochemistry is the study of reactions that occur at the surface of an electrode.
It involves the exchange of electrons between the electrode surface and the solution
and it is generally dependent upon the potential applied to the electrode. The
transfer of the analyte towards the surface of the electrode occurs by diﬀusion down
a concentration gradient (the concentration being small at the electrode surface due
to consumption during the reaction). In transport limited conditions the movement
of electrons between the solution and the electrode can be measured as current,
which is proportional to the bulk concentration of reacting species. Electrochemical
methods oﬀer good spatial and temporal resolution and a continuous monitoring of
the analyte.
2.1.1 Cyclic Voltammetry
Cyclic voltammetry (CV) is a widely used electrochemical method and involves
linearly scanning the potential applied to the working electrode, up and down at
a constant rate, to oxidise and reduce the species at the surface of the electrode.
When a potential is reached where a reaction can occur, an increase in current is
seen. A typical waveform and CV is shown in figure 2.1. This can be used to study
the reversibility of the reaction, the analyte concentration and can provide some
detail of the surface and the geometry of the electrode. The CV in figure 2.1B,
was obtained using a cylindrical electrode (diameter 125 µm) in 1.5 mM ferrocene
monocarboxylate (Fc), recipe shown in section 2.4.1. As the potential is scanned
more positive, Fc is oxidised to Fc+ and Fc is depleted from the electrode surface
49
2. METHODS & MATERIALS
creating a concentration gradient. The peak current can be related to the diﬀusion
coeﬃcient, the number of electrons exchanged, the electrode surface area, the analyte
bulk concentration and the scan rate, by the Randles-Sevcik equation. Upon the
reversal of potential, Fc+ is reduced back to Fc, due to the reaction being reversible.
Standard redox couples such as, Fc, Hexaamine ruthenium (III) chloride (RuHex)
and potassium ferrocyanide (FeCN), are commonly used to assess the electrode
surface prior to biosensor fabrication. In this thesis, the electrodes were connected
in a three electrode cell, to a potentiostat which is controlled using EChem software.
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Figure 2.1: Cyclic voltammetry
A: shows a typical waveform used in cyclic voltammetry B: A typical CV produced using a platinum
electrode (125 µm diameter, 2 mm long) in 1.5 mM ferrocene monocarboxylate.
2.1.2 Amperometry
Amperometry is another commonly used electrochemical technique. Here, the elec-
trode is held at a constant potential and the current is monitored over time. In
this thesis, two common methods use this technique: electropolymerisation and
biosensor characterisation. These methods will now be described.
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Electropolymerisation
Electropolymerisation involves the application of a fixed potential to an elec-
trode, which triggers the polymerisation of monomers within the solution to join
together. More information on the electropolymerisation of immobilising films is
given in chapter 4.
A typical electropolymerisation trace is shown in figure 2.2. Electropolymerisa-
tion is particularly well suited to non-conducting films as growth of the polymer is
self-limiting and produces a relatively thin film.
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Figure 2.2: Electropolymerisation
The typical trace seen during electropolymerisation of a film to the electrode surface. 50 mM
phenol in PBS pH 7. 0 V for 20 seconds, 0.9 V for 15 minutes, 0 V until end.
Unless otherwise stated, the biosensors used in this thesis, contain an electropoly-
merised poly(phenol) film to entrap the enzymes close to the surface of the electrode.
The schematic of the polymerisation of phenol is shown in figure 2.3 (Image taken
from (90)). The oxidised phenol molecule creates a radical that couples to a second
phenol molecule creating a para-linked dimer radical. This can occur repeatedly to
form a polyphenol film. Once formed, if a high potential is applied to the electrode,
hydroxyl radicals can be formed and can mechanically break up the polyphenol film
(90).
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Figure 2.3: Polymerisation of phenol
A schematic of the polymerisation of phenol. Image taken from (90). The phenol molecule is
oxidise to form a phenoxy radical which couples to other phenol molecules forming a polymer film.
Biosensor Characterisation
The biosensors were assessed using standard amperometric techniques, in an
electrochemical cell with a silver silver chloride (Ag|AgCl) reference and Pt wire
auxiliary electrode, unless an integrated electrode was used (discussed in chapter
3). Experiments were carried out using an in-house potentiostat. All measurements
were performed at +0.75 V vs. Ag|AgCl in buﬀer (PBS pH 7.2, Krebs pH 7.4). For
calibrations, aliquots of substrate were added using a glass Hamilton syringe, under
stirred conditions. The step changes in current corresponded to the concentration
of substrate added.
The biosensors were placed in the flow cell (Radel or PDMS) and calibrated
using a syringe switcher to perfuse the electrodes with varying concentrations. The
biosensor was held at 0.75 V and connected to using an in-house potentiostat to
measure current. On-chip characterisation is discussed more in chapter 6.
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2.2 Rapid Sampling Microdialysis
Rapid sampling microdialysis (rsMD) is the current clinical analysis system used
to monitor dialysate from brain injury patients. A microdialysis (MD) probe is
inserted during surgery and is linked to a mobile bedside rsMD system via a 1 m
length of low volume FEP connection tubing. The dialysate stream was fed into
the rsMD valve, which alternates injections between enzymatic beds of glucose and
lactate, at 30 second intervals. Details of all the equipment used in rsMD will now
be given and a schematic is shown in figure 2.4.
2.2.1 Microdialysis Probe
A MD probe (CMA70, CMA Sweden) was inserted during a craniotomy, into the
area of tissue estimated to be the ischemic penumbra, on the basis of Xenon CT
scans. The probe was perfused using sterile aCSF (CMA Sweden) at 2 µLmin−1.
2.2.2 Injection Valve
The MD probe outlet was connected to 1 m FEP tubing (Thames-Restek, Bucks).
At the other end, a needle (22 gauge, 0.75 inches, Hamilton, Switzerland) is used
to connect the tubing into a port on the injection valve. The custom-made 6 port
valve (Valco Instruments, Schenkon, Switzerland, USA) has a 0.2 µL dual internal
loop. Standard solutions used for calibration are manually injected into the valve
using a Hamilton glass syringe.
The six ports are in pairs, one pair is the inlet and outlet of dialysate. Another
pair connects a Fc stream to a glucose enzyme bed reactor. And the final pair of
ports connects a Fc stream to a lactate enzyme bed reactor. As the valve switches
position, a sample of dialysate is injected into the Fc stream and carried to the
reactor.
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Figure 2.4: rsMD schematic
The rapid sampling on-line clinical analysis system. aCSF is perfused through a MD probe,
which is placed during surgery in the at-risk penumbral tissue. The dialysate is transferred via
approximately 1 m low volume connection tubing to the injection valve, which switches every 30
seconds. This injects a sample of dialysate into a FIA buﬀer stream containing Fc. The sample
passes through either a glucose or a lactate reactor and the radial flow cells contain electrodes used
to detect the reaction products.
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2.2.3 Enzyme Beds
Enzyme beds consist of membranes (6 mm discs) that are loaded with enzyme.
Reactors hold these membranes in place and are made from biocompatible filter
components with three sections - stainless steel body and two PEEK end fittings.
To load to the membranes with enzyme, the enzyme was dissolved in ferrocene
buﬀer and filtered several times through a 25 mm filter holder (Swinnex, Millipore,
UK) containing a mixed cellulose ester membrane (0.025 µm pore, 25 mm, Millipore
UK). A ring was placed in the filter holder to create a seal so that the enzyme must
pass through the membrane. When successful the membrane turns a yellowy colour,
as intensive filtering adsorbs the enzyme in the filter. Several membranes of 6 mm
diameter were then punched from the original using a hole punch. To prevent
drying, the membranes were stored in Fc solution in the fridge. Two membranes,
one containing the substrate oxidase (SOx) and the other HRP, were sandwiched in
the reactors. SOx must be the first membrane, in the direction of flow, to ensure
the biochemical reaction takes place.
2.2.4 Radial Flow Cell
The electrodes used in conjunction with rsMD were housed in a radial flow cell
(BAS, USA). The flow from the enzyme reactors passes through a stainless steel jet
auxiliary. A 3 mm glassy carbon working, is embedded in the radial flow cell, as is
a Ag|AgCl reference electrode. The working and auxiliary electrodes are separated
using a 16 µm teflon gasket.
2.2.5 Data Analysis
When the injected sample is detected at the electrode, changes in current are seen
as peaks. The amplitude of the peaks is related to the concentration of substrate
in the dialysate. A calibration curve is formed from injections of known standards
directly into the valve. The peak heights are then compared to the calibration curve
for conversion into concentration. The raw data is processed using Matlab where
algorithms are used to remove common noise artefacts such as spikes, ripples and
baseline drift (91).
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2.2.6 The Clinical Trolley
The clinical trolley is used to hold all the equipment necessary for bedside moni-
toring. The clinical trolley is shown in figure 2.5. The trolley consists of several
shelves to hold the electrical equipment: HPLC and syringe pumps, powerlabs and
an uninterruptible power supply (UPS). The solutions are held in a side tray in
bottles. The moveable arm contains the flow injection valve and enzyme beds in the
front compartment (open in the photograph) and the potentiostats are contained in
the back.
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Figure 2.5: The clinical trolley
The trolley houses all the equipment required for rsMD monitoring at the patients bedside.
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2.3 Microfluidics
2.3.1 Mask: Design and Fabrication
In collaboration with Dr Xize Niu, several designs to generate and rejoin the droplet
of dialysate were generated. The designs were drawn out using AutoCad (AutoDesk)
and a thin dark-film mask printed (Circuit Graphics). The mask is transferred to
glass layered with chromium, after which it can be used multiple times to create a
master. The channel designs are discussed in more detail in chapter 5.
2.3.2 Master Fabrication
A negative master is generated using 1:1 contact photolithography. Photolithogra-
phy uses light to create a pattern in a photoresist, and involves a series of chemical
treatments to engrave or deposit the pattern. A commonly used photoresist is SU-8.
This is a negative photoresist, which becomes insoluble when exposed to UV light,
due to cross-linking of long molecular chains. It is popular due to its excellent adhe-
sion to silicon, high stability, formation of near vertical walls giving high resolution
and its biocompatibility.
The masters used in this thesis are fabricated by spin coating SU8-2025 negative
photoresist (Microchem) onto a silicon wafer (3-inches diameter, Compart Technol-
ogy) at 3000 rpm and baking at 65 ◦C for 5 minutes, followed by 30 minutes at 90
◦C. The glass mask is placed firmly on top and is exposed to UV light for 20 seconds
and then baked for 1 minute at 65 ◦C and for 5 minutes at 90 ◦C. This is known
as post exposure baking (PEB). The master is then placed in a developing solution
(SU8 developer) for 2 minutes and blown dry using nitrogen gas. Silanization oc-
curs for 30 minutes, which changes the surface chemistry of the master so that it
is chemically inert, which allows the microfluidic chip to peel easily away from the
surface once cured.
2.3.3 Use of Chips
FC-40 oil was used as the carrier fluid in the experiments (unless stated otherwise)
and was motivated using precision syringe pumps (PHD2000 Harvard Apparatus).
A high-speed camera (Phantom V) attached to an inverted microscope, was used for
video acquisition and Matlab and ImageJ were used to analyse the recorded images.
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2.4 Materials and Reagents
2.4.1 Ferrocene Monocarboxylate
Ferrocene monocarboxylate (Fc) was used in rsMD to mediate the reaction occurring
in the enzyme beds. It was regularly made to avoid contamination and is kept in
the fridge. Fc was also used in some electrochemical techniques as a redox couple,
such as cyclic voltammetry, to assess the surface of the electrodes.
It was composed of sodium citrate (0.1 M, Sigma), ferrocene monocarboxylate
(1.5 mM, Fluka), EDTA (1 mM, Fluka), and sodium chloride (150 mM, BDH lab-
oratory supplied). The pH was adjusted to pH 7.0 using 1 M hydrochloric acid. If
the solution was for use at the hospital, 0.5 ml of 5-chloro-2-methyl-4-isothiazoline-
3-one (Kathon CG, Rohms and Hass) was added as an antibacterial agent, and the
solutions were filtered with membrane filters (0.1 µm and 0.02 µm 47 mm Anodisc,
Whatman International Ltd) to avoid blocking of the small bore tubings.
2.4.2 Hexaamine Ruthenium (III) Chloride
Hexaamine ruthenium (III) chloride (denoted in this thesis as RuHex) was used a
redox species in electrochemistry to assess the performance of the working electrodes.
1 or 10 mMRuHex (Sigma) was dissolved in 0.1 M or 1 M potassium chloride (Sigma)
respectively (Ru(NH3)6Cl3). Before use the solution was de-oxygenated by purging
with nitrogen gas for 20 minutes.
2.4.3 Potassium Ferrocyanide
Potassium ferrocyanide (denoted in this thesis as FeCN) was also used as a redox
species in electrochemistry to assess the electrode performance. 1 or 10 mM FeCN
(Sigma) was dissolved in 0.1 M or 1 M potassium chloride respectively (K3Fe(CN)6).
2.4.4 Phosphate Buﬀer Solution
Phosphate buﬀer solution (PBS) was used during biosensor calibrations. It was com-
posed of 150 mM sodium chloride and 100 mM di-sodium hydrogen orthophosphate
2 hydrate (Sigma). The pH was adjusted to 7.2 using 0.1 M sodium hydroxide.
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2.4.5 Artificial Cerebral Spinal Fluid
Artificial cerebral spinal fluid (aCSF) was used as the dialysate in brain injury
microdialysis. It consisted of a physiological saline with the following concentrations.
150 mM sodium chloride, 3 mM potassium chloride, 2.5 mM calcium chloride and
1.8 mM magnesium chloride.
2.4.6 Krebs Buﬀer Solution
Experiments involving ATP biosensors were carried out using Krebs buﬀer solution.
Krebs composition consisted of 117 mM sodium chloride, 4.7 mM potassium chloride,
2.5 mM calcium chloride, 1.2 mM magnesium chloride, 1.2 mM sodium dihydrogen
phosphate, 25 mM sodium bicarbonate and 11 mM glucose. pH was adjusted to pH
7.4
2.4.7 Substrate Standards
Standard solutions of glucose, lactate and ATP (all from Sigma-Aldrich) were dis-
solved into PBS for biosensor calibrations. For animal and clinical studies, standards
were dissolved into aCSF and for ATP studies, into Krebs solution.
59
2. METHODS & MATERIALS
60
Chapter 3
Development of Microelectrodes
3.1 Introduction
The aim of this thesis is to develop a microfluidic system with incorporated elec-
trochemical sensors for the continuous measurement of dialysate from brain injury
patients. The electrochemical cell was changed in design to improve both the bio-
chemical measurements and for incorporation on the microfluidic analysis chip. This
chapter will focus only on the development of the electrodes used throughout this
thesis.
3.1.1 Working Electrode Material
As a sensing element of a biosensor, the electrode material must be sensitive to
the reaction of interest. Biosensors are described in detail in chapter 4, but the
molecule that the electrode will detect (a product of the enzymatic reaction) is
hydrogen peroxide (H2O2) and this will be discussed in this section.
Whilst there are many potential materials to use for an electrode the fabrication
process limits the choice by material and size. Easily fabricated electrodes could
include carbon fibre, gold and platinum. Carbon fibre electrodes are often used
to study neurochemistry. Neurotransmitters are easily oxidised and therefore easily
measured on a carbon fibre electrode which are frequently used to monitor molecules
such as dopamine (92, 93, 94).
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The ability of the electrodes to respond to H2O2 was characterised by the step
changes in current following the addition of increasing concentrations of H2O2 over
time. A calibration curve was thus obtained. It is known that carbon fibre and gold
do not oxidise H2O2 at a useable rate at a low potential and figure 3.1 compares
the response at a platinum and a gold electrode. Indeed, platinum exhibits a good
response with higher sensitivity towards H2O2 as compared to gold. Platinum was
therefore selected as the material of choice for the working electrodes, which are
used in this thesis.
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Figure 3.1: Hydrogen peroxide calibration on platinum and gold electrodes
0.5 mM, 1 mM, 2.5 mM, 5 mM, 7.5 mM, 10 mM, 15 mM, 20 mM, 30 mM, 50 mM step changes in
H2O2 concentration occurring every 50 s. The response of a 50 µm electrode is recorded.
H2O2 is oxidised by platinum at a low potential and the electrons transferred to
the electrode produce a measurable current. The reaction of H2O2 at the surface
of the platinum electrode is an adsorption controlled mechanism (95). The overall
reaction is shown in equation 3.1.
Pt+H2O2 −→ Pt+ 2H+ + 2e− +O2 (3.1)
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This is a two step process. When a potential of 0.7 V is applied to a platinum
electrode the reaction, shown in equation 3.2, occurs. When hydrogen peroxide is
present the reaction, shown in equation 3.3, occurs as soon as possible.
Pt+ 2H2O −→ Pt(OH)2 + 2H+ + 2e− (3.2)
Pt(OH)2 +H2O2 ￿ Pt+ 2H2O +O2 (3.3)
This cyclic reaction constantly supplies two electrons to the platinum surface for
as long as hydrogen peroxide is available. The reaction can also be broken down
into an absorption step (equation 3.4) and a reduction step (equation 3.5).
Pt(OH)2 +H2O2 ￿ Pt(OH)2.H2O2 (3.4)
Pt(OH)2.H2O2 −→ Pt+ 2H2O +O2 (3.5)
This mechanism is therefore analogous to a Michaelis-Menten enzyme mechanism
and hence surface availability (in the form of Pt(OH)2 sites), which catalyses the
conversion of hydrogen peroxide to water can limit the rate of reaction. If the sites
are saturated with hydrogen peroxide then the rate of reaction is at its maximum,
known as Vmax. This leads to complications such as competition for the reaction
sites, which could potentially lead to fewer points where the hydrogen peroxide
can be detected, ultimately leading to a lower sensitivity, as seen in figure 3.2.
One such competing reaction is shown in equation 3.6. This removes the active
Pt(OH)2 sites but does not produce the inactive Pt species. Hence, the overall
reaction cannot occur and sensitivity is low. Another competing reaction is shown
in equation 3.7. At low hydrogen peroxide concentrations this is not a problem as the
concentration of Pt(OH)2.H2O2 is low. However when the level of Pt(OH)2.H2O2
increases, production of the protonated complex can occur. This species cannot
undergo the reaction step and the current signal is lost.
Pt(OH)2.(hydroxidegroups) +O2 ￿ Pt(OH)2.O2 (3.6)
Pt(OH)2.H2O2 +H
+ ￿ Pt(OH)2.H2O2.H+ (3.7)
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Figure 3.2: Surface species for hydrogen peroxide oxidation on a platinum surface
Figure taken from Hall et al (95). Concentration of diﬀerent species on the surface of a platinum
electrode are shown as the bulk concentration of hydrogen peroxide increases.
3.1.2 Microelectrodes versus Macroelectrodes
Microelectrodes and macroelectrodes are defined by their dimensions (micrometre
and millimetre respectively). The currents seen at a microelectrode are typically
pA or nA, and are several orders of magnitude smaller than the currents passed
at a macroelectrode. The diﬀerence in size causes diﬀerences in diﬀusional mass
transport. At a macroelectrode the diﬀusion of molecules to and from the surface is
planar. Reducing the size to a microelectrode means that the enhanced edge eﬀects
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transform the diﬀusion field into a hemispherical shape and the dimensions of the
diﬀusion field around a microelectrode, exceed the dimensions of the electrode itself.
Subsequently the flux of molecules to the electrode surface is significantly higher than
the flux to a macroelectrode. This eﬃciency of mass transport allows steady-state
observations at low scans rates during cyclic voltammetry.
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Figure 3.3: Schematic of the diﬀusion field of electrodes
The electrodes are shown in blue and the diﬀusion of molecules to the surface of the electrode is
indicated by the arrows. Diﬀusion to a macroelectrode is planar whereas the diﬀusion field to a
microelectrode is hemispherical.
3.1.3 Microelectrode Theory: Inlaid Microdisk
At a suﬃciently long time the solution to the convective diﬀusion equation for an
inlaid micro disc electrode is given by equation 3.8.
I = 4nFDrC (3.8)
Where n is the number of electrons transferred, F is the Faraday constant (96487
Cmol−1), D is the diﬀusion coeﬃcient, r is the radius of the microelectrode and C
is the concentration of the species involved.
The diﬀusion coeﬃcient for ferrocene monocarboxylate (Fc) used, was 5.73 x
10−10 m2s−1 found in Bartlett and Pratt 1995 (96), which experimentally finds the
diﬀusion coeﬃcient for FeCOOH for cyclic voltammetry and ring disk experiments.
The diﬀusion coeﬃcient for hexaamine ruthenium (III) chloride (RuHex), used is 7.7
x 10−10 m2s−1 from Beriet and Pletcher, 1994 (97) and for potassium ferrocyanide
(FeCN), 6.5 x 10−10 m2s−1 also taken from (97). As hydrogen peroxide will be
detected at the electrode surface this too is included here. The process involves a
two electron transfer with a diﬀusion coeﬃcient of 1.3 x 10−9 m2s−1 (98).
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A summary of the current expected at diﬀerent sizes of electrodes for these
diﬀerent species is shown in table 3.1, based on equation 3.8.
Table 3.1: Currents expected from inlaid microdisc electrodes
Electrode Diameter / µm Concentration / mM Current / nA
Ferrocene monocarboxylate
125 1.5 20.7
50 1.5 8.3
25 1.5 4.2
125 1 13.8
50 1 5.5
25 1 2.8
Hexaamine ruthenium (III) chloride
125 1 18.6
50 1 7.4
25 1 3.7
Potassium ferrocyanide
125 1 15.7
50 1 6.3
25 1 3.1
Hydrogen peroxide
125 1 62.7
50 1 25.1
25 1 12.5
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3.1.4 Microelectrode Theory: Hemispherical Electrode
If the electrode is not flat, but curved in shape, it is said to be hemispherical in
geometry. The equation to find the current (I), which is expected when using a
hemispherical electrode, is given by equation 3.9.
I = 2πFDrC (3.9)
Where F is the Faraday constant (96487 Cmol−1), D is the diﬀusion coeﬃcient,
r is the radius of the electrode and C is the concentration of the species used.
Using the diﬀusion coeﬃcients from before, table 3.2 has been created to indicate
how much current would be expected from a hemispherical disc electrode. These
theoretical currents have been used in this thesis to assess the results obtained from
characterising the electrodes in table 3.4, section 3.3.3.
Table 3.2: Currents expected from hemispherical electrodes
Electrode Diameter / µm Concentration / mM Current / nA
Ferrocene monocarboxylate
125 1.5 32.5
50 1.5 13.0
25 1.5 6.5
125 1 21.7
50 1 8.7
25 1 4.3
Hexaamine ruthenium (III) chloride
125 1 29.2
50 1 11.6
25 1 5.8
Potassium ferrocyanide
125 1 24.6
50 1 9.9
25 1 4.9
Hydrogen peroxide
125 1 49.2
50 1 19.7
25 1 9.9
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3.2 Cylindrical Electrodes
The first approach, of incorporating microelectrodes into the clinical system for
analysis of low volume and low flow rate dialysate, was to use a wire in a fine bore
tube. This created a cylindrical electrode within a flow cell and a schematic is shown
in figure 3.4.
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Figure 3.4: Schematic of a radel flow cell
The schematic shows a cross section through a Radel tubing flow cell. The walls of the tubing
are shown in yellow. The electrode is threaded inside with the exposed surface (red) close to the
entrance of the flow cell. The insulation is shown in blue.
Cylindrical electrodes have the advantage of a large surface area, which gives an
easily measurable current. The electrodes were arranged into a flow cell designed to
attach to the rsMD outlet. This was to achieve a continuous recording of glucose
and lactate levels using biosensors, described in chapter 4.
3.2.1 Fabrication of Electrodes
Platinum/iridium wire (Advent) insulated with Teflon (125 µm diameter) and plat-
inum wire (A-M Systems Inc) insulated with Teflon (50 µm diameter) were used to
create working electrodes. The insulation was removed either by cutting the insu-
lation with a scalpel or by melting the insulation with a lighter. This exposed the
wire to create a cylindrical electrode, which was then cut to size. The insulation was
removed from the opposite end and an IC socket (RS components) was soldered on
as a connector. The silver wire (50 µm, Advent) was chloridised using potassium
dichromate solution (BAS Inc USA) to produce a Ag|AgCl reference electrode. To
assess the electrode prior to use, cyclic voltammetry was used which investigated
properties such as CV shape, peak height and peak separation. Figure 3.5 shows a
typical CV of a cylindrical wire in 1.5 mM Fc.
The main problem of electrode fabrication was the precise exposure of electrode
surface by removing the Teflon insulator. The main method used was scraping the
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Figure 3.5: CV of a cylindrical electrode
The potential is scanned from 0 V to 0.6 V at a rate of 100 mVs−1 at a 2 mm long cylindrical wire
electrode of diameter 125 µm, in a solution of 1.5 mM ferrocene monocarboxylate.
Teflon oﬀ with a scalpel. However, SECM images of the wires showed that this
can scratch the surface of the electrode and can also stretch and tear the Teflon,
figure 3.6. Therefore, later versions were created by shrinking the Teflon via heat,
to expose the wire. The wire was then cut to a specific length under a microscope.
The average limiting current for the 2 mm cylindrical electrodes with a diameter of
125 µm is 2.21 ± 0.57 µA (n=62). The majority of the error in this reading, comes
from the scratching the surface and reproducibly cutting to 2 mm in length.
Figure 3.6: SECM image of the cylindrical electrode
SECM was used to image the electrode surface and Teflon insulator, after exposing the surface
using a scalpel. Note the scratches on the surface and the stretching and tearing of the Teflon.
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3.2.2 Fabrication of Radel Flow Cell
Radel tubing was used for multiple reasons. The outer diameter is 1/16”, which is
compatible with HPLC fittings used in the rsMD system. This makes attachment
to the rsMD system easy. The tubing is also transparent, so any bubbles forming
on the electrode can be seen. Furthermore, it allows for the easy placement of the
wires within the tubing.
A flow cell containing the three electrodes was fabricated using RadelTM tubing
(UpChurch Scientific) in a conformation optimal for electrochemical measurements,
figure 3.7. In this way a dialysate stream was passed through the flow cell and
perfused the electrodes. There were two configurations for the incorporation of the
reference electrode. Initially the reference electrode was wound into a ball using 125
µm diameter wire and placed outside the flow cell. Later, the reference electrode
was fabricated from a thinner wire (50 µm) and placed within the flow cell itself.
!"#$%
&'%()*+,-.
/01,2,3*4
5676*6-'6
/ 8
9
Figure 3.7: Radel flow cell photographs
A: A close up of the 2 mm long cylindrical working electrode within 0.03” radel tubing. B: In
the first design of the flow cell, the reference electrode was curled into a ball at the outlet of the
tubing. Later it was incorporated within the lumen of the radel tubing using a 50 µm wire. C: The
complete radel flow cell, with all three electrodes within the tubing. Note that for all photographs,
the direction of flow is from left to right.
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3.2.3 Characterisation of Cylindrical Electrodes within a
Radel Flow Cell
The electrode placement was tested under flow conditions using a bare platinum
cylindrical electrode and a common redox species, Fc. Perfusion solution alternated
between PBS and 1.5 mM Fc using a syringe switcher. The electrodes were con-
nected to a potentiostat and the working electrode was held at a potential of 0.75 V
to oxidise the Fc. The current was recorded as the solutions changed. The response
of the flow cell at diﬀerent flow rates is shown in figure 3.8.
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Figure 3.8: Radel flow cell response to alternating Fc and PBS at diﬀerent flow rates
A 2 mm long bare platinum electrode (diameter 50 µm) was assembled into a flow cell, which was
perfused with buﬀer solution. The electrode was held at 0.75 V and the solution was switched
to 1.5 mM Fc. The change in current was recorded. The flow rate of both the PBS and the Fc
solution was changed. Flow rates used were 10, 5, 2, 1 and 0.5 µLmin−1.
As expected the results depended upon the flow rate. With larger flow rates,
the 90 % response time (T90) is smaller and the current detected is larger. This
is due to the mass transport of Fc being enhanced by the higher convective flow.
At a higher flow rate, the change in solution occurs more quickly and molecules
are being supplied to the surface of the electrode at a faster rate, increasing the
current. However for use with microdialysis, a problem occurs. At faster flow rates,
the microdialysis probe has a lower recovery and in the clinic a compromising flow
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rate of 2 µLmin−1 is used. By considering the flux (J) delivered by the flow, the
theoretical current that is produced at varying flow rates can be calculated and
compared to the experimental data (equation 3.10).
I = nFJ (3.10)
For 1.5 mM ferrocene monocarboxylate, at a flow rate of 1 µLmin−1, the flux to
the electrode is given by equation 3.11.
Flux(J) =
1.5× 10−3
106
× 1
60
= 2.5× 10−11 (3.11)
Table 3.3 shows the theoretical and experimental current response seen upon
perfusing 1.5 mM Fc solution at varying flow rates. At 0.5 µLmin−1, the oxidation
of Fc at the electrode gives the maximum current predicted by our calculation.
However, at a flow rate of 10 µLmin−1, only a sixth of the maximum current is
being recorded. This is due to the convection flow carrying away the molecules
before they can be detected by the electrode. In the intensive care ward, the flow
rate used is 2 µLmin−1, and at this rate the sensor only records half of the possible
current.
Table 3.3: Flow cell results: T90 and current against flow rate
Flow rate / µLmin−1 T90 / s Theoretical I / µA Experimental I / µA
10 13 24.12 4.05
5 23.4 12.06 3.36
2 46.4 4.82 2.66
1 76.2 2.40 2.16
0.5 153 1.21 1.61
Although the currents produced are large (µA), which allows for easy recording,
the response time is long at the slower flow rates. At 2 µLmin−1, the T90 is 46.4 s.
This would be too slow to resolve the dynamic changes expected. The slow responses
are due to a volume eﬀect at the electrode. The volume surrounding the electrode
(250 µm diameter tubing, 50 µm diameter 2 mm length wire) is 0.375 µL. At 0.5
µLmin−1, this would take 45 s to fill. This is too large a volume for the range of flow
rates required. However, it would be extremely diﬃcult to make it smaller using
the same approach. Therefore, microfabrication of disc electrodes and flow cells was
used to create smaller volumes.
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3.3 Needle Electrodes
A second approach was to use a microdisk electrode. Smaller electrodes were de-
sirable to take advantage of the benefits of using a microelectrode - namely the
enhanced sensitivity due to the geometry of the electrode. Disc electrodes were cre-
ated using a method developed by the O’Hare group (99). These disc electrodes are
held by epoxy resin within a blunted needle, which can be polished to give a smooth
surface. A photograph of a needle electrode is shown in figure 3.9.
1cm
Figure 3.9: Photograph of a combined needle electrode
27 gauge hypodermic needle. Contains a platinum wire (diameter 50 µm) and a silver wire (di-
ameter 50 µm) threaded through, sealed in with glue. Tip is polished flat to give a disc electrode.
Once cured needles can also be bent for easier placement in flow cells.
3.3.1 Needle Electrode Fabrication: Working Electrode
Teflon insulated platinum wires (A-M Systems Inc., US) were threaded through a
hypodermic needle. The wires were stripped of their insulator using a lighter to
expose the metal. The platinum wire and an electrical wire were either soldered
together within a glass capillary or glued together using a conductive silver epoxy
glue (RS Components). Epoxy resin (Robnor resins, CY1301 and HY1300) was
used to fill the internal volume of the needle and secure the wires in place. The
two solutions of the epoxy resin, were mixed thoroughly together and a desiccator
was used to remove any bubbles formed in the mixing process. The needles were
connected by a piece of tubing to a second hypodermic needle, which was used to fill
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the internal space and fix the wires in place. The two connected needles were secured
in an upright and level position. This prevented the epoxy resin from leaking out.
The needles were left to cure at room temperature for two days.
Once the epoxy had cured, the sharp end of the needle was cut using a diamond
saw (Buehler) to expose the platinum microelectrodes. The ends were polished
using alumina slurries. First, a 1 µm slurry was used. The electrode was held flat
against the polishing pad and moved in a figure of 8. This was repeated 25 times
and then the needle rotated by 90 ◦. This whole process was repeated 4 times. The
electrode tip was cleaned in distilled water in a sonicator to remove any particle
of the slurry, which may be stuck to the surface. The tip was then polished using
0.3 µm alumina slurry in the same way. Finally, 0.05 µm alumina slurry was used.
Cyclic voltammetry was used to assess the surface of the electrode and the electrode
was re-polished until a satisfactory CV was achieved. Diﬀerent sized platinum wires
could be threaded though the hypodermic needles to create diﬀerent diameter disc
electrodes. Three sizes were commonly used, 125 µm, 50 µm and 25 µm diameter
platinum wire.
3.3.2 Needle Electrode Fabrication: Reference Electrode
Reference electrodes were also fabricated in the same way, using silver wire instead
of platinum. Once polished flat using all three grades of alumina slurries, the silver
disc was chloridised by placing in Chloridising Solution (BAS) for 5 seconds, to
create a Ag|AgCl reference electrode.
3.3.3 Characterisation of Platinum Disc Electrodes
The platinum working electrodes were characterised using cyclic voltammetry. The
stainless steel shaft of the hypodermic needle was used as an auxiliary electrode
and the reference electrode was a Ag|AgCl created in a second hypodermic needle.
Figure 3.10 shows CVs conducted in a beaker, from disc electrodes of various sizes.
10 mM RuHex was bubbled with nitrogen to purge the solution of oxygen. CVs
were formed by scanning from 0 V to -0.4 V, where the direction was reversed to
bring the potential back to 0 V. The shapes produced are characteristic of disc
electrodes. The smallest electrode (25 µm diameter) gives a tighter shape as it
reached a steady state more quickly than a larger electrode.
Table 3.4 gives an overview of the average currents obtained from diﬀerent sized
electrodes in both Fc and RuHex. For comparison to the theoretical currents for an
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Figure 3.10: Disc electrode CVs using hexaamine ruthenium (III) chloride
10 mM Hexaamine ruthenium (III) chloride in 1 M KCl. 10 mVs−1 scan rate. A: 125 µm platinum
disc electrode B: 50 µm platinum disc electrode C: 25 µm platinum disc electrode.
inlaid microelectrode see table 3.1 and for the predicted currents of a hemispherical
electrode see table 3.2. The currents seen at a 125 µm disc electrode are larger than
the predicted value of an inlaid microelectrode of this size. The values obtained
using RuHex suggest that the polishing of the electrode was not producing a flat
disc but a hemispherical disc. Overtime, my polishing technique got better and the
currents became closer to the value expected, as indicated by the smaller standard
deviation of the CVs performed in Fc. A hemispherical electrode can be produced
by applying more pressure to the edges of the needle, most likely due to tilting the
angle of the needle on the polishing pad. This means that the edges are polished
more than the middle, thereby creating a dome shaped end.
Table 3.4: Limiting currents and electrode sizes
Redox species Electrode diameter/µm Current ± sd / nA
Fc / 1.5mM 125 24.5 ± 5.2 (n=10)
Fc / 1.5mM 50 10.9 ± 2.9 (n=62)
Fc / 1.5mM 25 6.3 ± 1.7 (n=125)
RuHex / 10mM 125 343 ± 56.9 (n=4)
RuHex / 10mM 50 83.1 ± 39.1 (n=6)
RuHex / 10mM 25 44.3 ± 9.2 (n=22)
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The 50 µm disc electrode produced currents between the expected currents for
an inlaid disc and a hemispherical electrode. This may be due to polishing the
needle at an angle producing a flat end but an oval shaped electrode. Therefore the
surface area increases but not to the same extent as a hemispherical electrode.
The 25 µm disc electrode were extremely hard to polish as the needle tip is so
fine and easily bent. The currents produced indicate that a hemispherical electrode
geometry was created. Table 3.5 shows an overview of the limiting currents obtained
at six 25 µm needle electrodes in 1.5 mM ferrocene monocarboxylate. In between
each CV, the electrodes were used during an experiment and re-polished. As a
reminder: the current expected at an in-laid 25 µm disc electrode is 4.2 nA and
with a hemispherical geometry 6.5 nA. Four out of the six electrodes gave currents
of that expected from a hemispherical electrode geometry. One electrode gave a
higher current but it had a large variability, indicating that the fabrication of the
electrode was not particularly good. One electrode consistently gave a lower current
than the others. However, the current is still higher than that expected at an in-laid
microdisc and closer to that of a hemispherical electrode.
Table 3.5: 25 µm diameter microelectrode intra-current summary
Electrode Current ± sd / nA
1 6.7 ± 1.1 (n=20)
2 6.6 ± 1.2 (n=14)
3 8.5 ± 4.1 (n=7)
4 6.4 ± 1.5 (n=16)
5 5.7 ± 1.4 (n=24)
6 6.4 ± 1.4 (n=12)
In conclusion, the 125 µm electrode was not used a great deal due to the need for
miniaturisation of the electrodes. These electrodes were mainly used for practising
the construction of the syringe needles and my polishing technique. The 50 µm
electrodes were easier to polish to a flat disc than the 25 µm electrodes due to
the size and strength of the larger sized hypodermic needle used. Most of these
electrodes produced currents that are expected of a hemispherical electrode.
76
3.4 The Combined Needle Electrode
3.4 The Combined Needle Electrode
To save space and create a smaller electrode system for placement in a flow cell,
a combined needle electrode was created. This includes all three electrodes for an
electrochemical cell, the working (Wrk), the reference (Ref) and the auxiliary (Aux)
electrode; a photograph is shown in figure 3.11.
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Figure 3.11: Photograph of needle electrodes
Combined needle electrodes in 3 diﬀerent sizes. The 25 gauge needle contains a 125 µm Pt wire
and 125 µm Ag wire. The 27 gauge needle contains a 50 µm Pt wire and a 125 µm Ag wire. The
30 gauge needle contains two 25 µm Pt wires and a 50 µm Ag wire.
3.4.1 Method of Fabrication
Both the silver wire and the platinum wire were threaded through the hypodermic
needle. As the wires were so fragile and the syringe needle so small, the connections
could no longer be soldered in glass capillaries to be sealed. Therefore, they were
individually glued together using a silver loaded epoxy adhesive (RS Components),
which is a conductive glue and was cured at 65 ◦C for 4 hours. The connections
were then glued to the inside of the syringe needle using Araldite glue before the
epoxy resin sealed all the wires in place.
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This was to ensure that there was no connection between the wires, which would
cause a short circuit. Once cured, the electrodes were prepared using the same
method as before. Figure 3.12 shows an SECM image of a needle electrode tip
containing both a silver and a platinum wire, polished flat to give a disc.
Figure 3.12: SECM image of a 30G electrode tip
30 gauge needle electrode (outer diameter 311 µm) with a 50 µm silver disc (coated diameter 75
µm) for use as a reference and a 25 µm platinum electrode (coated diameter 27 µm) used a working
electrode.
Table 3.6 provides the hypodermic syringe needle sizes (gauge and internal and
external diameters) used in this thesis. Table 3.7 gives information on the wires
used (diameters of coated and uncoated wires shown) in the fabrication of needle
disc electrodes.
Table 3.6: Needle sizes: gauge and diameters
Needle / G Internal / µm External / µm
25 260 514
27 210 413
30 159 311
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Table 3.7: Wire sizes: diameters of coated and uncoated
Material Insulator Coated diameter / µm Bare diameter / µm
Pt/Ir Teflon 200 125
Pt/Ir Teflon 75 50
Pt Isonel 27 25
Ag PTFE 235 200
Ag Teflon 177 125
Ag Polyester 75 50
3.4.2 Chloridising Reference Electrode
The main problem of combining the electrodes within one needle was how to chlo-
ridise the silver wire to form the reference electrode, without aﬀecting the other
electrodes. The potassium dichromate solution used for chloridising the silver wire,
also oxidised the working and auxiliary electrode. Therefore, both of these needed
to be cleaned after the chloridisation and before use. I could not re-polish, as this
removes the chloridised layer on the silver electrode. Therefore, I dipped the con-
struct into diluted hydrochloric acid (1 in 10 dilution). This removed the oxide layer
from the working and the auxiliary electrodes but not from the reference electrode.
However, if the electrodes were in the acid solution for too long the stainless steel
shaft could be eroded. The needle was rinsed thoroughly with water before use.
Some of the combined electrodes exhibited a previously unseen peak at ± 0.1 V,
seen in figure 3.13. This is a result of some silver atoms transferring to the platinum
working electrode during polishing. I have found that subsequent sonication can
remove these atoms to give a clean CV. However, the reference electrode needs to
be re-chloridised and the acid cleaning process repeated.
3.4.3 Validation
To check whether using a combined electrode in this conformation is viable, CVs
in Fc were conducted using external reference and counter electrodes, Figure 3.14.
These scans were then compared to the CVs obtained using the combined electrode.
A problem found with these constructs is that heat cannot be applied to electrode
after it has been cured, for example to solder on a connection. Heat causes any air
bubbles left in the epoxy resin to expand, deforming and cracking the epoxy resin.
This can potentially break the fine wires used. Figure 3.15 shows an example of
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Figure 3.13: CV showing silver molecules on the working electrode.
50 µm platinum disc in 1 mM potassium ferrocyanide in KCl, using an external reference and
auxiliary electrode. Scan rate 10 mVs−1. The peaks at ± 0.1 V indicates silver on the working
electrode.
this. After soldering on a connection lead to the stainless steel shaft of the needle
to create the auxiliary electrode, the epoxy glue deformed and pushed out from the
needle. The silver wire can still be seen at the tip, indicating the wire has snapped.
Any connections made after curing the epoxy resin, were therefore created using
silver epoxy (RS Components), which is a conductive glue that can be left at room
temperature to cure.
The combined electrode is an eﬀective method of incorporating all three elec-
trodes into one construct, which is easy to place in a flow channel. Using the
stainless steel shaft as the auxiliary and a chloridised silver disc as the reference
has been tested and compared to external electrodes. The CVs were very similar,
indicating that this is a good method of miniaturisation.
The method of fabrication has been optimised so that now, 30G syringe nee-
dles can be used with a 25 µm platinum disc as a working electrode. This allows
optimisation of the flow cell used, which is described in chapter 5.
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Figure 3.14: CVs using external and internal reference and auxiliary electrodes.
1.5 mM ferrocene monocarboxylate. Scan rate 10 mVs−1. 25 µm platinum disc electrode.
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Figure 3.15: Photograph of an integrated needle electrode after exposure to heat
A soldering iron was used to solder a connection onto the end of the electrode wires. Due to the
heat expanding any air in the epoxy glue, the filling including the electrodes has been pushed out
from the needle.
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3.5 Dual Electrodes
To increase the number of potential recordings, dual electrodes were fabricated. This
involved placing two platinum wires (25 µm) and one silver wire (50 µm) into the
syringe needle (30G) and following the same procedure that was used to create the
previously discussed versions of the needle electrodes.
3.5.1 Crosstalk
The dual electrodes were assessed using cyclic voltammetry in 1.5 mM Fc. Whilst
each electrode produced a satisfactory CV individually, cross talk between the elec-
trodes was found to occur when run simultaneously, aﬀecting the current seen at
each electrode. This is due to the inter-electrode distance being small enough for the
diﬀusion fields of each electrode to overlap. Figure 3.16 shows photographs of dual
electrodes taken using a microscope and a schematic of the diﬀusion field overlap,
which leads to cross talk. Each electrode is a 30G syringe needle with an outer
diameter of 311 µm.
As the relative positioning of the working and reference electrodes within the
needle cannot be controlled, each electrode made was individually assessed. This
involved photographing each electrode under a light microscope so the relative posi-
tions are known and characterising each electrode in terms of cross talk using cyclic
voltammetry. The combined dual electrodes were placed in a beaker of 1.5 mM Fc
and the potential at one electrode was scanned from -0.1 V to +0.5 V at a scan rate
of 1 mVs−1. The second electrode was held at 0 V. The currents at both electrodes
were recorded simultaneously. Figure 3.17 gives an example of the CVs from a dual
electrode assessed in this way and table 3.8 shows the collection eﬃciencies derived
from the dual electrodes.
Both working electrodes show a response, even though one electrode is held at 0
V. As the potential at the scanning electrode becomes more positive, the ferrocene
is oxidised to produce Fc+. This gives the characteristic CV. At the same time,
however, the second electrode also exhibits a negative response. This is because the
product of the scanning electrode, Fc+, diﬀuses to the second electrode where it can
be reduced back to Fc at 0 V. Therefore a reduction curve is seen. The percentage
of product that the fixed potential electrode picks up compared to the current seen
at the scanning electrode, is known as the collection eﬃciency.
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Figure 3.16: Photographs of the dual electrodes taken using a microscope
Each electrode contains two 25 µm platinum working electrodes and one 50 µm silver electrode.
The stainless steel shaft of the 30 G syringe needle is used for the auxiliary. The schematic
illustrates two electrodes with the diﬀusion fields overlapping. This leads to cross talk when the
electrodes are run simultaneously.
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Figure 3.17: CVs in 1.5 mM Fc showing cross talk of dual electrodes
Dual electrode, D3, in 1.5 mM Fc. D3A (orange) is held at 0 V through the experiment. D3B
(red) has a ramped potential applied at a scan rate of 1 mVs−1. Cross talk is seen by the response
at the electrode held at a constant potential.
Table 3.8: Collection eﬃciencies in 1.5 mM ferrocene monocarboxylate
Electrode AScan:BCollect BScan:ACollect
D1 21.86 21.88
D2 9.22 10.51
D3 12.04 12.62
D4 12.74 11.56
D5 2.76 4.17
D6 9.15 9.57
D7 20.62 21.18
The collection eﬃciency of each electrode is diﬀerent due to the diﬀerent geome-
tries. When the two electrodes are close together, the collection eﬃciency is greater,
as seen in electrode D1 or D7, which show approximately 20 % collection eﬃciency.
However, when the two electrodes are at further distances from each other, such as
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the electrodes in electrode D5, the collection eﬃciency is less because there is less
overlap of the two diﬀusion fields. Even when the two electrodes are at opposite
sides of the syringe needle, such as electrode D5, there is still cross talk between the
electrodes (approx. 3 %). This suggests that this design is not optimal for multi-
analyte detection. The percentage of cross talk when in a flow cell is described in
section 6.5 and a summary is shown in table 6.2.
3.5.2 Screen Printed Electrodes
Another option in the design of electrodes for multi-analyte detection is to screen
print electrodes. These could be implemented with a flow cell described later in this
thesis in chapter 5. The electrochemical cell setup was designed using AutoCAD and
is shown in figure 3.18. The working electrodes could be separated by an auxiliary
electrode. This will act as a shield as it can remove the species responsible for
the cross-talk before it can reach the other working electrode. However, due to an
analysis of the microfluidic chip, as discussed in chapter 6 section 6.4.3, the screen
printed electrodes were not used.
!
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Figure 3.18: Possible screen printed electrode design
Black lines indicate flow channel design (described in more detail in chapter 5) Blue lines indicate
the working electrodes, the red indicates the geometry of the proposed auxiliary electrode and the
green indicates the reference electrode.
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3.6 Conclusion
Electrodes contained within a flow cell, for continuous analysis of microdialysate
was proposed, to improve the time resolution of the clinical monitoring system.
Cylindrical electrodes were first investigated and were used within a custom made
Radel flow cell. The Radel flow cell has the advantage of easily integrating with
rsMD and allowing placement of electrodes with a larger surface area. This gives
more current, which is easier to detect. However, it was found that the response
time of such a flow cell was too slow to accurately measure the dynamic changes
expected in the microdialysate, due to a large volume surrounding the electrode. The
design was impractical to miniaturise and hence, needle electrodes were fabricated
for placement within a microfluidic chip.
The development of syringe needle electrodes has been described and the in-
laid micro-disc electrodes characterised using cyclic voltammetry. Miniaturisation
was continued by using smaller gauge needles and smaller platinum wires. The
integration of the auxiliary and reference electrodes produced an eﬀective combined
syringe needle electrode with an outer diameter of 311 µm. This allows placement
within a micro-fabricated device, which is described in more detail in chapter 5.
Whilst the combined electrode works well, it was very diﬃcult to control the
organisation of dual electrodes within the syringe needle. Even when the electrodes
are at opposite sides of the syringe needle, there is still some crosstalk between the
electrodes, and hence they were not used for multi-analyte detection.
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Chapter 4
Biosensor Development
4.1 Introduction
Biosensors combine the specificity of a biological agent such as an enzyme, with a
detection mechanism such as an electrochemical electrode. Biosensors are typically
small in size with adequate sensitivity from millimolar concentrations of glucose
(62) to micromolar range (66, 100) of glutamate. In this chapter, I will focus on the
fabrication of biosensors for use with microdialysis.
4.1.1 Enzymes
Enzymes are an important component of biosensors and they provide a specific
reaction, which relates to the concentration of analyte. Enzymes are proteins, which
act as catalysts in the biological world. They have an active site, which is responsible
for the specificity of the chemical transformations. The substrate briefly (and non-
covalently) binds to the enzyme creating an enzyme-substrate (ES) complex. Most
of the interactions between the enzyme and substrate are weak and include ionic
bond, hydrogen bonds and hydrophobic interactions. Successful formation of the
ES complex therefore requires the two molecules to be in close proximity and have
a large amount of complimentarily. This provides the basis of the high specificity
the enzyme has for its substrate. This section will now give some information on all
the enzymes used in this thesis.
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Glucose Oxidase
Glucose oxidase (GOx) is an oxido-reduction enzyme, which catalyses the reduc-
tion of glucose. Naturally, it is produced by some insects as an anti-bacterial and
anti-fungal agent (101), due to the production of hydrogen peroxide, which causes
oxidative stress (especially if the intended target doesn’t produce scavengers of H2O2
such as catalase). In industry, GOx is used in food preservation, diagnostic glucose
biosensors are widely used to monitor diabetes, and in bioreactors glucose levels
are monitored during fermentation. The structure of GOx is shown in figure 4.1.
It is a homodimeric protein (each subunit is 80kDa) and is normally isolated from
Aspergilus niger. The active site of the enzyme is situated within a deep pocket and
for catalysis to occur, two flavin adenine dinucleotide (FAD) cofactors are required
as electron carriers (102). The dimensions of GOx are 6.75 x 6.75 x 21.54 (nm) and
the molecular weight is 65.69 kDa (103).
Figure 4.1: Structure of glucose oxidase
The two identical subunits are shown in light and dark blue. FAD molecules are shown in pink.
Taken from Wong et al (104).
The proposed mechanism of GOx is shown in equation 4.1 (105).
Eox + S ￿ EoxS ￿ Ered + P
Ered +O2 ￿ Eox +H2O2
(4.1)
where Eox and Ered are the oxidised and reduced form of the enzyme respectively,
S is the substrate, P is the product and EoxS is the ES complex.
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Glucose oxidase catalyses D-glucose to D-gluconolactone and hydrogen peroxide.
This reaction is shown in equation 4.2.
C6H12O6 +O2 −→ C6H10O6 +H2O2 (4.2)
Hydrogen peroxide is easily measured electrochemically and its formation is di-
rectly related to the glucose concentration in the sample. For complete enzymatic
catalysis, the enzyme requires an electron donor (glucose) and an electron acceptor.
Naturally, oxygen acts as the electron acceptor, however other molecules may do
so. Cass et al in 1984 described the basis of a glucose biosensor using a ferrocene
mediated enzyme electrode (106), which showed improved sensitivity. GOx has an
isoelectric point of 4.2 (107) and therefore at pH 7, will have a net negative charge.
Lactate Oxidase
Lactate oxidase (LOx) is a member of the flavin mononucleotide (FMN)-dependent
α-hydroxy acid-oxidising enzyme family and crystal structures have revealed the lo-
cation of the active site at the FMN (108, 109). LOx is obtained from Aerococcus
viridans and has the dimensions of 11.73 x 13.47 x 18.56 nm and a molecular weight
of 330.99 kDa (108). It has an isoelectric point at pH 4.6 (110).
Figure 4.2: Structure of lactate oxidase
Ribbon representation of lactate oxidase. The LOx tetramer complexed with d-lactate with each
monomer depicted in a diﬀerent colour. LOx has fourfold symmetry. Taken from Furuichi et al
(108).
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LOx catalyses the reaction of lactate to pyruvate and hydrogen peroxide as shown
in equation 4.3.
C3H5O3 +O2 −→ C3H3O3 +H2O2 (4.3)
The mechanism is complex and has been extensively studied. It is described
detail in (111). The first half of the reaction is a reduction of the enzyme to convert
lactate to pyruvate. The second half of the reaction, is an oxidation of the enzyme
by the electron carrier, oxygen, to form hydrogen peroxide.
Horse Radish Peroxidase
Horse radish peroxidase (HRP) is often used in biochemistry to amplify small
signals and increase the sensitivity of an assay. HRP is a haem-containing enzyme
with dimensions of 4.28 x 6.75 x 11.7 nm and a molecular weight of 34.52 kDa (112)
Figure 4.3: Structure of horse radish peroxidase
Ribbon representation of HRP. The iron heme is in the centre of the enzyme shown in black with
the iron atom as the red sphere. The two calcium atoms are black spheres and lie within the helical
regions of the enzyme, with one in the distal region and one in the proximal region. Image taken
from RCSB Protein Data Bank.
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HRP catalyses the oxidation of many substrates and the overall equation is shown
in equation 4.4 (113).
H2O2 + Sred ←− HRP −→ 2H2O + Sox (4.4)
In this thesis, HRP is used in the clinical FIA system, developed previously by
the group. This involves second generation biosensors in which HRP is used to
enhance the signal by mediating glucose and lactate enzyme beds with ferrocene
monocarboxylate, as discussed in common material and methods in chapter 2.
Hexokinase
Hexokinase (HEX) is used in conjunction with GOx to create an ATP sensor,
described in more detail in section 4.6. There are four important mammalian hex-
okinases. HEX I is a housekeeping enzyme, HEX II is present in many cancers and
little is known about HEX III. These three enzymes have a very high aﬃnity for
glucose even at low concentrations. HEX IV is also known as Glucokinase and has
an important role in metabolism. It is obtained from Saccharomyces cerevisiae and
has dimensions of 14.48 x 7.88 x 6.19 nm and a molecular weight of ∼50kDa (114).
A representation of the structure is shown in figure 4.4. In this thesis, HEX IV is
used and will be denoted as just HEX.
Figure 4.4: Structure of hexokinase
Ribbon representation of HEX. The enzyme structure is made up of mainly alpha helixes and beta
sheets. Image taken from RCSB Protein Data Bank.
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HEX is required for the first step in glycolysis to phosphorylate glucose to
glucose-6-phosphate, and maintain a downhill gradient to facilitate glucose into the
cells. The addition of a phosphate group to a molecule traps the glucose inside the
cell as hexose phosphates cannot easily cross cell membranes. Glucose-6-phosphate
is also an allosteric inhibitor. The reaction is shown in equation 4.5.
Glucose+ ATP −→ Glucose6phosphate+ ADP (4.5)
4.1.2 Biosensor Classification
Biosensors can be described in terms of three generations based upon their operation.
The biosensors described in this chapter are first generation sensors.
First Generation
First generation biosensors detect the natural product or reactant of the enzyme
at an electrode, as shown in figure 4.5. Hydrogen peroxide is produced as the
enzyme catalyses the reaction of substrate to product. The current produced from
the oxidation of hydrogen peroxide at the electrode surface is therefore directly
related to the concentration of the substrate. This model requires a constant supply
of oxygen but it is less sensitive to oxygen than if oxygen was detected directly.
This is because the hydrogen peroxide recycles as a natural mediator. The main
problem in this design is interference by other electro-active redox species found in
the sample.
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Figure 4.5: Schematic of first generation biosensors
First generation biosensor, where S = substrate P = product, SOx = substrate oxidase. The
electrode detects a natural product of the enzymatic reaction.
Second Generation
Second generation biosensors use a synthetic mediator, such as ferrocene mono-
carboxylate (Fc), to shuttle electrons, which replaces the need for oxygen, shown in
figure 4.6. Synthetic mediators are often incorporated to increase the sensitivity of
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the assay and reduce the interference from other naturally occurring molecules to
some extent. Fc is in a much higher concentration (1.5 mM) than oxygen (200 µM)
and the electrochemistry involved with Fc is faster. However, the mediator needs to
be in close proximity to the enzyme and electrode surface and have a high turn-over
rate with both the enzyme and the electrode. The enzyme beds used in rsMD are
second generation sensors.
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Figure 4.6: Schematic of second generation biosensors
Second generation biosensor, where S = substrate P = product, SOx = substrate oxidase, Fc =
ferrocene monocarboxylate. A synthetic mediator is used to shuttle electrons to the electrode.
Third Generation
Third generation biosensors transfer electrons directly from the enzyme to the
electrode. This eliminates interference, however reproducibility is poor. Redox
proteins that have the active site at the surface are well suited to this type of
sensor. However in GOx, for example, the flavin molecules are 20 nm from the
protein surface (115). This is too far for eﬀective electron transfer and attempts to
improve this, such as wiring, may result in damaging the enzyme. A schematic is
shown in figure 4.7. Recently, the direct attachment of laccase onto functionalised
carbon electrodes (116) and the immobilisation of GOx onto carbon nanotubes (117),
have been successfully investigated and allows for fast electron exchange and a good
biosensor performance.
!
" #$%&'()*%
+%,
!-.
Figure 4.7: Schematic of third generation biosensors
Third generation biosensor, where S = substrate P = product, SOx = substrate oxidase. Electrons
are directly transferred to the electrode.
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4.1.3 Biosensor Fabrication
An amperometric biosensor requires the enzyme to be in close proximity to the elec-
trode surface. Immobilisation of enzymes onto the surface of an electrode, without
aﬀecting the catalytic activity and biological selectivity is fundamental to the pro-
duction of a successful biosensor. Once they arrive at the electrode surface, enzymes
can be physically adsorbed to the surface of the electrode by the hydrophobicity of
the enzyme core and possibly hydrogen bonds depending upon the electrode sur-
face. There is little chemical modification of the enzymes but a major disadvantage
is leakage of the enzyme from the electrode surface. To reduce desorption, covalent
bonding to the electrode surface via functional groups can be induced, but this po-
tentially damages the enzyme. Cross-linking enzymes involves covalently bonding
the enzyme molecules together and this method is commonly used by Gerhardt (67).
However this technique requires very careful optimisation otherwise it may reduce
the stability and functionality of the enzymes.
An alternative is to encapsulate the enzymes into a gel, which is easily fabricated,
porous and stable. The gel is a matrix in which coupled reactions can take place,
improving the performance of the sensor and allows fast access of the analytes.
The formation of polymer films can entrap enzymes to the electrode surface. De-
position of a film such as nafion (118, 119) has been widely reported however there
are problems with the reproducibility and the thickness of the film. Electropolymeri-
sation builds a mesh-like framework of polymers, by monomer units joining together
to form a chain (120, 121). Deposition of the polymer film occurs in the exact lo-
cation where the appropriate potential is applied, so that on an electrode array,
individual electrodes can be coated independently of each other, opening up a wide
range of possibilities. Many factors influence the growth, properties and morphology
of the polymer film, such as concentration of monomers within the diﬀusion zone,
electrode potential, temperature and properties of the solvent used. Also, some
films such as polyphenol, are self-limiting in growth, producing thin, insulating and
hydrophobic films (122). Commonly used polymers are pyrrole (123, 124), phenols
(125) and phenylenediamines (126).
This report focuses on three commonly used films to entrap glucose oxidase. Poly
o-phenylenediamine (o-PD) is reported to be approximately 10 nm thick, stable
and strongly adherent (127). Polyphenol is said to have a significant eﬀect on
blocking interference, the reproducibility is said to be good and the response rapid
and relatively stable (128). Poly m-phenylenediamine (m-PD) is thought to be
relatively thin at approximately 10-30 nm, with a rapid response time, however the
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sensitivity significantly decreases after 7 days in storage (118). A literature overview
of the main characteristics of glucose biosensors formed using these three films is
shown in table 4.1. The references used to create this table are; oPD (126, 127, 129),
mPD (118, 130, 131, 132) and phenol (125, 128, 133, 134, 135).
Table 4.1: Literature summery of glucose biosensors fabricated with diﬀerent films
Characteristic oPD mPD Phenol
Sensitivity 440 nA.mM−1.cm−2 99 nA.mM−1.cm−2 1200 nA.mM−1.cm−2
Stability 20hrs continuous use Sig. drop after 7 days After 7 days, falls by 25%
T90 / s < 2 s < 1 s < 4 s
LOD 3 µM 50 µM 20µM
Thickness 10 nm 10 - 30 nm 3nm, 7.5nm with enzyme
4.1.4 Enzyme Kinetics
During the development of the biosensors used in this thesis, the enzyme kinetics
were assessed. Enzymes are very eﬀective catalysts because they lower the activation
energy (Ea or ∆G‡) of the reaction. As a result, the reaction rate is increased and
products are formed faster. The enzyme may be aﬀected by a variety of factors,
including concentration of substrate, temperature, pH of solution and the presence
of inhibitors.
The majority of enzymes follow the Michaelis-Menten kinetics. The reaction rate
is the number of reactions per second that are catalysed per mole of enzyme. The
reaction rate increases with increasing substrate concentration [S], asymptotically
approaching the maximum rate, Vmax. Vmax is therefore the maximum catalytic rate
that can be achieved by a particular enzyme. Km is the Michaelis-Menten constant
and is defined as the substrate concentration at which the reaction rate is half its
maximum speed. It inversely represents the enzymes aﬃnity for the substrate and
is a measure of how stable the enzyme-substrate complex is. The Km for glucose
oxidase is reported to be in the low 20 mM range at pH 7 (102, 136, 137). The
expected Km of lactate oxidase is 0.7 mM as recorded on the Genzyme data sheet.
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The Michaelis-Menten formula is shown in equation 4.6.
V =
Vmax[S]
Km + [S]
(4.6)
where V is the reaction rate, Vmax and Km are as previously described and [S]
is the substrate concentration.
Inhibition of the enzyme can change its performance and hence the Vmax and
Km values, an overview of which is shown in figure 4.8. There are two types of
inhibition, competitive and non-competitive.
Competitive inhibitors compete with the substrate to bind to the enzyme’s active
site. Therefore more substrate is required to reach the same velocity that it would
do with no inhibitor present. Hence, the same Vmax can be reached albeit at a
higher substrate concentration, resulting in a larger Km. Application of a polymer
film to the surface of the electrode could have the same eﬀect on Km, for a diﬀerent
reason, by reducing the diﬀusion to the electrode surface. At a high enough substrate
concentration, the same Vmax is reached, but at the lower concentrations, diﬀusion
is limiting the current, resulting in a larger apparent Km.
Non-competitive inhibitors bind to a part of the enzyme molecule that is not
the active site. The viability of the enzyme is then compromised and its eﬃciency
reduced. This results in a lower Vmax as there are less enzyme molecules to process
the substrate, however as the active site of the viable enzymes is not impaired, the
Km remains the same. This eﬀect could be seen if the orientation of the enzymes
entrapped in polymer films is such that the substrate cannot be processed by the
enzyme. The Vmax would be reduced as the number of enzymes processing the
substrate is reduced, but the functionality of the active site is not aﬀected.
If at lower substrate concentrations there was no inhibition, the biosensor cal-
ibration curve would start by following the red line in figure 4.8. If, at a certain
threshold the substrate acts as a non-competitive inhibitor, then the calibration
curve would switch to the green line. A scenario that could produce this eﬀect is if
the higher concentration of substrate altered the polymer film such that some of the
enzymes could no longer function. This results in a lower Vmax and a lower than
expected Km.
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Figure 4.8: How inhibition of enzymes aﬀects Vmax and Km
Competitive and non competitive inhibition are assessed in terms of Vmax and the Km. x axis is
increasing velocity, y axis is increasing substrate concentration.
Sometimes the binding of a ligand or molecule can enhance the binding of sub-
sequent ligands by changing the enzyme conformation and increasing the binding
aﬃnity at the other vacant sites. This is known as cooperative binding, which was
quantified by Archibald Hill. The Hill coeﬃcient provides a quantification of the
degree of cooperative binding. A well known example of this is the sigmoidal binding
curve of oxygen to haemoglobin. The Hill equation is shown in equation 4.7 (138).
I =
Vmax
1 + (Km/[glucose])α]
(4.7)
Where I is a measure of the rate of enzymatic reaction and α is a measure of the
deviation from the ideal Michaelis-Menten behaviour.
The Hill equation is widely used to study the enzyme kinetics of biosensor cali-
bration curves as often there is a deviation from linearity at both lower and higher
substrate concentrations. It is often used when describing allosteric enzyme biosen-
sors where there can be several allosteric binding eﬀectors (139).
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4.2 Investigating Immobilising Films
Following table 4.1, three immobilising films were tested using glucose oxidase. A
potential can be applied to an electrode to polymerise a film in two ways: a fixed
potential (electropolymerisation) or a ramping potential (cyclic voltammetry). The
films were assessed using both methods and the monomers investigated are shown
in figure 4.9 and were:
• o-phenylenediamine (oPD)
• m-phenylenediamine (mPD)
• Phenol
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Figure 4.9: The structure of monomers investigated for use as immobilising films
The chemical structures of three monomers, o-phenylenediamine, m-phenylenediamine and phenol,
which are investigated for use as immobilising films, are shown.
4.2.1 Polymerisation by Cyclic Voltammetry
Electrodes (2 mm cylindrical or disc electrode) were placed in a solution containing
50 mM of the monomer. For all films, the solution is purged with nitrogen for 20
minutes before the potential is scanned at 50 mV/s over a suitable range (oPD and
mPD: 0 V to 1 V. For phenol: 0 V to 1.5 V). For phenol only, the experiment is also
repeated without purging the solution. The current is recorded as the potential is
scanned, producing a CV.
Figure 4.10A shows the resulting CV of oPD polymerisation, using a 2 mm long
125 µm diameter electrode. There are two peaks in the polymerisation process, one
at 0.65 V and the second at 0.75 V. The majority of the monomers are polymerised
during the first scan seen easily as the large decrease in current intensity.
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Figure 4.10: Film polymerisation using cyclic voltammetry
A: 2 mm long 125 µm diameter cylindrical electrode in 50 mM oPD in PBS. Potential scanned
from 0 to 1 V at a scan rate of 50 mV/s in deoxygenated solution. B: 125 µm disc electrode in 50
mM mPD in PBS. Potential scanned from 0 to 1.5 V at a scan rate of 50 mV/s in deoxygenated
solution. C: 2 mm long 50 µm diameter cylindrical electrode in 50 mM phenol in PBS (oxygenated
solution). Potential scanned from 0 to 1.5 V at a scan rate of 50 mV/s. D: 2 mm long 50 µm
cylindrical electrode in 50 mM phenol in PBS (deoxygenated solution). Potential scanned from 0
to 1.5 V at a scan rate of 50 mV/s
Figure 4.10B shows the CV resulting from the polymerisation of mPD, using a
125 µm platinum disc electrode. Again, after the first scan there is a large drop in
current indicating that a large part of the film is formed quickly. By the 20th scan
the CV shows no peaks indicating a fully formed film.
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Figure 4.10C and figure 4.10D shows the polymerisation of phenol in oxygenated
and deoxygenated solutions respectively. In both cases, a 2 mm long, 50 µm diameter
cylindrical platinum electrode was used. In oxygenated solutions the electrochem-
istry looks much simpler as there is only one peak at 0.63 V and the majority of the
film is again formed within one scan. For deoxygenated solutions, the CVs show two
clear peaks at 0.7 V and 0.95 V. After the first scan, the peak at 0.7V disappears
but the second peak remains. This second peak can still be seen in the 20th scan.
Oxygenated solutions were therefore chosen as the electrochemistry was simpler and
the film was fully formed after the 20th scan.
4.2.2 Film Formation: Electropolymerisation
The biosensors used in this thesis were fabricated using electropolymerisation. The
electrode was placed in 50 mM film monomer and 4 mg/mL enzyme. The pH of the
solution was buﬀered to pH 7.2. The electrode was placed in the enzyme solution for
10 minutes. This is the stabilisation time. The working electrode was held at 0 V
for 20 s, polarised to the required potential for 15 minutes for electropolymerisation
of the film and then held at 0 V for 20 s. The potential applied was 0.75 V, 1 V and
0.9 V for oPD, mPD and phenol respectively. Following electropolymerisation, the
biosensor was gently rinsed with de-ionised water and stored dry overnight at 4 ◦C
before use. Exceptions in this thesis include, the quantity of LOx used (halved to 2
mg/ml) and for the ATP biosensor, 40 mg/ml HEX and 10 mg/ml GOx was used.
Cyclic voltammetry was used to check for successful film polymerisation after
biosensor fabrication. CVs of a bare and a coated electrode are shown in figure 4.11.
Enzyme kinetics were investigated to assess the functionality of GOx in the films.
Aliquots of glucose was added to a stirred beaker in a step-wise fashion. The Vmax
and Km were found by plotting the change in current against concentration and
fitting the points with the Hill equation in a graphing software (Igor Pro). An
overview of 4 sensors of each film is shown in table 4.2. Note, the expected Km of
GOx is reported to be in the low 20 mM range at pH 7 (102, 136, 137).
oPD has the lowest Km value, indicating that the functionality of the enzyme is
good, and the enzyme has a strong aﬃnity for for glucose. The current, however,
is low with an average Vmax of only 7.6 nA. This means that the sensitivity of
the sensors will be low and small concentrations of glucose will be very diﬃcult to
see. Phenol coated sensors have the highest Vmax, indicating that the turnover of
substrate is highest and the sensors will have the best sensitivity and the Km is
similar to the reported Km of glucose oxidase.
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Figure 4.11: CVs of a bare and an oPD coated electrode
The potential is scanned from 0 V to 1 V and back again at 50 mV/s and the change in current
recorded. A 125 µm diameter, 2 mm long, cylindrical platinum electrode in 1.5 mM Fc, was
assessed before and after an oPD film was electropolymerised on the surface.
Table 4.2: Enzyme kinetics of glucose biosensors: film assessment
Film Km / mM Vmax / nA
oPD (n=4) 20 ± 5.4 7.6 ± 1.6
Phenol (n=4) 26.5 ± 1.29 19.25 ± 11.03
mPD (n=4) 39.37 ± 3.6 14.72 ± 10.1
Although mPD coated sensors have a reasonable Vmax, the Km of the enzyme is
high at approximately 40 mM. This indicates that the enzyme has been damaged
during the polymerisation of the film.
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4.2.3 Film Selectivity: Flow Injection Analysis
Each film was assessed for its ability to reject unwanted signals from other electro-
active species that may be present in the analytical sample. For these selectivity
measurements, flow injection analysis (FIA) was carried out comparing a coated
electrode and a bare electrode.
To test the three films against the common interferents, an in-house flow cell was
produced, using a silicone elastomer, as described previously by Anastassiou et al
(140). The flow cell was connected to a quaternary HPLC pump (HP1050, Aligent),
used to change solutions. The flow rate was set at 1 mLmin−1 and baseline current
was collected by pumping potassium chloride buﬀer solution. The pump was then
changed to a solution, which contained various interferents, for the duration of
20 s, after which potassium chloride was again perfused. This was repeated four
times. The responses of unmodified 50 µm platinum electrodes were compared to
the coated 50 µm platinum electrodes. Both the unmodified and coated electrodes
were simultaneously assessed for selectivity, in the presence of 1 mM ascorbic acid
(AA), 1 mM dopamine (DA), 10 mM FeCN and 10 mM RuHex. The potential
applied to the electrode was +0.75 V, +0.75 V, +0.6 V and -0.4 V respectively.
The responses to hydrogen peroxide were also deduced from a separate standard
calibration. The results are shown in table 4.3.
An example of the responses seen at a phenol coated electrode compared to a
bare electrode is shown in figure 4.12. The responses to the injected species is greatly
attenuated by the application of a polymer film to the electrode surface. RuHex is
the only species where a response is clearly seen at the coated electrode, however
the response is clearly reduced.
A reading was taken at the peak of the signals at both electrodes, and compared
to the baselines. The ratio of the change in current at the coated electrode (I) to
the change in current seen at the unmodified electrode (Iclean) is an indicator of the
permeability of the film, and the results are shown in table 4.3.
All species are attenuated by the films implying that the films have introduced a
diﬀusion barrier to the electrode surface. H2O2 is the easiest to pass through all of
the films. This is ideal because this is the product of the enzymatic reaction, which
the electrode is detecting. The ability of H2O2 to permeate the films is one of the
qualities of why these three films are so commonly used in first generation biosensor
designs.
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Figure 4.12: FIA analysis
50 µm Pt disc electrode. A: 1 mM AA (blue), B: 1 mM DA (green) C: 10 mM FeCN (purple)
D: 10 mM RuHex (pink). 20 s injection pulses were carried out against a background solution
of potassium chloride at 1 mLmin−1 for the four diﬀerent molecules. Measurements from both
electrodes were carried out simultaneously.
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Table 4.3: FIA results : I / Iclean Mean±StDev n=4. Charge of the injected specie
at pH 7 and relative sizing of the species are also shown
Film H2O2 AA FeCN RuHex DA
Phenol 0.72±0.16 0.0027±0.0001 0.0077±0.0005 0.12±0.006 0.0053±0.0008
oPD 0.51±0.014 0.12±0.002 0.0043±0.0002 0.25±0.5 0.06±0.028
mPD 0.72±0.01 0.59±0.073 0.037±0.0068 0.057±0.1 0.29±0.021
Charge Neutral Negative Negative Positive Positive
Size Small Medium Large Large Medium
Looking at the IIclean ratio for each polymer film, the order for the most excluded
specie to the least excluded specie is:
* Phenol: AA, DA, FeCN, RuHex, H2O2
* oPD: FeCN, DA, AA, RuHex, H2O2
* mPD: FeCN, RuHex, DA, AA, H2O2
4.2.4 Size versus Charge
The size and charge of molecules may have an eﬀect on its apparent permeability
through a film. The oPD film looks to be excluding molecules on the basis of size,
with the exception of RuHex. The oPD film excludes the medium sized AA and DA
less than the larger FeCN molecule. This shows that there is no eﬀect of charge as
AA and DA are similarly excluded but are positively and negatively charged at pH 7,
respectively. This could be related to the Debye length being suﬃciently small that
the charges have little eﬀect. The mPD film also looks to be excluding molecules on
the basis of size, similar to the oPD film, but here RuHex fits the trend. The phenol
responses indicate that the film is not excluding species based on either the charge
or the size. Whilst no concise conclusion can be determined over the permeation
properties, this was not investigated further as the poly(phenol) film gave the best
exclusion of AA and DA, than either oPD or mPD.
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4.2.5 Polymer Selectivity
Polymer selectivity was further assessed by calculating the percentage of interfer-
ence of AA in the H2O2 detection. Polymer selectivity can be calculated using
equation 4.8 (141).
S% =
IAA
IHP
× 100 (4.8)
Where, S=polymer selectivity, AA=ascorbic acid and HP=hydrogen peroxide.
The optimal value of S%, as defined here, is zero for biosensor applications. The
selectivity of each film was assessed by applying this equation to the results from
the FIA experiment. The results are shown in table 4.4. mPD has the highest S%
out of the three films. It is three times larger than oPD, again suggesting that film
formation is not as good. The S% for oPD is still large, indicating that there will be
interference from ascorbic acid. The S% for phenol is very small and close to zero,
indicating that phenol is a good barrier to interferences from other electro-active
species.
Table 4.4: Polymer selectivity
Film S%
Phenol 0.37 ± 0.08
oPD 23.58 ± 3.9
mPD 82.47 ± 10.3
4.2.6 Film Decision
Poly(phenol) is reported to be 3 ± 1.2 nm thick and with glucose oxidase 7.4 ± 0.8
nm thick (134). The growth of the phenol films is self-limiting and as a consequence
is thin and free of defects such as pinholes (142). Poly(phenol) is a good insulator,
which prevents interference from unwanted species by blocking them from the elec-
trode surface, and minimise fouling. This is all represented in the permeability and
selectivity data shown. The best film to use is phenol because the permeability and
selectivity is superior to oPD and mPD. The Km and Vmax of the glucose biosensors
fabricated using phenol gave the best sensitivity and a similar Km to that reported
in the literature. Therefore the biosensors used in this thesis will be fabricated using
a phenol film, electropolymerised at 0.9 V, to entrap the enzyme to the electrode
surface.
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4.3 Glucose Biosensor: Radel Flow Cell
Electropolymerisation of 50 mM phenol at 0.9 V was used to entrap glucose oxidase
(4 mg/mL) on the electrode surface. The electrode and flow cell construction was
detailed in the previous chapter. The biosensor was placed in a beaker containing
PBS, which is highly stirred, at 0.75 V. Aliquots of a concentrated glucose solution
were added to the PBS to create known step changes in concentration. Wires were
all 2 mm in length but diﬀerent diameters were used and the sensitivity of the
biosensors was characterised on the diﬀerent electrode sizes.
In a beaker, the 50 µm diameter cylindrical biosensor had a sensitivity of 1.95
± 0.64 x 107 nAmM−1cm−2 and a 90 % response time (T90) of 3.0 s ± 1.5 (n=10).
The 125 µm diameter biosensor had a similar sensitivity of 1.45 ± 0.18 x 107
nAmM−1cm−2 but a longer T90 of 6.8 ± 1.4 (n=10).
The glucose biosensors were designed for a Radel flow cell, which was to be placed
after the valve on the rsMD trolley. The Radel flow cell design and construction was
described in chapter 3. Here, a glucose biosensor fabricated on a cylindrical electrode
was placed inside and solutions perfused the flow cell at a flow rate of 1 µLmin−1.
The solutions were alternated between aCSF and glucose in varying concentrations
using a syringe switcher. Figure 4.13 shows a typical trace for a cylindrical glucose
biosensor placed in a Radel flow cell.
Table 4.5 shows that the current for a particular glucose concentration is inde-
pendent of flow rate for all normal microdialysis flow rates (0.1 to 10 µLmin−1).
Such performance is more than suﬃcient to detect glucose continuously in vivo.
Table 4.5: Response of glucose biosensor in the flow cell: current response
[Glucose] / µM I / nA @ 8.8µLmin−1 I / nA @ 1µLmin−1
1000 17.2 19.9
500 7.98 7.15
250 3.62 3.75
The limit of detection (LOD), calculated as 3 standard deviations of baseline
noise 30 seconds before the addition, of this flow cell for glucose is 6 µM. The
average LOD for a 50 µm wire is 5.3 ± 1.6 µM (n=10). Glucose responses were
routinely recorded for low glucose concentrations such as 50 µM. As expected the 90
% response time, T90, for the flow cell varies with dialysate flow rate, see table 4.6.
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Figure 4.13: Wire biosensor in Radel flow cell
In vitro calibration of the radel flow cell for glucose. Wire size 50 µm diameter, 2 mm length. Flow
rate 1 µLmin−1. Solutions were switched between aCSF and varying concentrations of glucose.
Glucose concentrations are 250, 500 and 1000 µM.
Table 4.6: Response of glucose biosensor in the flow cell: T90
Flow rate / µLmin−1 T90 / s
1 77
2 39
8.8 20.5
Although the sensitivity of the biosensor is good, the response time when in the
flow cell is too slow to detect the fast changes seen in the brain. Although eﬀorts
were made to make the volume of the flow cell smaller, the bore of the tubing must
be suﬃcient to fit three wires inside and hence it was still too large to achieve the
fast response times required. Therefore, further work involving microfabrication of
the flow cells was done and designs discussed in chapter 5. For electrochemical mea-
surements in the smaller flow cells, needle electrodes were developed (as discussed
in chapter 3). These disc electrodes will now be assessed as biosensors.
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4.4 Glucose Biosensors: Disc Electrodes
Glucose biosensors were fabricated on disc electrodes by entrapping glucose oxidase
to the electrode surface using electropolymerisation of polyphenol. The structure
of the electrodes was described in chapter 3. The biosensors were characterised in
a beaker, in the same fashion as the cylindrical biosensors, which is described here.
The sensors were also used on-chip, which will be discussed later, in chapter 6.
4.4.1 Glucose: Beaker Calibrations
The biosensors were characterised in a beaker containing PBS, which is highly
stirred. Aliquots of a concentrated glucose solution were added to the PBS us-
ing a glass hamilton syringe, to create known step changes in concentration in the
bulk media. Figure 4.14 shows a typical calibration in a beaker using a 25 µm glu-
cose biosensor. The sensitivity of the biosensors, the response times and the enzyme
kinetics were characterised on diﬀerent electrode disc sizes, 125 µm, 50 µm and 25
µm diameter discs.
The glucose biosensors were typically calibrated up to 80 mM. This is to assess
the functionality of the enzyme trapped on the surface. At the high millimolar
concentration the sensor should be approaching Vmax and the Km of the enzyme can
also be assessed by calculating the glucose concentration at half Vmax. Figure 4.14A
shows a graph of the change in current at increasing glucose concentrations using
a 25 µm glucose biosensor. Here Vmax is seen as a plateauing of the trace and Km
is the glucose concentration at half Vmax as indicated on the graph. The curve has
been fitted with the Hill equation in IgorPro. The coeﬃcient values ± one standard
deviation of the fitted line in figure 4.14A are: Vmax = 218.8 ± 9.7 pA, Km = 20.1
± 1.4 mM.
The reported Km of GOx should be about 24. Overall, the Km of the biosensors
varied. The average Km for 25 µm disc biosensors (n=28) was 20.2 ± 14.5 mM.
Upon closer examination, there were three populations, sensors with the expected
Km (24.2 ± 4.0 n=8), sensors with lower Km (11.1 ± 3.3 n=12) and sensors with a
higher than expected Km (39.2 ± 6.5 n=7). There was no way of predicting which
group the biosensor will fall into before calibration.
The sensor shown in figure 4.14 responds well to glucose and has a high Vmax.
The Vmax also varied greatly between sensors, the average Vmax for 25 µm disc
biosensors (n=28) was 162.2 ± 113.5 pA. The large variability in the enzyme kinet-
ics was not limited to only the smaller electrodes but was seen across all sizes of
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Figure 4.14: Glucose biosensor beaker calibration
Calibration of a glucose biosensor (25 µm) in a beaker. Biosensor was held at a constant potential
of 0.75 V. A: Calibration up to 80 mM glucose concentration. Vmax and Km values shown on graph
are used from the curve fitting in IgorPro. Mean ± standard deviation of measurement shown. B:
Calibration up to 5 mM. This is is the physiological range. C: Raw data trace of a step change in
concentration from 0 to 100 µM glucose. The arrow indicates the timing of addition.
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biosensor. This indicates that the functionality of the enzyme influences the overall
performance of the biosensors greatly. However, this is the the part of the process
of which there is least control.
Figure 4.14B shows a closer view of the calibration in the physiological range
(up to 5 mM). Here you can see a lag in the response to glucose at very low con-
centrations. This is often seen with glucose biosensors and therefore instead of the
Michaelis-Menten curve, the Hill equation has been used to fit the calibrations, as it
allows for this initial lag (138). The biosensor was quick to respond to the addition
of glucose and the T90 of this sensor is 1.8 s. This is in-line with the literature
reports, which state the response time as under 4 s (125).
Even though the current is in the pA range, a clear change is observed at the
addition of 100 µM glucose, which is shown in figure 4.14C. The change in current is
6 pA and the LOD is 1.5 µM. The initial rise to above 100 µM before settling down
is likely to be due to the addition of the concentrated glucose solution creating
a localised high concentration before mixing into the bulk solution. The larger
diameter disc electrodes gave maximum current in the nA range. All electrode sizes
gave LOD in the low µM range, which is less than the reported literature LOD value
of approximately 20 µM (135).
Overviews of the sensitivity and the response times for multiple glucose biosen-
sors on diﬀerent sized disc electrodes, are shown in table 4.7. The development
of the electrodes coincided with the testing of the biosensors and therefore as the
design of the electrodes was optimised for the flow cell (which decreased in size) the
larger electrodes were less used.
Table 4.7: Responses of glucose biosensors
Electrode size / µm Sensitivity / nAmM−1cm−2 T90 / s
125 (n=4) 3.1 ± 0.4 x 105 7.17 ± 2.9
50 (n=15) 3.9 ± 0.6 x 103 3.1 ± 1.3
25 (n=70) 3.1 ±1.3 x 103 5.18 ± 4.1
The sensitivity decreases with the size of the electrode. The enhanced diﬀusion,
due to greater edge eﬀects at smaller electrodes, does not seem to be helping the
sensitivity of the sensor. This is probably because, not only is the glucose more
likely to diﬀuse to the enzyme but also hydrogen peroxide is also more likely to
diﬀuse away from the surface of the electrode and into the bulk media without
being detected.
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The response times of the sensors are all in the order of seconds. The 50 µm
diameter disc biosensors have a faster time response than the 125 µm disc electrodes
(P value = 0.00052, df = 17) and the time response is also, surprisingly, faster
than the 25 µm disc electrode (P value = 0.054, df = 83). Furthermore the 25
µm electrodes are more sensitive to noise and as indicated by the large standard
deviation. The magnitude of the change in current is much smaller and the addition
of concentrated glucose solution using a Hamilton glass syringe, causes noise that
is much greater than the change seen in the signal. When there is little noise upon
the addition the response times are approximately 1 to 2 seconds.
4.4.2 Glucose: Stability
A glucose biosensor was fabricated on a 125 µm disc electrode and calibrated in a
beaker the day after fabrication (day 1). After three weeks of storage in the fridge,
the same biosensor was calibrated again and it responded to glucose with a much
lower sensitivity, shown in figure 4.15.
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Figure 4.15: Biosensor calibration on day 1 and day 21
in vitro calibration of a glucose biosensor (125 µm) in a beaker on the day of fabrication (day 1)
and 3 weeks later. Both calibrations were run at a constant potential of 0.75 V.
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The sensitivity on day one is 3.3x105 nAmM−1cm−2, whereas three weeks later
that has decreased to approximately 20% of that value to 6.24x104 nAmM−1cm−2.
This indicates that biosensors do not store well and need to be fabricated before
each experiment to achieve the best sensitivity.
A newly made 50 µm diameter glucose biosensor was tested for stability by
continuously running overnight in a beaker containing 1 mM glucose. The overnight
trace is shown in figure 4.16. The sensor is stable in the presence of glucose for 12
hours, with some fluctuations due to a change in the speed of stirring around 450
minutes. This shows that the sensors are stable enough for continuous monitoring
in an intensive care unit.
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Figure 4.16: Overnight running of a glucose biosensor
A glucose biosensor (50 µm) was run at 0.75 V in a beaker containing 1 mM glucose, a day after
fabrication.
4.4.3 Glucose Biosensor: Beaker Assessment
Glucose biosensors of various sizes were assessed in a beaker using step changes
of concentration. This section will now discuss whether these sensors are fit for
purpose to be placed within a flow cell. Table 4.8 assesses the sensors in terms
of electrode size for the key factors. The sensitivity, LOD and response time were
assessed and it was found that all sizes performed well. Whilst the 125 µm had
far greater sensitivity it was found that placement on-chip was very diﬃcult due
to its size. The 25 µm sensor was very sensitive to noise and disruption and gave
the lowest sensitivity. Therefore the 50 µm electrode was more focused upon when
placed on-chip in chapter 6 as it had a slightly better sensitivity and a better signal
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to noise ratio than the smaller size allowing for more accurate recording, and a
needle size smaller than 125 µm made for easier use on-chip.
Table 4.8: Assessment of glucose biosensors in a beaker
Electrode size Sensitivity LOD T90
125 ￿￿ ￿￿￿ ￿￿
50 ￿￿￿ ￿￿￿ ￿￿￿
25 ￿￿ ￿￿￿ ￿￿
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4.5 Lactate Biosensor
Lactate biosensors were fabricated by soaking the combined needle electrode in a
solution containing 2 mg of lactate oxidase per mL of 50 mM phenol in PBS, pH 7.2.
The phenol was electropolymerised by applying a potential of 0.9 V for 15 minutes,
as previously described. The sensors were characterised in a stirred beaker, discussed
here, before placement on a microfluidic chip described in later chapters.
4.5.1 Lactate Biosensor: Sensitivity and Response Times
The lactate biosensors were mainly fabricated on two diﬀerent sizes: 125 µm and 50
µm. Aliquots of lactate were added to the PBS as described in the glucose biosensor
section. The expected staircase trace was seen and upon addition of the lactate
there was noise in the form of large spikes. This was either noise from movement
close to the electrode due to the addition or to a localised high concentration of
lactate being sensed before it is dispersed into the bulk solution. This also occurred
in the calibration of the glucose sensors and is an artefact of the method. Figure 4.17
shows a calibration curve of a 50 µm disc lactate biosensor in a beaker. The change
in current is plotted against the concentration of lactate and the data points were
fitted with the Hill equation using IgorPro.
The expected Km value using LOx is 0.7 mM (as stated on the Genzyme data
sheet). The average Km for the 50 µm disc biosensors is 0.5 ± 0.2 mM (n=8) and for
the 125 µm disc biosensors is 0.8± 0.6 mM (n=8). An overview of the sensitivity and
the response times of lactate biosensors on two diﬀerent sizes of electrode, are shown
in table 4.9. Whilst fit for purpose, the overall sensitivity could be improved. The
current responses for lactate sensors are in the pA range even though the larger disc
electrodes are used. The glucose biosensors fabricated on the same size electrodes
gave responses that are in the nA range. This could be due to using 2 mg/mL of
enzyme instead of the 4 mg/mL used of GOx. This was reduced to conserve enzyme
stocks. Another reason for lower sensitivity could be that the activity (U/mg) of
LOx is much less that of GOx (20-60 U/mg and >250 U/mg respectively). Therefore
it is unsurprising that that the sensitivity is lower and further work could be done
to increase loading of the enzyme to the electrode surface. Despite this, the LOD
of all lactate sensors of all sizes was approximately 10 µM.
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Figure 4.17: Calibration of a lactate sensor
Aliquots of lactate were added to a beaker of stirred solution and the current responses recorded.
The lactate biosensor was held at a constant potential of 0.75 V throughout. A typical calibration
curve of a 50 µm lactate biosensor is shown. Mean ± standard deviation of measurement shown.
Vmax = 207 ± 3.3 pA, Km = 0.56 ± 0.01 mM.
Table 4.9: Responses of lactate biosensors
Electrode size / µm Sensitivity / nAmM−1cm−2 T90 / s
125 (n=8) 2.7 ± 1.5 x 103 5.5 ± 3.3
50 (n=8) 1.8 ± 0.6 x 103 6.9 ± 3.9
4.5.2 Lactate Biosensor: Beaker Assessment
The lactate biosensors have been assessed in a beaker for two diﬀerent sized elec-
trodes. The 25 µm disc electrode was not tested as the sensitivity of the larger two
electrodes was much lower than that seen for the glucose sensors. A 25 µm electrode
provides a lower current and further work to optimise the signal must be done. This
section will now discuss whether the lactate sensors tested, are fit for purpose to be
placed placed within a flow cell. Table 4.10 assesses the sensors in terms of electrode
size and the key factors are investigated and awarded ticks.
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Table 4.10: Assessment of lactate biosensors in a beaker
Electrode size Sensitivity LOD T90
125 ￿￿ ￿￿￿ ￿￿
50 ￿￿ ￿￿￿ ￿￿
Whilst the lactate biosensors do not perform as well as the glucose biosensors,
they do perform well enough for use to monitor lactate changes associated with
brain injury.
The method of fabrication was optimised for glucose and it is possible that the
diﬀerences in the enzyme may aﬀect how well the same method fabricates a diﬀerent
biosensor. Table 4.11 assesses the sensitivity of glucose and lactate sensors in terms
of electrode size and enzyme activity (with 4 mg used for GOx and 2 mg used for
LOx). A smaller electrode will increase the flux of substrate towards the surface
due to the diﬀusional field. If the sensitivities were scaled just by area, the expected
sensitivity using a 50 µm disc electrode, compared to a 125 µm disc electrode,
would increase. For the glucose sensors this is true, but for the lactate sensors a
clear decrease in sensitivity is seen. This suggests that the lactate sensors would
benefit by increasing the enzyme loading on the electrode surface. This could be
done by increasing the concentration (and using a smaller volume) of the enzyme
and phenol electropolymerising solution.
Table 4.11: Comparing enzyme activity (U/mg) and sensitivities (nAmM−1cm−2)
Enzyme Activity 125 µm 50µm
GOx 250 3.1 x 103 3.9 x 103
LOx 60 2.7 x 103 1.8 x 103
GOx
LOx 8.33 1.14 2.17
Therefore the method of fabrication could be optimised for lactate, with partic-
ular attention paid to the enzyme loading on the surface of the electrode to improve
the sensitivity.
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4.6 ATP Biosensor
As a continuation of the work done on the glucose biosensor, an ATP sensor was
created. The sensor was was developed and tested at Imperial College by an un-
dergraduate student (Talia Wieder) under my instruction. In collaboration with Dr
Bhavik Patel, Ms Wieder used the sensors to investigate ATP release from ileum
tissue. This work has been published in the journal Biosensors and Bioelectronics.
The ATP sensor has the same basis as the glucose biosensor and uses the nee-
dle electrode construct. The diﬀerence between a glucose biosensor and an ATP
biosensor, is the addition of a second enzyme, hexokinase (HEX). The detection of
ATP on the biosensor is based on a competing reaction of HEX with GOx, shown
in figure 4.18.
Figure 4.18: Schematic diagram showing the operation of the ATP biosensor.
The ATP electrode is fabricated on a needle electrode, using a combination of HEX and GOx
entrapped in a polyphenol film.
4.6.1 Stability in the Response to Glucose Concentrations
Due to the competing nature of the biosensor, GOx must provide a stable and
reproducible response. In figure 4.19A a typical calibration of glucose on a 50 µm
ATP biosensor is shown. The biosensor is responding well to glucose, indicating
that the function has not been aﬀected by the addition of the second enzyme.
The method of fabrication was investigated further to try and optimise the sen-
sitivity. The stabilisation time allows for the enzyme in solution to adsorb to the
electrode surface before electropolymerisation of the polyphenol film. Periods of 5,
10 and 30 minutes were investigated and results are shown in figure 4.19B.
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Figure 4.19: Investigating the GOx component of the ATP biosensor
A: A typical glucose calibration response on the ATP biosensor. B: the influence of stabilisation
prior to electropolymerisation of the film, responses are shown as mean ± SD (n = 6). C: a typical
experimental response of the ATP biosensor when exposed to 11 mM glucose. D: the overall drift
between 10 sensors, responses are shown as mean ± SD and n = 10 for 11 mM glucose. All
experiments are carried out in Krebs buﬀer pH 7.4, at 0.75 V vs. Ag|AgCl.
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The Vmax was used as an indicator of the eﬀectiveness of longer stabilisation
times. The Vmax for 10 minutes stabilisation time was 853.56 ± 7.8pA (n=6) and
was significantly greater than that at 5 minutes (144.54 ± 30.7 pA, p<0.001, n=6).
However, there was no diﬀerence when the stabilisation time was further increased
to 30 minutes (825.69 ± 19.5 pA, p=0.24, n=6). A stabilisation time of 10 minutes
was chosen for the fabrication of the ATP biosensor.
Figure 4.19C shows a typical response to an addition of 11 mM glucose. This
concentration of glucose was used as it is present in Krebs buﬀer, which is utilised
for in vitro biological recordings. The response from multiple ATP biosensors is
shown in figure 4.19D and shows a stable recording for all 10 biosensors used over
a period of 20 minutes. There was no significant diﬀerence between the currents
post stimulus for 20 minutes, showing excellent stability. Between electrodes there
was a percent relative standard deviation (%RSD) of 5.27% to the same stimulus,
indicating good reproducibility in the fabrication of the ATP biosensors.
Overall the ATP biosensor showed excellent stability and reproducibility for the
detection of glucose, thus making it suitable for the monitoring of ATP. There was
minimal drift in the signal, which is essential to assure accurate responses of ATP
are obtained during in situ and in vitro measurements.
4.6.2 Characterisation of ATP Biosensor
The response to additions of ATP in the presence of 11 mM glucose, is shown in
figure 4.20A. The ATP electrode shows a stable current when 11 mM glucose was
added alone. There are then systematic decreases when aliquots between 0.25 µM
and 2 µM ATP are added.
Following the addition of ATP, approximately 45 s is required to resolve the ATP
concentration. This is better than some ATP biosensors (143) but is slower than
other ATP electrodes, where response times in the order of milliseconds have been
achieved (144, 145). However, for the biological areas of interest within this study,
the ATP biosensor is fit for purpose.
A typical calibration curve for the ATP biosensors is shown in figure 4.20B. There
is a good linear relationship between 0.25 and 4 µM and the limit of detection (LOD),
defined as the concentration equivalent of 3 times the standard deviation at the y-
intercept, was 9.9 ± 3.2 nM, with a sensitivity of 45.8 ± 1.22 pAµM−1 (n=8). Such
sensitivity is essential to study small fluctuations in ATP release during biological
measurements.
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Figure 4.20: Calibration response of ATP biosensor.
A: ATP biosensor responses are shown. All sensors were exposed to 11 mM glucose (grey arrow)
and ATP concentrations in the µM were added. B: The diﬀerence in the current from the 11 mM
glucose response (black trace) and the ATP response (dark grey trace) was obtained and plotted
as function of ATP concentration. All experiments are carried out in an amperometric mode at
0.75 V in Krebs buﬀer pH 7.4. Data shown as mean ± SD where n=8.
The LOD is at least between 10 and 100 times greater than all other sensors
developed utilising the same GOx/HEX scheme in the literature, as the size of our
electrode is far smaller that of previous studies (143, 144, 146, 147, 148).
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4.6.3 ATP Biosensor Conclusion
The ATP biosensor was then used in an in vitro study in collaboration with Dr
Patel. The sensor was used for the detection of mucosal released ATP from ileum
tissue and the results are shown in the published work.
An ATP biosensor with exceptional sensitivity, long-term stability and selectivity
from common biological interferents has been developed. The biosensor was shown
to have sensitivity and limit of detection, suitable for in vitro biological monitoring.
The ATP biosensor was stable under biological conditions and was able to conduct
long term biological recordings from in vitro ileum tissue without any signal atten-
uation. The biosensor was used to detect variations in ATP release from isolated
ileum and colon tissue successfully.
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4.7 Conclusion
Biosensors were developed to measure key metabolites in the brain microdialysate.
Glucose was initially studied and the method of fabrication was optimised. Three im-
mobilising films were tested for suitability for entrapping GOx close to the electrode
surface. The electropolymerisation of phenol was chosen to fabricate biosensors, as
the selectivity against common interferents, such as dopamine and ascorbic acid,
were far superior to the other two films tested. Glucose biosensors were then fabri-
cated upon cylindrical electrodes and placed within a Radel flow cell. Although the
sensitivity of the sensors was good, the response times were too slow for the dynamic
changes expected in brain dialysate. This was attributed to the large volume of the
flow cell and further miniaturisation was required. The microfabrication of flow cells
is discussed in the next chapter.
Glucose biosensors were assessed on needle disc electrodes. Here, the glucose
biosensors showed good sensitivity to glucose in the beaker, with fast response times.
Surprisingly, the sensitivity at the smallest electrode was less, but this could be
due to the enhanced diﬀusion of hydrogen peroxide away from the electrode. The
stability of the biosensors in storage was not suﬃcient and the biosensors were
therefore made fresh for each experiment. However, continuous usage of a newly
made biosensor was satisfactory over a 12 hour period, which is suﬃcient for clinical
monitoring. After assessment, it was concluded that the 50 µm electrode size had
the best chance of giving an accurate and reliable signal when placed on-chip.
Lactate biosensors were also fabricated for the analysis of lactate levels in the
dialysate. The method used for the glucose sensors was followed, substituting GOx
for LOx. Whilst the LOD was good, and the 90% response was satisfactory, the
sensitivity was low. The process of fabrication could be optimised to improve this
aspect of the lactate sensors, and this is required if these sensors are to be used in
the intensive care ward.
ATP biosensors were a development of the glucose biosensor and included a sec-
ond enzyme, HEX. The ATP biosensor showed excellent reproducibility and stability
to the glucose response and good sensitivity to ATP. When used in vitro to measure
ATP release from colon and ileum sections, the ATP biosensor performed well. The
in vitro work was a collaboration with Dr Patel, and the biosensor development and
the in vitro results have been published.
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Chapter 5
A Microfluidic Tool Kit
5.1 Introduction
Microfluidics has been incorporated into this thesis, as a platform to miniaturise the
current clinical analysis system, and also to address problems many microdialysis
users face. These are primarily Taylor dispersion (more discussion found in chapter
6) and long time delays from the sample leaving the microdialysis probe and being
transferred to analysis. Some background on microfluidics followed by the develop-
ment of a microfluidic toolkit, designed for use in conjunction with microdialysis,
will be described.
5.1.1 Continuous Flow Microfluidics
Continuous flows involve nanolitre volumes of continuous liquid flow within micro-
fabricated channels. An external pressure, such as a mechanical pump or an inte-
grated micro-pump, propels the liquid flow through the system. Whilst this type of
microfluidic device will miniaturise the analysis system and has proved successful in
areas such as on-chip electrophoresis (80, 149) and polymerase chain reaction (PCR)
(84, 85), it does not address the problem of dispersion and time delays associated
with microdialysis.
5.1.2 Digital Microfluidics
An important recent advance in microfluidics has been the use of an immiscible
carrier fluid to break the analytical flow stream into discrete segments or droplets.
This area is becoming known as digital microfluidics. The advantage of digital
microfluidics is that droplets are easily manipulated and independently controlled.
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Droplets can be merged together (150, 151, 152), thoroughly mixed (153, 154),
split (155, 156), sorted (157, 158) and incubated (159), followed by analysis on-chip
(160, 161). Droplets can also be manipulated by geometry of the channels alone,
which removes the need for moving parts (such as valves or pumps (162)).
Digital microfluidics provides reproducible operations using low volume reactors
and the high control and rapid mixing in droplet-based systems has decreased re-
action times and provided a high throughput platform. The advantage of this is a
low cost device, with minimum interference from the user, for many applications.
5.1.3 Microfluidics and Microdialysis
The first on-line biosensor for microdialysis used tubular electrodes (163) and the
first miniaturised device incorporating microdialysis sampling with on-chip chemical
analysis of glucose and lactate, was described in 1997 (164). Whilst successful, it was
a complicated multiple layer system designed for plasma analysis, which typically
has much higher concentrations of glucose and lactate. There are examples of using
on-line microdialysis coupled to amperometric analysis (164, 165), but the majority
of studies are conducted in animals. Clinically, as previously discussed, only rsMD
has been used, but this too has problems. All of these studies are conducted in
continuous flows and hence ignore the problems of dispersion and the time delay
before analysis.
In the clinical environment, microfluidic devices have been used only in labora-
tories, but development is moving towards point-of-care testing (166, 167, 168, 169).
The low volumes and easy manipulations make this an attractive idea. Using mi-
crofluidics on-line to measure continuously from a patient at the bedside, is a new
concept and combining microfluidics and microdialysis has many advantages. The
use of digital microfluidics can eliminate Taylor dispersion, cross-contamination, di-
lution of samples and evaporation due to compartmentalisation of reagents (170)
within the carrier fluid.
It is my view that microdialysis is in many ways the killer application that ben-
efits from microfluidics. Using a faster flowing oil stream, the aqueous dialysate
droplets can be quickly propelled down the connection tubing reducing the time lag
between sampling at the MD probe tip and analysis. Hence, the microdialysate flow
rate through the probe can be reduced, achieving a higher analyte recovery, without
compromising on the transit time. As the dialysate droplets are segmented in an
immiscible fluid, there is no mixing between successive droplets and hence no smear-
ing of sharp concentration changes due to the Taylor dispersion seen in continuous
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flows. This will greatly improve temporal resolution and allow monitoring of fast
analyte changes.
The group of Kennedy et al were the first to interface digital microfluidics to
microdialysis analysing the signals optically via laser induced fluorescence (171).
Whilst in a research environment optical analysis is a good solution and is easy to
implement in a two-phase system, it is inappropriate for use in an intensive care ward
due to the large and expensive equipment. The development of novel techniques to
manipulate and analyse the droplets will introduce a potentially beneficial system for
all microdialysis users and I aim to integrate digital microfluidics and microdialysis
with electrochemical analysis. With good design, droplets can be easily manipulated
and the improvement in fabrication techniques provides the opportunity to fabricate
an on-chip electrochemical detector.
5.1.4 Chip Fabrication
The methods of fabrication initially started with photolithography using silicon, as
the technologies were well-developed from the semi-conductor industry. Due to in-
creased popularity of LOC devices, specific characteristics were more in demand,
such as optical transparency and biochemical compatibility. This led to the ad-
vancement of technology for a wider range of materials including glass, metals and
plastics. Soft lithography is the method of fabrication used to create structures in
polydimethylsiloxane (PDMS) (172), a popular material of choice. PDMS is easily
moulded and cured and it is optically transparent down to a wavelength of 300 nm.
PDMS is durable with a good chemical stability and has a low interfacial free energy
(22 dyn/cm) (172). PDMS is naturally hydrophobic with a water contact angle of
112 ◦, is gas permeable and chemically inert (173). The drawbacks of PDMS include
swelling of cured PDMS and shrinking (of about 1%) of the polymer upon curing
((172)). The softness of the elastomer limits the aspect ratio of microstructures that
can be fabricated without pairing or sagging, which lowers accuracy. Delamarche et
al (174) show that the aspect ratio must be between 0.2 and 2 to obtain defect free
stamps.
5.1.5 Droplet Generation
By use of an immiscible fluid such as oil, aqueous solutions can be segmented into
droplets, due to the liquid-liquid interfacial tension and shear force between the two
phases. These droplet compartments are well-defined and reproducible and can act
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as reaction cells in which kinetic parameters can be extracted (175). Multiphase
flows are most commonly generated by the use of T junctions (176) and flow fo-
cussing geometries (176, 177, 178, 179). A T junction is where an inlet channel
containing the disperse phase joins perpendicularly to a continuous phase (170).
Induced shear forces within the two phase system causes the head of the disperse
phase to be elongated into the main channel until the neck thins to a point where it
breaks. The characteristics of the droplets formed can be tightly controlled through
relative flow rates, viscosities, surface tension and geometry (153). Flow focusing
is where both phases are forced through a narrow gap and the droplets are formed
by symmetric shearing. This geometry is harder to implement. In this thesis a T
junction is used to generate droplets.
5.1.6 Carrier Fluid
The carrier fluid (the fluid with the higher wettability on the channel surfaces) is
most often oil in digital microfluidics. An alternative is air, thus removing the po-
tential safety problems oil causes on a clinical ward. Here, a flow focussing method
provides better stability of droplet formation and droplets could be produced faster.
However, a much higher flow rate is needed (20 µLmin−1 plus) and ideally a vac-
uum pump or gas cylinder would be used to propel droplets. When tested, the
droplet generation was unstable and it was harder to manipulate the droplets due
to the compressibility of air. Evaporation of water from the droplets is a problem
in air resulting in a false analysis due to the concentration of analytes changing.
Also, droplets could come in contact with the channel surfaces, resulting in cross
contamination of samples due to adherence of proteins. Oil has the advantage of
a mechanical force to manipulate the fluids and wet the surface of the channels,
removing cross-contamination and evaporation issues. Therefore, in this thesis oil is
used. Initial experiments used hexadecane, a hydrocarbon with a chain of 16 carbon
atoms. However, the majority of work was conducted using FC-40, a perfluorocar-
bon, which has high stability to various chemicals, excellent lubricity and dielectric
properties, and is non-toxic.
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The first test was to create a droplet flow stream. Oil and water were perfused
through a crude T junction fabricated by hand. Once droplets were formed, the
next question was how to analyse the contents of the droplets. A second chip was
fabricated and droplets of ferrocene monocarboxylate (Fc) were generated. Elec-
trodes housed in Radel tubing (as described in section 3.2.2) were placed in the
droplet stream.
5.2.1 Methods: Chip Fabrication
A crude chip was cast to create a T junction and generate droplets. A second chip
was created using the same method and electrodes inserted into the droplet stream.
The method was as follows:
Polyester resin and activator (Robnor resins, RX771C/NC and Ardour hard-
ener HY1300GB) were mixed in a ratio of 3:1, poured into a polydimethylsiloxane
(PDMS) mould consisting of a single channel (width 500 µm and depth 250 µm)
and heated at 60 ◦C for 10 minutes. A slide made of PET was treated in a plasma
chamber for 12 seconds. The cast was placed on the PET and returned to the oven
at 80 ◦C for 1 hour. Drilling through the side of the cooled chip created a T junction.
Radel tubing of inner diameter 750 µm (1/16” OD), was used as connection tubing
and glued into place using epoxy resin. The second chip, used Radel tubing to house
the electrodes, which were also glued into place. Oil was connected to the inlet at
a flow rate of 176 µLmin−1 and Fc was connected to the T junction inlet, with flow
rates varying from 1.5 µLmin−1 to 2 µLmin−1. Figure 5.1 shows a photograph of
these chips.
5.2.2 Methods: Electrodes
Two working electrodes were tested in the initial chip: a cylindrical working elec-
trode , diameter 50 µm length 2 mm, and a 50 µm disc electrode. These electrodes
were tested using both a bare electrode and an electrode coated with poly(sodium-
4-styrene-sulfonate) poly(L-lysine-hydrobromide) (PSSPL) (Sigma-Aldrich). A dip
coating method was used with PSSPL to create a hydrophilic layer on the working
electrode. To do this, first the clean working electrode was dipped into 25 mM poly-
styrene sulfonate for 30 seconds. The electrode was then left vertically to dry with
the tip pointing up, for 30 minutes. The electrode was then dipped into poly-lysine
solution for 30 seconds and left, vertically, overnight to dry at room temperature.
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Figure 5.1: Photograph of the initial chip
A simple straight channel was cast into polyester resin and sealed to a glass slide. Perpendicular
channels were drilled to create either a T junction or channels in which electrodes are inserted.
The above photograph has three perpendicular channels, one each for the working, auxiliary and
reference electrodes. Connections at the inlet and outlet were made using epoxy glue (Araldite).
5.2.3 Initial Findings: Droplet Generation
Generation of droplets within this crudely made chip was surprisingly easy. However,
although high flow rates were used the droplets were very long in length. This was
due to the large geometry of the channels and hence large volumes used. Using this
method of fabricating the chips, it is very diﬃcult to make the channels smaller by
hand and hence a better technique is required. Later versions of the microfluidic
chips were fabricated using soft lithography.
5.2.4 Initial Findings: Analysis of Droplets
Two main issues arose from placing the electrodes directly into the droplet stream.
It was found that the electrodes must be contained within the same droplet for
analysis of its contents. If one electrode is within the oil or within another droplet
then the circuit is broken and a reliable reading cannot be taken. This was not a
problem here as the droplet length was very long. Also, if the electrode came in
contact with the oil, the oil fouled the electrodes by wetting the surface and blocked
out the aqueous signal, see figure 5.2.
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Figure 5.2: Response of 2 mm cylindrical electrode in droplet flow
The working electrode was held at a constant potential of 0.5 V vs Ag|AgCl and the current
recorded in a droplet stream of ferrocene monocarboxylate and hexadecane oil.
To investigate this further, a 50 µm disc electrode was moved between hexadecane
oil and ferrocene solution in a beaker and the electrochemical response recorded,
shown in figure 5.3. The electrode functioned well after dipping in the oil for 1 s,
figure 5.3B. However, if the surface is exposed to the oil for a longer time period,
the aqueous signal is lost due to surface fouling, figure 5.3C.
To overcome the fouling, a hydrophilic PSSPL film was applied to the surface
of the electrodes using a dip coating method. Application of PSSPL stabilised the
signal of droplets even after repeated long exposure to oil. PSSPL allows wetting of
the electrode surface by the aqueous solution and therefore the oil passes by without
covering the surface. Looking at the responses of a bare electrode compared to a
PSSPL electrode there is a reduction from approximately 10 nA to 0.8 nA in current
when run at a potential of 0.5 V, figure 5.3D . Hence, there is a trade-oﬀ between
stability of the electrode in a multiphase flow and the signal recorded. If this film
was subsequently used on a biosensor this would severely impair the sensitivity of
the sensor, rendering it useless for monitoring ischemia.
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Figure 5.3: Response of 50 µm electrodes to hexadecane oil
A: Cyclic voltammogram in a beaker of 1.5 mM ferrocene monocarboxylate versus Ag|AgCl. Scan
rate 50 mV/s B: The working electrode was held at 0.5 V and the electrode repeatedly dipped
in hexadecane for 1 s periods. C: The working electrode was held at 0.5 V and was repeatedly
transferred to the oil for 150 s before being moved back to the ferrocene solution. D: PSSPL coated
50 µm electrode on chip in a droplet stream of 1.5 mM ferrocene monocarboxylate and hexadecane.
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5.2.5 Lessons Learnt
Whilst we were able to make droplets easily using a polyester drilled T junction,
the end product was messy and inflexible. The main channel was formed using a
master made by curing PDMS over a wire. There is a limit on the size of wire
that can be used to do this reproducibly and to a good enough standard. As the
inlet for the aqueous phase was made by drilling, the surface of the channel walls
were not very smooth. Also this channel was much larger than the main channel.
Hence, large droplets were formed with short spacings of hexadecane oil. Due to this
ratio, the overall flow rate of the droplet stream was not as fast as we had hoped.
The connections to the inlet and outlet were very diﬃcult to make successfully and
permanent once glued in placed. This led to problems when trying to optimise the
system as more flexibility was required. These issues were addressed by using PDMS
chips.
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5.3 Droplet Generation
PDMS was used to give more flexibility in chip and channel design. George White-
sides first used rapid prototyping to create microfluidic systems in PDMS (180).
Whitesides also used PDMS to create complex three dimensional structures, which
he describes as basket weaves (181). This section will look at the T junction fabri-
cated using soft lithography in PDMS, which is used throughout this thesis.
5.3.1 Chip Fabrication
The method of fabricating the mask and master is defined in chapter 2. Once a
master is created, it can be re-used to fabricate chips several times. This step is
described here.
The PDMS chip is made by thoroughly mixing 25 g PDMS base and 2.5 g
curing agent (Sylgard 184 elastomer) (10:1 ratio by weight) in the open laboratory.
Approximately 90 % of the mixed PDMS is poured over the master, which has been
cleaned by blasting with nitrogen. The extra 10 % is poured into a clean petri dish
and kept to one side for use later as the base. PDMS casting either took place in
a chemistry clean room or in the fume cupboard of a wet lab. The master PDMS
is degassed using a desiccator attached to a vacuum pump. If after 10 minutes
there are still bubbles on the surface, a pasteur pipette was used to pop them. The
master PDMS is baked for 1 hour at 65 ◦C on a hot plate. Once cured, the PDMS
is peeled from the master, cut into chips using a sharp scalpel and holes punched for
connection tubing, using a blunted needle tip (see table 5.1 for details). The extra
PDMS in the petri dish, is now placed on a hot plate (65 ◦C) for 12 minutes. The
base PDMS is semi-cured and is tested by lightly touching the surface with a fully
cured piece of PDMS, and the two should stick together. The texture should be
such that only a light imprint of the fully cured PDMS is left on the surface. If the
base is not cured enough then the chip will sink and the channels will fill up, and
if it is too cured then the two halves will not stick together. The chips are placed
channel side down onto the semi-cured PDMS base and sealed together by baking
at 65 ◦C for at least 4 hours but preferably overnight.
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Table 5.1: Sizes of commonly used tubing and electrode needle compared with the
blunted needle used to punch the hole
Electrode size / Gauge Hole punch size / gauge
25 20
27 22
31 22
Tubing OD / µm Hole punch size / gauge
780 (FEP) 20
1090 (Portex) 18
610 (Portex) 20
5.3.2 Optical Detection
Droplets in the PDMS chip were visualised using several optical methods. A USB
microscope (VHM-004, Discovery, Veho) was found to be suﬃcient to check the
microfluidic chips in detail when in use in the wet laboratory. Here, coloured dyes
were often used in the aqueous flow for contrast. This USB microscope had the
added advantage of coupling the video to the data acquisition software used for the
electrodes (Chart, ADInstruments). A high speed video camera was also used to
gain videos of droplets through the PDMS chips. An inverted optical microscope
(IX71, Olympus) served both as light source and detector. To collect images and
videos, a CCD camera (Phantom Miro 3, Vision Research) was connected to the mi-
croscope, shown in figure 5.4. Fluorescent measurements were also taken when using
droplets of fluorescein (Sigma-Aldrich). This involves Laser Induced Fluorescence
(LIF), which is discussed in section 5.5.1 and the method involved using the optical
microscope in epifluorescence mode. A mercury lamp (U- LH100HG, Olympus) was
used for wide-field illumination and images collected by using the same objective
(UPlanFL N 10x/0.30, Olympus). The fluorescence emission and the illumination
were separated using fluorescence mirror sets (U-MF2, U-MWIG3, Olympus). To
acquire the emission light, an EM-CCD camera (iXon+, Andor Technologies) was
used and analysed with the accompanying software.
133
5. A MICROFLUIDIC TOOL KIT
!"#$%&'
(&)&"*'+#)
,,!
-+""#" .#/01
%&)1
2)*%31+14/5+$
6'*7&
8)9&"'&:
;+/"#1/#$&
#<=&/'+9&
>+7541$&&:
?"*;&47"*<<&"
@AA);
:+#:&4%*1&"
2B!C DE F-E
!,E
B>
DC
F-C
!,E
!,C
GHH);
:+#:&4%*1&"
Figure 5.4: High speed camera setup
The experiments were conducted using an inverted microscope coupled with a high speed CCD
camera. Droplets were generated using either a T junction in a microfluidic chip or using a robotic
head, both of which are described in the following sections.
5.3.3 Droplet Generation: T junction
To form a droplet flow, a T junction was fabricated using PDMS. This consists of a
main channel, in which the carrier phase flows, and a second perpendicular channel
containing the disperse phase. Figure 5.5 shows the master used. An extensive
evaluation of the eﬀect of geometry on droplet size and stability was carried out by
Dr Xize Niu for this project. The best results were obtained using the design shown.
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Figure 5.5: Master of T junction
The master is used to fabricate PDMS chips. The square pads contain square pillars and were
designed as filters for dust or large particles in the solutions. To avoid droplet break up, this
feature was omitted at the outlet.
At the junction where the two immiscible fluids interact, droplets spontaneously
form. The aqueous phase pushes into the main channel and the flow of the oil drags
it down the channel. The neck of the aqueous flow will thin until it is unstable and
it breaks, forming a droplet. This is shown clearly in figure 5.6 and in Video 1 on
the associated DVD. The size and frequency of the droplets formed is very tightly
controlled by the geometry of the channels, the flow rate ratio and the relative
viscosities of the liquids used. Due to the immiscibility of the two phases, the
droplets remain separate. Although droplets do not mix together, the solution
within one droplet is well mixed. There is a no-slip condition at the walls but at the
interfaces of aqueous solution and oil the velocity is equal to the convective velocity
of the droplet.
!"#"$ !"#"%&' !"#"(&'
Figure 5.6: High speed sequence of droplet generation
A high speed camera was used to record the generation of droplets in a PDMS T junction. Hex-
adecane oil and water were pushed into the chip using syringe pumps at 225 and 150 µLmin−1
respectively. The width of the channels is 100 µm. A frame is shown every 3 ms.
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This diﬀerence results in a flux of fluid in a strong circulatory, secondary flow
within the droplet i.e. the solution is dragged to the back of the droplet and circles
back to the front by passing through the middle, figure 5.7. Therefore each droplet
has rapid and thorough mixing and homogeneous concentration profiles.
Figure 5.7: The flow within an aqueous droplet
A schematic indicating the movement of solution within an aqueous drop due to the no-slip condi-
tion at the walls. As the droplet moves down the channel, the solution is pushed towards the back
of the droplet and circles back through the middle.
5.3.4 Droplet Generation: Robotic Head
Droplets were also formed using a robotic head designed by Dr Xize Niu (Drop-
Tech). This allows the aqueous solution to change with great precision. The tubing
is attached to the robotic head and the end of the tubing is positioned at the
interface between oil and sample. Suction is applied and the robotic head moves up
and down, moving the tubing end across the interface. The initial version allowed
for two diﬀerent aqueous solutions and a newer version of the robotic head now
exists, allowing for fifteen diﬀerent aqueous solutions and is programmable using
Labview. The fifteen well robotic head is shown in figure 5.8.
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Figure 5.8: A photograph of the robotic head in a 15 well setup
15 sample wells are arranged in a circle above a large well filled with oil. The 15 samples rotate
around and the tubing is moved up and down between the oil and the aqueous solution.
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5.3.5 Droplet Frequency
LIF was used to investigate the eﬀect of flow rate on the droplet frequency and
size, figure 5.9. The oil was pumped through the system at a constant rate of 10
µLmin−1. The aqueous flow rate was changed from 2 µLmin−1 to 4 µLmin−1. The
number of droplets produced increased with aqueous flow rate, as expected.
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Figure 5.9: LIF data of droplets
LIF used to detect fluorescein droplets at diﬀerent flow rates. The red trace has an aqueous flow
rate of 2 µLmin−1 and the blue trace has an aqueous flow rate of 4 µLmin−1. The oil was pulled
through the system at a flow rate of 10 µLmin−1 in both cases.
5.3.6 Droplet Length
A sequence of droplets containing fluorescein was recorded using LIF, figure 5.9. The
resulting trace was analysed by calculating the relative standard deviation (%RSD)
of the length of the droplet at half height. Generation of a droplet every 3 seconds
gives a %RSD of 0.63 (n=25). At a generation rate of 1 droplet every 1.5 seconds
the %RSD = 1.39 (n=25). These numbers indicate that the droplet generation is
very stable in terms of length, and hence volume, of the droplets produced. The
easiest way of changing the length of the droplets, and hence the volume, during
operation is to change the ratio of flow rates.
Table 5.2 summarises the findings from manipulating the flow rates of the aque-
ous and oil phases. The length of the droplets in the FEP tubing connected to the
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outlet of the microfluidic chip, was measured using a ruler and therefore is an ap-
proximate reading. Another way of changing the volume of the droplets is to change
the geometry of the channels however, this requires new designs and re-fabrication.
Table 5.2: Approximate length of droplets in FEP tubing compared to aqueous and
oil flow rates
Aqueous / µLmin−1 Oil / µLmin−1 Droplet length / mm
2 10 3
2 7 4
2 5 5
2 2 6
2 1 7
1 4 4
2 4 6
5 4 10
7 4 very near continuous
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5.4 Digital Microfluidics and Microdialysis
5.4.1 Laser Induced Fluorescence
Laser Induced Fluorescence (LIF) is a spectroscopic measurement used for detection
and analysis of molecules. The laser used is a diode laser. The species to be visualised
are excited by a laser beam using a particular wavelength. When the species de-
excites, a larger wavelength than the excitation wavelength is emitted. This is
detected and the species is said to fluoresce. A laser was aligned and focused on the
microfluidic analysis chip. Droplets of fluorescein were pushed through the chamber
and the resulting emittance was recorded and analysed. Excitation wavelength of
fluorescein is 490 nm.
5.4.2 Microdialysis Probe Recovery
A recovery experiment was conducted to test the application of digital microfluidics
for a microdialysis system. This involved placing a microdialysis probe (Animal
probe: CMA12, membrane length 2 mm, CMA Microdialysis) in the vortex of a
vigorously stirred fluorescein solution [1 µM]. The probe was perfused with buﬀer
solution at varying flow rates. The outlet of the microdialysis (MD) probe was
connected to a T junction chip via FEP tubing of varying lengths (approximately
10 cm, 1 cm and 0 cm). When required droplets were formed using FC-40 oil. The
dialysate was transferred to an analysis chip where fluorescence measurements were
taken. LIF was used to record the level of fluorescein in the dialysate as the perfusate
flow rate was changed. 100 % recovery was recorded by perfusing the analysis chip
with 1 µM fluorescein. Recovery in continuous and droplet flow regimes were tested
and was calculated using equation 5.1.
Recovery(%) =
(FluorescenceIntensity)Dialysate
(FluorescenceIntensity)PureF luorescein
× 100 (5.1)
The recovery results using 3 diﬀerent connection tubing lengths are shown in
figure 5.10. As expected, the recovery largely depends upon flow rate. At lower flow
rates there is a higher recovery due to the solution within the probe having longer
to equilibrate with the external solution.
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Figure 5.10: Recovery of fluorescein in droplet and continuous flows
The figure compares the recovery in continuous and droplet flow. A: Continuous and droplet
flow recoveries using approximately 10 cm connection tubing length. B: using approximately 1cm
tubing length C: the outlet of the MD probe is attached directly onto the T junction.
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With approximately 10 cm of FEP tubing between the probe outlet and the T
junction (figure 5.10A), there is little diﬀerence between the recovery seen in the
continuous and discrete flow regimes. Unexpectedly, when a shorter tubing length
is used, approximately 1 cm, there is a slight diﬀerence in the recoveries at lower
flow rates (figure 5.10B).
The average diﬀerence in recovery levels between droplet and continuous flow are
displayed in figure 5.11 for a low (1 µLmin−1) and a higher flow rate (7 µLmin−1).
Two connection tubing lengths, 1 cm and 10 cm, are also displayed. A student t-test
was conducted on each group (n=3) to see if the discrepancy is significantly diﬀerent
from zero. Only one group was statistically significant; 1 cm connection tubing at
1 µLmin−1 had a P value of 0.049. The other three groups were not significant.
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Figure 5.11: The diﬀerence in recovery between continuous and droplet flow
Average diﬀerences and standard deviation shown. Two lengths of tubing are shown for both a
low (1 µLmin−1) and high (7 µLmin−1) flow rate.
This was investigated more closely with an experiment that specifically looked
at the eﬀect of tubing length on recovery, at a low perfusion flow rate. The recovery
experiment was conducted as before, however only a perfusion flow rate of 1 µLmin−1
was used. A small connection tubing of approximately 1 cm was used to connect the
outlet of the MD probe to the T junction. Droplet and continuous flow regimes were
tested in this setup. The connection tubing was then changed to a longer length,
of approximately 10 cm, and the recovery in both regimes tested. The small tubing
was then replaced and the experiment repeated. Figure 5.12 shows the results.
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Figure 5.12: Comparison of fluorescein recovery in droplet and continuous flows
with diﬀerent tubing lengths
Trace A (purple) uses approximately 1 cm of connection tubing between probe outlet and T
junction. Trace B (green) uses approximately 10 cm tubing. Trace A2 (pink) is a repeat of A.
Continuous flow regime shown in the top graph, droplet flow in the bottom.
143
5. A MICROFLUIDIC TOOL KIT
The level of fluorescein seen in the continuous flow regime did not change over the
course of the experiment. This suggests that it is not to do with back pressure in the
system. However, in droplet flow, variable levels of fluorescein are seen. The upper
levels of the traces indicate the aqueous flow and the lower levels the oil. When a
longer tubing (trace B, green) is used, the level of fluorescein is similar to that in
continuous flow. However during droplet flow, the level of fluorescein increases by
about 50 %.
For confirmation, the outlet of the microdialysis probe was attached directly
onto the microfluidic T junction. Figure 5.10C shows the recovery results. The
microfluidic chip was heavy in comparison to the probe and balancing the chip on
the outlet was, practically, very diﬃcult to achieve (NB the tip of the probe had to
be in the vortex, so the positioning of all components was very tricky). There is an
enhanced recovery at lower flow rates, with the recovery at 1 µL/min−1 increasing
by 30 % in absolute terms.
From visual inspection of the intersection at the T junction, the flow of the
dispersed phase momentarily stops as the neck of the droplet breaks oﬀ. If this
eﬀect propagates back to the fluid in the probe, then it could enhance recovery in
the microdialysis probe by allowing the fluid in the probe more time to equilibrate.
This would account for the higher recoveries found in droplet flow compared to
continuous flow. The approximate length of these droplets was measured in FEP and
found to be 3 mm equating to a volume of 0.034 µL. The volume of the membrane
at microdialysis probe tip is 0.4 µL and therefore at any one time would contain
the volume for approximately 12 droplets of dialysate. So, if the stop-start motion
generated at the T junction did propagate back to the solution at the tip, it is
feasible for the recovery to be aﬀected. However, this eﬀect can only be harnessed if
the T junction can be placed close to the MD probe membrane. Clinically approved
probes used in the study of brain injury have an outlet tubing, which is too long for
this eﬀect to make a diﬀerence.
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5.4.3 Micro Particle Imaging Velocity (microPIV)
To look more closely at the flow at the T junction, fluorescent microspheres (F8834
Molecular Probes) were perfused through a T junction during droplet generation
at a flow rate of 2 µLmin−1. FC-40 oil was used as the carrier fluid at a flow rate
of 2 µLmin−1. The T junction was visualised using a USB microscope (VMS-004,
Discovery, Veho) and the resulting videos analysed using a particle tracker plugin
in ImageJ, figure 5.13.
Figure 5.13: The tracking of a particle in a T junction
The image shows the positions of a fluorescent microsphere at each frame of the video as it is
carried through the T junction in the disperse phase. Note that the spacing is not even between
the positions of the microsphere as it travels down the perpendicular channel.
The velocity changes as each droplet is generated. When the disperse phase
pushes into the main channel the velocity increases as it gets carried by the flow of
the oil. When a droplet breaks oﬀ into the oil phase, the velocity in the aqueous
channel decreases. This aﬀects the distance that the microspheres move as they are
carried in the aqueous solution, figure 5.14A.
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The motion in the aqueous flow during segmentation was also investigated by
using a pressure driven pump with integrated flow sensors. The fluids were controlled
and driven by pressure created using a gas cylinder. The flow sensors were integrated
to monitor the flow rate of the fluids. The flow rate of the aqueous phase during
segmentation is seen in figure 5.14B. When a droplet breaks oﬀ into the oil flow,
the flow rate decreases rapidly before returning to a steady level as a new droplet
begins to form.
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Figure 5.14: Movement of the disperse phase in a T junction
A: The velocity of a microsphere within the aqueous solution, as it moves down the channel, is
shown. Velocity was calculated using a particle tracker plugin in ImageJ. B: Flow sensors were used
to measure flow rate within a pressure driven droplet generation system. Green arrows indicate
the segmentation of droplets.
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Overall, when the T junction was connected to the outlet of the animal MD
probe, either directly or with 1 cm of connection tubing, an enhancement in the
recovery rates were seen. This is an interesting eﬀect, which is likely to be due to
the stop-start motion of the aqueous phase at the T junction, seen in the microPIV
study. This stop-start motion could be propagated back to the solution at the
membrane, allowing more time for the analytes to diﬀuse across the membrane.
However, this would only occur when the connection length is suﬃciently small,
presumably due to the ability of the plastic syringes and connection tubing to swell
slightly and accommodate the changes in flow. Therefore this eﬀect would not be
seen in a clinical probe due to the long lengths of tubing required for the outlet. In
future research, combining the MD probe with droplet generation may be beneficial
and a more thorough study would be needed.
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5.5 Manipulation of Droplets
Ultimately digital microfluidics will be applied in the clinical environment. Here, I
describe some parameters, which can and will be changed when the droplet stream
is introduced.
5.5.1 Surface Tension
Surface tension can be altered by the addition of surfactants to the oil. The ability of
a liquid to wet a surface depends upon the adhesive and cohesive forces acting upon
the interaction. In a straight microfluidic channel the wetting of the channel walls
depends upon the hydrophobicity of the surface and of the liquids. In figure 5.15A,
the oil wets the surface. This is the case with PDMS as it is a hydrophobic material
and the adhesive forces acting between the PDMS surface and the oil are stronger
than the cohesive forces acting within each. The aqueous solution has stronger
cohesive forces and tries to avoid contact with the PDMS surface. When surfactants
are added to the oil, the interfacial tension between the oil and the aqueous phase
is reduced. Surfactants are amphiphilic, containing both a hydrophobic region (the
tails) and a hydrophilic region (the heads). At a T junction, the ability of the
aqueous phase to push into the oil channel is controlled by the interfacial surface
tension. Surfactants sit at this interface, lowering the surface tension, making it
easier for the aqueous phase to push into the oil. Therefore longer droplets are
formed when surfactants are added to the oil as the neck of the droplet can be
stretched thinner. The surfactants can also sit at the interface between the oil and
the PDMS channel walls. The surface, therefore loses its hydrophobicity, and the
aqueous solution may wet the surface, as seen in figure 5.15B. Here, there are oil
droplets forming in the aqueous solution.
For the purpose of my work, it is essential that oil wets the surface of the channels,
as this eliminates mixing between the droplets. If surfactants are required then the
PDMS surface must be modified to create a super-hydrophobic surface, for example
by the use of Duxback. Duxback is commonly used to treat car windows to repel
rain water, however, can also be applied to PDMS with the same eﬀect.
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Figure 5.15: Depiction of droplets in a channel with diﬀerent wetting properties
The aqueous solution is shown in blue. A: the oil is wetting the surface of the channel so the aqueous
droplet has convex edges. B: The aqueous solution wets the surface of the channel producing a
concave edge eﬀect and oil droplets.
5.5.2 Flow Rates
As previously described, the flow rates of both the oil and the dialysate will aﬀect
droplet formation. In the clinical environment however, it can also be used to
reduce the lag time. At 2 µLmin−1, with a connection tubing of length 1 m, the
time lag between the analyte leaving the probe and reaching the assay for analysis is
approximately 10 minutes. Although this is better than oﬄine measurements, such
that traditional microdialysis, it is still not real-time. As we are proposing that fast
changes in metabolites through events, such as spreading depolarisations (SDs), are
detrimental to the overall outcome of the patient, it is our goal to measure the events
as close to when they happen as possible. Digital microfluidics is a great way of
propelling the dialysate to analysis. By using a fast flowing oil stream, the droplets
can be propelled over 1 m of connection tubing without the recovery of the probe
being aﬀected. In fact, it has the additional advantage of enabling the dialysis flow
rate to be lowered without increasing the time lag. This will increase the recovery
of the probe without losing the time resolution needed.
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5.6 Analysis Chip
As seen from preliminary studies with electrodes and oil, fouling of the electrode
surface is a big issue. A coating (PSSPL) applied to the electrode surface was tested
and although it stopped the oil wetting the surface, it resulted in low sensitivity.
Therefore, a second analysis chip was designed that could remove the oil and rejoin
the droplets into a continuous flow. The aim was for the analysis chip to be placed
away from the patient, after the 1 m of necessary connection tubing, and for it
to contain all the electrodes required for analysis. In this section I describe two
chip designs using the general approach of passive coalescence. A more detailed
discussion of passive coalescence follows in section 5.7
5.6.1 Analysis Chip: Design 1
The first design of the analysis chip, to separate the oil and aqueous flows is shown
in figure 5.16. The droplet stream approaches a set of pillars, which separates two
outlet channels. The oil is filtered through the pillars into a secondary channel.
Meanwhile, the aqueous droplets rejoin to form a continuous flow in a main outlet
channel. Within this channel, sensors can be placed on-chip for analysis and the
continuous dialysate path can be connected to rsMD for validation. Also the solution
can be collected and used in traditional microdialysis analysis techniques.
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Figure 5.16: Analysis chip design 1
An outline of the mask used to fabricate the analysis chip. Pillars separate the two channels and
act as a filter to remove the oil. The varicosities on the dialysate outlet arm are to contain the
analysis electrodes. Channel width is 100 µm.
150
5.6 Analysis Chip
This analysis chip was designed to run under suction. The oil is pulled through
the system using a syringe pump placed at the oil outlet in figure 5.16, from a bottle
at the oil inlet at the T junction, which precedes this chip. The aqueous phase is
both pushed into the T junction and pulled at the dialysate outlet on the analysis
chip using syringe pumps. The dialysate push and pull flow rates are equal (typically
2 µLmin−1) and the oil flow rate is defined by the oil suction (typically 5 µLmin−1).
This has the advantages of independently controlling the oil and aqueous flow rates
and lowering the back pressure in the system. This is particularly important when
a microdialysis probe is used, as back pressure can cause the membrane to rupture
or can influence recovery.
Figure 5.18 shows a droplet entering the analysis chip and the two phases sep-
arating. A video of the droplets joining in design 1 (Video 2) can be found on the
associated DVD. In figure 5.18A the oil is being pulled through the pillars at 5
µLmin−1, the rejoined dialysate is moving at 2 µLmin−1 and the incoming droplets
are moving at a combined flow rate of 7 µLmin−1. Due to the droplets moving faster,
the incoming droplet catches up with the rejoined dialysate. The oil continues to
deplete through the pillars, shown in figure 5.18B.
Additional free energy is required for a droplet to pass through the pillars. This
is defined by the surface tension. During a given time interval, the change in aqueous
volume between the pillars as the droplet passes, is the same irrespective of the size
of the pillar spacing. However, the shape of the aqueous solution is diﬀerent when
comparing pillars, which are close together and those which are far apart, figure 5.17.
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Figure 5.17: Pillar spacing eﬀect on droplets
Pillars are represented by the peach rectangles. A: shows pillars closely spaced. The walls are
hydrophobic so the aqueous solution forms a highly curved structure B: shows pillars with large
spacing in between them. The same amount of volume if now spread over a wider area.
151
5. A MICROFLUIDIC TOOL KIT
This leads to the surface area being much larger when the pillars are close to-
gether. As the surface energy depends upon the surface area and surface tension,
the additional free energy at pillars, which are close together is much larger than
when the pillars are spaced far apart. Therefore it is harder for the aqueous droplets
to pass between pillars that are closer together. The surface tension of water is 0.072
Jm2, whereas the surface tension of FC-40 is 0.016 Jm2 (182). The lower surface
tension of the oil allows it to pass more easily through the pillars, and as the channel
walls are hydrophobic, the oil wets the surface, making it easier still.
The pillars are spaced such that the droplet is unable to flow between the pillars.
It passes straight along and joins the rest of the dialysate, shown in figure 5.18C.
A problem with this design is highlighted in figure 5.18D. Once the droplet has
joined the rest of the dialysate, the aqueous phase blocks oﬀ the oil channel. As a
result, the oil flow rate tends to zero, and both the droplet and the dialysate flow
rate is now 2 µLmin−1. If this eﬀect is propagated back to the generation of the
droplets at the T junction, then both the generation and the rejoining will have to
be synchronised. In practice, this is diﬃcult to achieve and the setup took a couple
of hours but, once balanced, the separation of the two phases worked spontaneously.
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Figure 5.18: Design 1: images from a high speed camera
The chip was videoed using a high speed camera. Channel walls have been outlined for clarity.
Frames were cut from a video and show the droplet stream entering left to right. The aqueous
droplet phase is dark and the oil phase is transparent. A, B and C are 20 ms apart and D is 1 ms
later.
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The application of constant suction, at the oil and dialysate outlets, resulted
in air bubbles forming in the channels. The air could be pulled from either the
FC-40 oil, as FC-40 oil has an oxygen solubility of 15.1 molm−3 at 25 ◦C (183),
from the aqueous solution or through the PDMS, which is well known to have a
high gas permeability (184). These air bubbles caused many problems by stretching
and compressing, resulting in changes to the relative flow rates of the three flows
(droplet, oil and aqueous). In this situation the oil and aqueous flows were not
separated.
To try and stop air being pulled through the PDMS, I sealed the chip in an epoxy
resin glue (Robnor resins, RX771C/NC and Aradur hardener HY1300GB 1:2.5),
figure 5.19. The glue did not seal to the tubing used for inlet and outlet connections
so once cured I could easily remove and change the tubings when required. However,
it was not suﬃcient and air was still being pulled into the chip. Therefore it was
concluded that the air was being drawn from the solutions and a change in design
was required.
Figure 5.19: A PDMS chip sealed in glue
The objective was to stop air permeating through the PDMS and forming air bubbles in the
channel. The PDMS chip was sealed in epoxy glue.
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5.6.2 Analysis Chip: Design 2
In response to the problems seen in design 1, a second design was fabricated, fig-
ure 5.20. Here, the oil can be filtered through two side channels in either direction,
about an analysis chamber. The dialysate droplets coalesce within this chamber,
which is 1360 µm x 500 µm. With a wall height of 100 µm the chamber will hold
68 nL of dialysate. The design also contains a T junction to generate droplets on
the same chip and a dosing arm, which is discussed later in section 5.9. If any of
these channels were unwanted during a specific experiment, then the chip was first
flooded with oil and the inlets to the unwanted channels blocked.
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Figure 5.20: Analysis chip design 2
An outline of the mask, which is used to fabricate the analysis chip is depicted. Pillars separate
the two phases about an analysis chamber where the electrodes for analysis are placed. The design
also contains a T junction for droplet generation and a dosing arm for addition of reactants such
as enzyme or calibration solutions of known standards (see section 5.9). Main channel width is
250 µm.
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Figure 5.21, shows frames from a high speed video (Video 3 on the associated
DVD), in which a droplet enters and emerges from the chamber. The oil phase rejoins
the aqueous phase after the chamber and recreates the droplet flow. The aqueous
droplets join together in an analysis chamber, which creates a constant aqueous
environment with suﬃcient dimensions to place two integrated needle electrodes.
The symmetrical extraction of oil, and the recreation of the droplet flow reduces the
formation of disruptive air bubbles. Suction now only needs to be applied to one
outlet, rather than two individual outlets as in design 1. Therefore the flow rates
do not need to be balanced by the user as the suction applied in design 2 will aﬀect
all three flow paths (the oil, the aqueous flow and the droplet flow).
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Figure 5.21: Design 2: images from a high speed camera
The frames are cut from a video recorded using a high speed camera and show the progression of a
droplet as it passes through the analysis chamber. Each frame is 20 ms apart, the oil is transparent
and the water droplets are dark.
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5.7 Passive Coalescence
The geometry of the channels and pillars filter out the oil without any moving
parts and the separation occurs spontaneously via passive coalescence. The spaces
between the pillars are such that they are smaller than the width of the chamber
outlet and smaller than the representative droplet diameter. This ensures that the
aqueous droplets do not enter the side channel as either a whole droplet or as sister
droplets. The incoming droplet flattens against the stationary chamber droplet and
the interstitial oil is depleted. The two interfaces interact via Van de Waals forces
and the droplets merge. Detail of the coalescence of droplets in design 1 is shown
in figure 5.22A and in design 2 in figure 5.22B.
!"#"$ !"#"%&' !"#"(&' !"#")&'
!""#$
%&'()*+,-'!
!"#"$ !"#"*$&' !"#"+$&'
.""'#$
/&'()*+,-'.
Figure 5.22: Detailed view of droplet coalescence
The frames are cut from a high speed video and the chamber walls have been outlined for clarity.
A: shows the progression of a droplet joining the aqueous channel as the oil is filtered into a
secondary channel through the pillars in design 1. Each frame is 3 ms apart. Note at 3 ms there
is a collection of oil on the side of the droplet furthest from the pillars, which is still seen at 6 ms.
B: shows the progression of a droplet joining the aqueous solution within the analysis chamber in
design 2. The symmetrical design solves the problem of trapped oil by allowing access to a second
side channel.
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To investigate the merging of droplets closer, a high speed video was recorded
with a frame rate of every 2 ms. Figure 5.23 shows a still from the video. Even
at this frame rate it was not enough to capture the coalescence of two droplets,
but a hybrid photograph is seen. The frame rate is not fast enough to distinguish
either state and shows the droplet both separated and merged with the chamber
solution. Bremond et al show a snapshot of two droplets merging together (151).
Capturing a frame every 0.1 ms allowed them to see the formation of two nipples in
the contact area, after the droplets had flattened against each other and had pulled
apart slightly. They speculate that these nipples allow the coalescence to occur.
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Figure 5.23: A still from a high speed camera showing detailed merging of droplets
Frame rate is 2 ms. The shadow is where the frame rate is not fast enough to catch either state.
The image shows both the separated and joined droplets.
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5.8.1 Flow Rate Optimisation
To look at which flow rates were optimal, the oil flow rate was varied whilst the aque-
ous flow rate was kept constant at 2 µLmin−1. This altered the size and frequency of
the droplets and hence altered the way they interacted at the chamber. Figure 5.24
shows the results. At a distance of 0 µm, the edge of the aqueous solution held
within the chamber is in line with the beginning of the wall, as indicated by the
orange dotted line. Once a droplet has entered the chamber it stops briefly, whilst
the oil between it and the next droplet is removed. At this point a measurement
is made from the edge of the chamber solution to the zero line. A positive reading
indicates that the chamber is full and the aqueous solution is protruding into the
channel, and a negative reading indicates that the chamber is not full enough.
When the oil flow rate is close to the aqueous flow rate there is a great deal
of variability in the measurement. Closer inspection of the videos show that the
chamber does not function very well. The oil sometimes flows through the chamber,
inhibiting the coalescence of the droplets. At very large flow rates the chamber again
does not function very well. Here the droplets are too small and they do not join
together properly, allowing oil through the chamber. Droplets are seen to bundle
together before coalescing. Within the range of 5 to 15 µLmin−1, the chamber works
very well, with the spread of reading being much tighter. It is within this range that
the oil flow rate should be. The most reliable flow rate is 5 µLmin−1, because the
distance is most consistent and close to zero (hence close to the chamber area where
the sensors can be placed) and this flow rate was most often used.
5.8.2 Siphoning from the Chamber
The ability to pass the dialysate to rsMD after on-chip analysis, was required to
validate the microfluidic system. In design 2 the outlet of the chip cannot be directly
connected to rsMD as was initially intended with design 1, as the droplet flow is
reformed. Whilst the solution can be collected and allowed to separate into two
phases for traditional analysis, online rsMD was still desired. During fabrication a
small hole can be punched in the chamber into which tubing can be inserted. If
suction is applied at a very slow flow rate (typically < 1 µLmin−1), then an aqueous
stream can be formed by drawing out the solution from the chamber. The flow rate
must be low, so that the chamber does not become void of aqueous solution. There
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Figure 5.24: Analysis of droplet catching with varying oil flow rates
Aqueous flow rate constant at 2 µLmin−1. Oil flow rate was varied from 1 to 20 µLmin−1. Zero
distance is indicated by the dotted orange lines. Chamber droplet size measured from this line
when aqueous solution inside was still. A positive distance is towards the pillars and a negative
distance is inside the chamber itself. Photographs are stills from high speed videos.
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will be some dispersion in the continuous aqueous flow, which is unavoidable, but
this may be reduced if the chip was connected to the valve using a small length of
low bore connection tubing. Figure 5.25 and Video 4 on the associated DVD, shows
the chamber siphoning. The main problems which occurred were ensuring the valve
connections were air tight and that the frequency of droplets was such that the
chamber did not empty. This was very diﬃcult to do, even with the connection
tubing hard-wired into the rsMD machinery. For this reason, this procedure was
not employed during the animal and clinical work described in this thesis. However,
there is the possibility of optimising this procedure for future work.
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Figure 5.25: Siphoning from the analysis chamber
The still from a video is annotated showing droplets of green food dye being formed using a T
junction, passed through a serpentine and then a continuous aqueous stream being pulled from the
chamber at a very low flow rate for analysis via rsMD.
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5.9 Droplet Dosing
The ability to control and manipulate droplets on-chip led to the idea of dosing
droplets. This involves the addition of a known solution to each droplet before
analysis. The solution added could be a variety of options, including reagents for
reactions, such as enzymes or reaction mediators, or standards for calibrating on-chip
sensors. The addition of reagents is an important aspect of chemical and biological
analysis. Reliable and precise addition is diﬃcult and many designs have been
postulated in the literature. Two designs were tested in this thesis: a T junction
and a specially designed side arm channel.
5.9.1 Dosing using a T junction
Instead of flowing oil through the main channel and segmenting an aqueous flow, the
T junction can be used to add an amount of solution to a passing droplet stream. A
droplet stream is pushed through the oil channel and the dosing solution is pushed
through the perpendicular channel. This is shown in figure 5.26 and Video 5 on the
associated DVD. Here, coloured dye has been added to water to demonstrate the
addition. Yellow droplets are entering from right to left and blue water is added to
each droplet as it passes, turning it green.
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Figure 5.26: Droplet dosing using a T junction
Yellow droplets have already been generated (aqueous 2 and oil 5 µLmin−1) and are being pushed
through the oil channel of the T junction. Continuous blue solution is being pumped in the
perpendicular channel (0.5 µLmin−1). Green droplets are created due to the addition of the blue
solution to the yellow droplets.
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Dosing using a T junction was first reported by Henkel et al (185). Addition of
reagents via a T junction is said to be eﬃcient as it forces the solution around a
sharp bend. This causes a directional change in flow, giving rise to a perpendicular
secondary flow that improves mixing of the two solutions (186, 187). However, these
reports are within continuous flows. Within the droplet literature, it is reported
that there asymmetric shear stresses at the inlet boundary disrupting the dosing
(154, 188, 189). This is seen in figure 5.26 where the blue solution is not evenly
added to the yellow droplets. That is, the blue solution is added as a thin layer to the
yellow droplet until the end of the droplet where a larger volume is added. Whilst,
there are ways to thoroughly mix the droplets through design, such as serpentines,
the uneven addition may give rise to an error in the volume of blue solution added.
Synchronisation was also problematic with extra droplets being formed in between
the incoming droplet stream. This too has also been widely reported (185, 188, 190).
Therefore the geometry of the chip was altered and a specifically designed side arm
was introduced.
5.9.2 Dosing using a Side Arm
A side channel was included in the design of the analysis chip (seen in design 2,
figure 5.20). The junction where the dosing arm joins the droplet channel has been
altered from a T junction to include room for the incoming solution to expand into.
This is displayed in more detail in figure 5.27 and Video 6 on the associated DVD.
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Figure 5.27: Droplet dosing using a side arm
A still from a video showing a solution which is added to each droplet as its passes the side arm.
The solution could be enzymes, to analyse the contents of the droplets or standards to calibrate
the system at specific time points. The flow rate of the oil was 30 µLmin−1, the aqueous solution
was 5 µLmin−1 and the dosing solution was 0.5 µLmin−1.
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The coalescence of the dosing solution and the droplet is spontaneous and the
graph in figure 5.28 shows the mean length of the droplet before the dosing channel
and after the dosing channel by analysis of the high speed video in ImageJ (n=4).
The volume of each droplet before dosing is approximately 5 nL and the additional
volume from the dosing channel is approximately 3.6 nL.
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Figure 5.28: Droplet lengths before and after dosing addition
This graph displays the length of the droplets before and after an addition. The flow rate of the oil
was 30 µLmin−1, the aqueous solution was 5 µLmin−1 and the dosing solution was 0.5 µLmin−1.
The length of the droplets were measured in ImageJ. The mean length is shown with standard
deviation error bars; n=4.
The %RSD of droplet length before addition was calculated to be 2.46% and
after addition to be 3.49%. This will include some error in the measurement of
length, which was calculated directly from the video using ImageJ. The dosing of
the droplets has increased the error, however the %RSD value is still low.
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Instead of joining the main channel at right angles, the perpendicular dosing
arm has a ramp on the downstream wall. This angle creates room for the dosing
solution to expand into and avoid a pressure build-up as it will no longer occupy
the full channel width. The idea of allowing the dosing solution more room to
expand has also been seen in the literature, however a diﬀerent design was used
(188). This creates an addition that is evenly spread through the droplet, as seen
in figure 5.29. It also reduces the possibility of extra droplets forming (188) as it
delays the forward motion of the dosing solution. A serpentine was included to mix
the droplets thoroughly by chaotic advection before analysis within the chamber.
Figure 5.29: Droplet dosing using a side arm
Blue droplets have already been generated (aqueous 2 µLmin−1 and oil 8 µLmin−1) and are
being pushed through the main channel. Continuous yellow solution is being pumped into the
perpendicular channel (1 µLmin−1). Green droplets are created.
Droplet dosing has the possibility of allowing for a primitive form of self calibra-
tion, which is required for all clinical instrumentation. A standard could be added
to the droplets to calibrate the sensors. This could be automated to occur every
few hours so that the performance of the sensor can be tracked during the course of
monitoring and any changes in sensor sensitivity can be accounted for in analysis.
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5.9.3 Size of Droplets and Mixing
During preliminary investigations a coloured food dye was often added to the water
to watch the droplet dosing more easily. After the junction where the dosing channel
meets the main droplet channel, a serpentine (An S shaped channel) was employed.
The serpentine passively stretches and folds small droplets, which yields chaotic
mixing in an otherwise laminar flow. Using food dye to visualise the droplets, it was
discovered that if the droplets were too large, then the serpentine was not suﬃcient
for total mixing. Here, mixing occurs upon diﬀusion alone, and the mixing time
scales are therefore very long. This is seen clearly in figure 5.30 where the two
solutions remain distinct within the droplet even when within the analysis chamber.
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Figure 5.30: Mixing in a large droplet
This photograph shows a droplet stream of coloured water and FC-40 oil (2 µLmin−1 and 5
µLmin−1 respectively). The T junction used to generate droplets is just out of shot, top right.
Red droplets are made at the T junction. Blue water is added to the droplet using a dosing arm (1
µLmin−1). Due to the long length of the droplet there is not suﬃcient mixing and the two colours
remain separate in the droplet. At the analysis chamber, the two colours are still distinct.
In the literature there are many accounts of thorough and rapid mixing in smaller
droplets and many report using serpentines. In a straight channel there is convection
in each half of the droplet. However, in a serpentine channel, the two halves are
reorientated and striations occur, promoting mixing. This is due to chaotic advection
which repeatedly stretches and folds the droplets. This is seen in figure 5.31, which
is taken from (191). Therefore, if this technique were to be integrated into the
clinical system for automated additions of calibration standards, then the system
must take droplet length into account and be designed accordingly.
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Figure 5.31: Mixing in small droplets in a serpentine
This figure is taken from (191). Mixing by chaotic advection is shown. As a droplet passes
through a winding channel it is stretched and folded as it is reorientated. This facilitates diﬀusion
and thoroughly mixes the contents of the droplet.
5.9.4 Addition of Enzyme Solutions
Another way of using the dosing capabilities of microfluidics is to dose in enzyme
solutions. The serpentine would thoroughly mix the enzyme with the dialysate.
This could allow for an exhaustive reaction between the substrate and the enzyme,
provided that the channel length is such as to allow for a complete reaction between
enzyme and substrate. This may increase the sensitivity of the sensors. The first
attempt is shown in figure 5.32. 1 mM glucose droplets were made at a T junction
with FC-40 oil at 2 µLmin−1 and 5 µLmin−1 respectively. The droplets were passed
to the analysis chip which had a dosing channel filled with 4 U/ml GOx. Within
the analysis chamber was a 125 µm platinum electrode with external reference and
auxiliary electrodes. The flow in the dosing channel was initially oﬀ until a baseline
current was recorded. The dosing flow was turned then on at a flow rate of 2
µLmin−1.
The change in current seen as enzyme-dosed-droplets pass, is much larger than
that seen using a glucose biosensor on the same size electrode. As the flow rates of
the glucose and the enzyme solutions were set to the same (2 µLmin−1), each droplet
contained 0.5 mM glucose and 2 U/mL of GOx. This gives rise to a sensitivity of
4.9 x 105 nAmM−1cm−2, higher than that seen using a disc electrode (see table 4.7
for reference). However, the eﬀect did not last long as the droplets containing the
enzyme started sticking to the surface of the channels as shown in figure 5.33. Note,
that when only buﬀers are used during dosing, this eﬀect is not seen. However, once
the enzyme is added, the aqueous solution wets the PDMS surface.
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Figure 5.32: Droplet dosing: addition of GOx
Droplets of 1 mM glucose were run through the analysis chip. Current from a 125 µm Pt disc
electrode with external reference and auxiliary electrodes, placed in the analysis chamber, was
recorded. GOx (40 mg dissolved in 10 mL aCSF) was added by turning on the flow in a dosing
channel. Flow rates were 5 µLmin−1, 2 µLmin−1 and 2 µLmin−1 for FC-40 oil, glucose and GOx
respectively.
Once the PDMS surface was covered with aqueous solution, droplets no longer
formed. The chips were rinsed with distilled water and the experiment was repeated.
To get a baseline 1 mM glucose droplets were run without the enzyme dosing. It
was noticed that the baseline had shifted upwards and fluctuations were occurring,
figure 5.34A. Using the USB microscope linked to the Chart (ADI) recording soft-
ware, the timings of these fluctuations in current were investigated. When a glucose
droplet enters the chamber the current increases. Once the droplet has passed the
current falls. It is most likely to be that some enzyme has stuck to the PDMS during
the previous experiment. As the glucose droplets pass through the channels, there
is some reaction, forming hydrogen peroxide, which is detected at the electrode.
Figure 5.34B is a zoom of the baseline in figure 5.32, which it at the very begin-
ning of the experiment before any enzyme had been perfused through the chip. The
fluctuations are not seen here. In general, the movement of the dialysate through
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Figure 5.33: Enzyme dosed glucose droplets sticking to the channel surface
Droplets of 1 mM glucose were dosed with GOx solution dyed red with food dye. After one droplet
passed, subsequent droplets wet the PDMS channel surface.
the chamber is not seen by the electrode, and hence it can be concluded that the
enzyme is stuck somewhere within the channels.
The concentration of the enzyme in the dosing solution was initially high, and to
try and reduce the amount of enzyme sticking to the PDMS channels, the concen-
tration was reduced to 1 U/mL. However the same problem of the enzyme sticking
to the channel surface still occurred and disrupted the droplet structure.
To try and stop the enzyme sticking to the PDMS, the channels were treated
with Duxback. Duxback makes the surface super-hydrophobic. A small amount of
Duxback was injected through the channels and the chip was heated on a hot plate
at 80 ◦C for 5 minutes to evaporate the solution. The chip was then primed with
oil before the experiment. A poly(phenol) coated 125µm diameter disc electrode
was placed in the chamber on a Duxback treated chip. 1 mM glucose droplets were
continuously generated (Glucose flow rate was 2 µLmin−1, FC-40 flow rate was 4
µLmin−1) and pushed through the chip. The pump containing the enzyme syringe
was turned oﬀ and on (at a flow rate of 2 µLmin−1) to dose the droplets with 1
U/mL GOx.
169
5. A MICROFLUIDIC TOOL KIT
!
"
##
$
%
&'
('
%
)
*+,$'('-
!
"
!
"
##
$
%
&'
('
%
)
*+,$'('-
Figure 5.34: Glucose droplet baseline
A: Droplets of 1 mM glucose were pumped over a previously used chip. Fluctuations in baseline
are shown using a 125 µm Pt disc electrode placed in the analysis chamber. B: Baseline from
figure 5.32 shown in detail and on the same scale as A.
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The result is shown in figure 5.35. Whilst this worked for a while, the eﬀect was
not long lasting and eventually the enzyme attached to the surface of the PDMS
and disrupted the droplet flow as before.
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Figure 5.35: Glucose droplets dosed with GOx on a Duxback treated chip
1 mM droplets were flowing through the chip throughout the whole experiment (denoted G). The
glucose droplets were dosed with GOx and the current increased (denoted G+GOx). The electrode
is a 125 µm poly(phenol) coated electrode.
It is possible that this method could produce a sensitive assay, however the
properties of the enzyme, the PDMS, and the oil surfactant need to be thoroughly
investigated and optimised. Leach et al used a 1 % solution of bovine albumin for
one hour prior to enzyme measurements, to reduce enzyme adhesion to the PDMS
channels (192); it would be possible to investigate these methods for future work.
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5.10 Clinical Safety
For the application of digital microfluidics into a clinical environment, the system
must be fool-proof and safe at all times. The oil was of great concern, as a reversal
of flow would push the oil towards the patient. This could cause non-sterile fluid
to enter the patient and increase risk of infection and adverse eﬀects. To make the
system safe, the oil was sucked throughout the whole system from an open bottle
placed lower than the head of the patient, using a syringe pump placed after the
analysis chip. This way if any pump failed or if there is a blockage at any point
throughout the system then the easiest path for the fluid to flow is to the open bottle
and not back through the MD probe. See figure 5.36. Using suction at the end of
the system also reduces the back pressure on the microdialysis probe compared to
conventional microdialysis.
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Figure 5.36: Schematic of clinical microfluidics
Schematic showing the setup for use of microfluidics on a clinical ward. The oil is in an open
beaker placed below the head of the patient. The oil is pulled through the system by suction from
a syringe pump placed on the clinical trolley. The dialysate is pushed through the system using a
small microdialysis pump attached to the patient.
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5.11 Conclusion
To miniaturise the clinical system and create a low volume flow cell to house elec-
trodes, microfabrication was used. This led to the development of a microfluidic
tool kit for microdialysis users. It was decided that digital microfluidics would sig-
nificantly improve the clinical system by eliminating Taylor dispersion and reducing
the time lag of transferring the sample of dialysate from the brain to analysis, a
problem for all microdialysis users.
A T junction was fabricated, to high quality, to produce a robust and precise
method of droplet generation. Optical methods were used to investigate the proper-
ties and the manipulation of droplets. Droplet frequency, length and volume can be
altered by varying the channel geometry, the relative flow rates and the surface ten-
sion. The compatibility of digital microfluidics and microdialysis was tested using
an animal MD probe. Recovery of fluorescein was evaluated using LIF. Surpris-
ing results were found, with higher recoveries in droplet flow when the outlet of the
probe is connected directly onto the T junction. This was investigated further, using
microPIV, with the result that the stop-start motion at the T junction changed the
flow of dialysate at the semi-permeable membrane. This may have a consequence
when combining the MD membrane and droplet generation into one device. How-
ever, for the purposes of clinical microdialysis, where the clinical probe has a long
outlet, this has little consequence.
Once droplets of dialysate were reproducibly created, a method of analysing
the droplets contents with biosensors was required. The evolution of an analysis
chip, designed to be situated away from the patient, with two designs for electrode
placement, was discussed. Although design one successfully separated the oil and
dialysate into two separate channels using suction, the system was inherently high
pressure and the balance of flow rates was hard to fine-tune. Separation did not
occur if the system was unbalanced at any point. As well as unsuccessful separation,
the high pressure also pulled air through the PDMS and air bubbles formed in the
channels, creating further problems. These bubbles blocked the flow and caused
diﬃculties, due the ability of air to stretch and compress. The second design, with a
symmetrical separation, was therefore developed. To maintain balanced pressures,
the droplet flow was recreated, after an analysis chamber. The oil was filtered into
two side channels about the chamber, which was designed to house needle electrodes
for analysis. Optimal flow rates were discussed, as well as the collection of droplets
for traditional analysis. The creation of a continuous aqueous flow via slow suction
from the chamber is preferable, as this allows for comparison of results against rsMD.
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This however, needs to be hard-wired into the system and at present it too is prone
to air being drawn through the system.
Droplet dosing was investigated by the use of a T junction and a dosing side
channel. A serpentine was included in the analysis chip design to mix the droplets
after an addition from this side channel. This could be used as a form of self-
calibration in the hospital, by standard additions of substrates. However, it was
diﬃcult to synchronise the flow from the dosing arm and the incoming droplet flow.
Addition of enzymes was also investigated, however further problems of surface
wetting occurred, which disrupted the droplet form. This has been successfully
reported in the literature and so a more thorough investigation is required. Possible
parameters to look at are; the properties and concentration of the enzyme solution,
the PDMS surface hydrophobicity and the use of a surfactant to balance the change
in surface tension, which the enzyme may introduce.
Clinical safety is utmost and a method of incorporating and running the digital
microfluidic tool kit in a fail-safe mode, with no danger to the patient, was described.
The system is now ready to incorporate electrodes and biosensors for on-chip analysis
of dialysate.
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On-Chip Sensors
6.1 Introduction
This chapter brings together the electrodes from chapter 3, the biosensors from
chapter 4 and the microfluidic platform from chapter 5. Here the optimisation of
the placement of the electrodes and biosensors within the analysis chamber will be
discussed and the characterisation of biosensors on-chip is shown.
6.1.1 Optical Analysis on Microfluidic Chips
The most popular analysis technique of multiphase flow is LIF (171). In LIF, low
optical path length is compensated for by high intensity illumination and the high
sensitivity detection, possible as the excitation and detection wavelengths diﬀer.
Whilst there are many research applications in which LIF is appropriate, it is not
technically possible in many situations, such as online detection on a clinical ward
or on a wearable device. There have been reports of incorporating optical fibres and
LED light source to miniaturise the device (193, 194) with analysis via colorimetric
enzyme assays (195, 196). However, the use of external bulk optics is still seen to
be preferable.
6.1.2 Electrodes in Microfluidic Chips
Electrochemical microelectrodes are an attractive alternative to optical methods,
due to their high sensitivity, small size, low noise and simple electronics. Electrodes
were originally assembled into channel electrodes where the fluid path was defined
using a gasket. Consideration of the convective-diﬀusion equation for these systems
allowed initially analytical descriptions (see (197, 198) for reviews) and more recently
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numerical descriptions (198, 199) of common electrochemical techniques coupled to
homogeneous solution reactions. The use of fast flow rates and the fabrication of
microelectrodes by microlithographic techniques, allowed the development of flow
cells to study ultra-fast kinetics (200, 201).
The advancement of microlithographic techniques allowed the construction of
microelectrodes in channels, in either band or array (202) formations. Recently
developments in the fabrication of microchannels, has allowed flexible control over
both the electrode size and channel dimensions and the possibility of miniaturisation
of systems for lower flow velocities. Flow profiles within such microchannels have
been simulated (203). Theoretical descriptions for a microelectrode array placed
in a flow channel under steady state conditions for flow and concentration, have
been used to analyse the eﬀects of flow on coupling between electrodes (204) and to
determine the flow profile (205). An analysis of the temporal response of a microband
electrode placed in the inlet of a channel has been used to determine the dimensions
of the microchannel (206). Reports of microelectrodes analysing multiphase flows
are few. One report analyses electrochemical processes at a continuous flowing phase
boundary (207), but others concentrate on incorporating electrodes for manipulation
of droplets (157), electroporation (208), enzyme kinetics (209) and electrophoretic
separations (210) rather than analysis.
A major problem for the chemical analysis of droplets is that the carrier oil can
coat the electrode surface, thus degrading the interface between the electrode and
the droplet sample. To solve this diﬃculty, we have created a droplet coalescence
chamber, into which only the aqueous phase enters. This was described in chapter
5.
6.1.3 Mass Transport and Diﬀusion Layers
Diﬀerent positions of the electrode in relation to the channel ceiling aﬀects the CV
because diﬀusion to the electrode surface becomes inhibited and the diﬀusion fields
become altered.
Kinetics of an electrochemical reaction at an electrode surface depend upon the
diﬀusion of the reactants to the surface and diﬀusion of the products away as both
determine the surface concentrations. If the electrode is flush to the top wall of a
channel, the diﬀusion layers are determined by the electrode shape and size as well
as the geometry of the flow cell. When the electrode is recessed, the walls will also
aﬀect the diﬀusion to and from the electrode surface. Therefore a relationship exists
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between the relative sizes of the electrode and the height of the chamber walls, which
eﬀects the electrode diﬀusion layer.
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Figure 6.1: Schematic of electrode diﬀusion fields on-chip
A: 125 µm in a 25G needle, B: 50 µm electrode in a 27G needle, C: 25 µm in a 30G needle. Arrow
represents fluid path. Disc electrode indicated in blue. Relative size of diﬀusion field shown in
pink, taken as 5 times the radius (211). Channel height 100 µm.
Figure 6.1 shows a schematic of diﬀerent electrode sizes placed on-chip in two
positions, flush to the ceiling and recessed. The sizes are in the correct scale and the
channel height is 100 µm. Figure 6.1A indicates the diﬀusion field for a 125 µm disc
electrode in a 25G needle. The diﬀusion field is clearly aﬀected in both positions.
Figure 6.1B shows the diﬀusion field for a 50 µm disc electrode in a 27G needle.
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When placed flush with the ceiling the diﬀusion field is inhibited by the floor of the
channel. When recessed the diﬀusion field looks unaﬀected, however the analyte
has to diﬀuse up towards the electrode before reaching the diﬀusion field. Also, it
is unlikely that the electrode will sit in the middle of the electrode and therefore
is likely to be aﬀected by the walls. Figure 6.1C indicates the diﬀusion field of a
25 µm disc electrode in a 30G needle. In both positions the diﬀusion field seems
unaﬀected. However when recessed the performance of the electrode will be aﬀected
due to the reason just stated. In theory, the best electrode to place on-chip, is the
25 µm electrode, flush to the ceiling. However, using this size to fabricate biosensors
with a good performance is much harder.
This chapter will now discuss the placement of needle electrodes on-chip, firstly
by investigating electrode performance using cyclic voltammetry. The eﬀect of seg-
menting the aqueous flow upon the signal seen at the electrode is discussed. Optimal
placement of the electrodes along the length of the chamber, at a height relative to
the chamber ceiling and for the case of dual electrodes, the orientation to the direc-
tion of flow is also assessed. Finally, biosensors were placed on-chip and calibrated.
Experiments assess the viability of the sensors for monitoring dynamic changes seen
in the brain.
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6.2 Electrochemistry in Digital Microfluidics
The placement of the electrodes on-chip can make a lot of diﬀerence to the response
seen. It very quickly became apparent that if the electrode holes were punched
too close to the walls of the chamber then problems would occur with the chip
design. It is very tricky to punch the holes correctly; the most common mistake was
holes being punched over the wall of the chamber leading to an opening into the oil
side channels. The electrode constructs are very large and rigid, compared to the
PDMS chamber, so if the holes are punched too close to the exit of the chamber,
the electrodes can distort the design by deforming the PDMS. This opened up the
exit of the chamber and the chamber could no longer filter the oil out into side
channels. An example of each of these problems is shown in figure 6.2. To avoid
the deformation of the PDMS chip design, the holes for the needle electrodes were
punched towards the pillars, avoiding the exit of the chamber.
Figure 6.2: Photograph of electrode placement aﬀecting chamber design
There are two holes for electrodes. The left-hand side electrode hole is punched over the chamber
wall creating a path between the chamber and the side channel. The right-hand side electrode
clearly deforms the chamber design. If droplets were run through this chip the design would not
catch the droplets within the chamber.
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The first validation of the sensors in segmented flows was conducted using elec-
trochemistry and standard redox couples, RuHex and Fc. The sensors were placed
on-chip (figure 6.3) through which the redox species were perfused, and the applied
potential scanned to produced a CV. From this trace any problems with the chip
and the sensors can be determined.
Figure 6.3: Photograph of a needle electrode placed on-chip
The 300 µm tip of the integrated needle sits in the collection chamber of the analysis chip design
2. This one needle contains a 25 µm platinum working, 50 µm Ag|AgCl reference electrode. The
stainless steel shaft is used as the auxiliary. The PDMS chip is approximately 2 cm across.
Figure 6.4 compares the CVs using 125 µm and 50 µm disc electrodes under three
conditions: in a beaker, on-chip in continuous flow and on-chip in droplet flow. The
limiting currents of both sized electrodes, in a beaker, indicate that the geometry
of the electrode is hemispherical (as discussed in chapter 3). When placed on-chip
in continuous flow, the 125 µm electrode shows a small decrease in peak height
compared to the 50 µm disc electrode. When comparing continuous and droplet
flows, there is another decrease in the limiting current, seen at both electrode sizes.
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However, a satisfactory CV is recorded in droplet flow, with no interruptions or noise
from the movement of the droplets merging in the chamber. Therefore, there will
be a clear, continuous signal recorded when using biosensors to analyse the contents
of the droplets.
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Figure 6.4: CVs in continuous and droplet flow
10 mM RuHex in 1 M KCl used as the redox couple. 10 mVs−1 scan rate. Blue line indicates the
CV conducted in a beaker, the pink line in continuous flow on-chip and the purple line in droplet
flow. A: shows the CV using a 125 µm platinum disc electrode. B: shows the CVs using a 50 µm
platinum disc electrode.
6.2.1 Placement of the Electrodes Relative to the Chamber
Ceiling
It was found experimentally that there was a lot of variation in the response of
the electrode when placing the electrode on-chip. The position of the electrode,
in relation to the floor and ceiling of the chamber, was investigated further using
electrochemistry.
CVs were performed on-chip in a continuous flow of Fc, at diﬀerent electrode
positions within the PDMS chip. Figure 6.5A shows the results in a 100 µm high
chamber and figure 6.5B in a 250 µm high chamber.
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Figure 6.5: On-chip CVs at diﬀerent heights in a 100 µm and 250 µm high chambers
1.5 mM Fc. Continuous flow 1 µLmin−1. Scan rate 10 mVs−1. 30G integrated needle. 25 µm
platinum working electrode. A: 100 µm B: 250 µm.
The electrode is introduced to the chamber by pushing it through the PDMS via
a hole punched during fabrication. Ideally it should be placed close to the ceiling
without being recessed, but as it is placed by eye, this positioning can be variable.
When placed by eye the resulting CVs (OnChip traces) are seen, figure 6.5. The
electrode was then pushed until it was felt to touch the floor of the chamber. Here,
there is no CV as the surface of the electrode is not exposed to the solution, only
the PDMS floor. The electrode was then pulled out so that it was visibly recessed,
denoted Recessed in figure 6.5. The electrode was finally pulled up further and the
CV recorded again.
From using two diﬀerent heights of channel, the electrode is more accurately
placed by eye in a 250 µm high chamber i.e. the CV looks the closest to that in
a beaker. The CV in 100 µm high chamber placed by eye, is similar to the CV of
the visibly recessed electrode. Therefore, to maximise the response of the biosensors
on-chip, a larger chamber should be used. This, however, increases the sample size,
which may not be desired. The method of electrode placement could be made more
accurate, for example by using a microscope.
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6.2.2 Electrochemistry in Diﬀerent Flow Regimes
Disc electrodes of diameter 25 µm were also investigated using cyclic voltammetry
on-chip, and Fc was used as the redox couple. The CVs in continuous and droplet
flow were again compared to that seen in a beaker, figure 6.6. The placement of the
electrode on-chip is better with less reduction of the limiting current from the CV
produced in a beaker. There is a diﬀerence in the observed currents recorded using
these electrodes under continuous and droplet flow, but the CV produced in droplet
flow was still highly acceptable.
 Continuous 
 Droplet 
 Beaker
Figure 6.6: CVs in diﬀerent flow regimes using ferrocene monocarboxylate
On-chip CVs of a 25 µm disc electrode in 1.5 mM Fc in a beaker (blue trace), continuous flow (1
µLmin−1, pink trace) and droplet flow (Fc flow rate at 1 µLmin−1 and oil flow rate at 2 µLmin−1)
Scan rate 1 mVs−1, potentials versus integrated Ag|AgCl reference, chip channel height 100 µm.
The decrease in the limiting current seen in the diﬀerent flow regimes, is not
due to a diﬀerence in the positioning of the electrode and could be due to two
reasons. One, the Fc might partition into the oil changing the concentration within
the aqueous droplets and two, the electrode may be fouled by the oil because the
chamber does not work immediately.
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The shake-flask method was used to investigate partitioning eﬀects. A CV was
recorded in Fc in a beaker. Oil was added to the beaker with a volume ratio equal
to the flow rate ratio used to create droplets. The beaker was shaken to disperse the
Fc into the oil. A CV was recorded again and the limiting current assessed. The
beaker was then shaken for longer and CV was recorded for the third time in the
Fc. Figure 6.7A shows the resulting CVs at the three stages. Comparing the CVs,
it can be concluded that the Fc does not partition into the oil, as all the CVs are
identical.
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Figure 6.7: CVs looking at ferrocene monocarboxylate and oil
A: Shake-flask method; 1.5 mM Fc. FC40 Oil. Scan rate 1 mVs−1. 30G integrated electrode.
25µm platinum working electrode. Blue line indicates the CV in ferrocene, the pink line after one
shake, the orange line after a second shake. B: CVs run as the oil flow is switched on; 1.5 mM
Fc. Scan rate 10 mVs−1. Aqueous flow rate 2 µLmin−1, oil flow rate 5 µLmin−1. 30G integrated
electrode with a 25 µm diameter platinum working electrode.
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To assess potential fouling of the electrode by the oil, a clean electrode was
assessed in continuous flow. Multiple CVs were run on-chip as the oil pump was
turned on to generate droplets. To record multiple CVs as the oil is introduced, the
scan rate was increased from 1 mVs−1 to 10 mVs−1. Looking at these CVs, shown
in figure 6.7B, it can be seen that the chamber does not start working straight
away and the droplets passing straight through the chamber are seen as noise in the
scan (black line: scan1). After three scans the CV is smooth and shows no noise
(blue line), indicating that the chamber is now collecting the aqueous droplets and
removing the oil eﬀectively, however the limiting current has been lowered. The
scans are equivalent to six minutes and indicate that during this time, the surface
of the electrode has been aﬀected slightly. However, once the chamber is working
correctly, the CV is still acceptable and the electrode can still be used for droplet
analysis.
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6.3 Dispersion in Continuous and Droplet Flows
Taylor dispersion in continuous flow is a problem for online microdialysis as dynamic
changes of an analyte in the brain are smeared as the dialysate passes down a long
connection tubing (79). Continuous flow in a circular tubing, is laminar and devel-
ops a velocity profile, which is not uniform across the cross section. The fluid near
the walls moves slower than the fluid at the centre of the tubing due to friction. This
discrepancy in velocity distorts the distribution as shown in figure 6.8A. Diﬀusion
then acts to reduce the sharp change in concentration, which leads to a smearing
eﬀect, figure 6.8B. The changes in the detected signal of the step change in concen-
tration is shown in figure 6.8C. This section will investigate the eﬀect of segmenting
the dialysate into droplets upon dispersion using both optical and electrochemical
methods.
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Figure 6.8: Taylor dispersion in continuous flow
A: A step change in concentration is indicated by the red bolus. Flow down the tubing is from left
to right, B: diﬀusion causes smearing to equalise the concentration across the tubing, C: Initially
the change in concentration of the input bolus is fast and the signal large, as indicated by the
dotted line. However as the bolus travels down the tubing, the signal height decreases and the
time course lengthens. This is shown by the solid lines
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6.3.1 Optical Measurement
To simulate clinical microdialysis conditions, a step change in concentration was
transported over 1 m of low volume connection tubing in both the continuous and
droplet flow regimes at a flow rate of 4 µLmin−1. Diﬀerences in droplet colour,
created by the addition of food dye, were used for optical measurements. The change
in concentration was created on-chip by turning on and oﬀ pumps and documented
using the high speed camera. The resulting videos were analysed in ImageJ using
grayscale as a function of concentration over time. Results are shown in figure 6.9A.
The continuous flow regime has a 90% response time, T90, of 19.1 s. However, in
droplet flow, when the change is measured at the point where the droplet coalesces,
the T90 is dramatically reduced to <<16 ms, the frame rate of the video analysed.
This is a >100-fold increase in time resolution, which provides a paradigm shift
for microdialysis users by allowing the measurement of small sharp changes in the
concentration on a sub-second timescale. Figure 6.9B shows the measurement 30
µm into the chamber and here the T90 has increased to 200 ms. Therefore dispersion
is already having an eﬀect on the time resolution over this small distance.
Using the high speed videos, detailed images of the droplet coalescence were
collected. A video of droplets joining the aqueous solution in the analysis chamber,
with a frame every 2 ms, was analysed. Figure 6.10 shows three consecutive frames
from this video. In figure 6.10A the incoming droplet looks to be touching the
solution held in the chamber. In figure 6.10B the camera has captured two states.
One the same as A where the droplet is separate and also where the incoming
droplet has merged with the solution in the chamber. Figure 6.10C shows that the
droplet had joined and the oil is being filtered out. Coalescence of aqueous droplets
therefore occurs in under 2 ms as figure 6.10B shows an intermediate picture where
the interfaces are seen as both separate and joined together.
Therefore, close to the point of coalescence there is a cliﬀ-like change in con-
centration. As the droplets coalesce in under 2 ms, diﬀusion has no eﬀect. As the
droplet is pushed into the chamber over a longer time period, diﬀusion can occur
and the concentration change is altered by dispersion. Hence, the position of the
electrode within the chamber is important and to improve time resolution the sensor
should be placed as close as possible to the point of coalescence.
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Figure 6.9: Optical comparison of continuous and droplet flow regimes upon disper-
sion over 1 m tubing
Data was collected from high speed videos. Total flow rate 4 µLmin−1. Continuous flow indicated
by a red line, the blue line indicates data collected from just inside the meniscus. In B droplet
data collected at diﬀerent positions in the channel is compared where the green line indicates the
recording 30 µm into the chamber.
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Figure 6.10: Coalescence of droplets
Frames every 2 ms from a high speed video. A: The incoming droplet touches the aqueous solution
in the chamber. B: An intermediate image indicating that the coalescence of droplets occurs in
under 2 ms. C: The aqueous solutions have joined together and the oil is being filtered through
the pillars into the side channels.
6.3.2 Electrochemical Measurement
Dispersion over the 1 m connection tubing was also investigated using electrochem-
istry with electrodes placed on-chip. The results were compared to the optical mea-
surement, shown again for easy comparison in figure 6.11A. Initially a redox couple
was used with a bare platinum electrode. A step change from 0 mM to 1.5 mM Fc
was created on-chip in continuous flow. The solution was passed through 1 m of low
volume connection tubing at 2 µLmin−1, to an analysis chip containing a clean 50
µm platinum working electrode. The experiment was repeated in droplet flow and
the results are shown in figure 6.11B. The experiment was then repeated using a
biosensor. A glucose sensor was fabricated using a 50 µm platinum disc electrode (as
previously discussed in chapter 4) and placed on-chip. A step change in concentra-
tion from 0 mM to 1 mM glucose, was created in continuous flow and transported
over 1m of connection tubing at a flow rate of 1 µLmin−1. The experiment was
repeated in droplet flow and the responses are shown in figure 6.11C.
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Figure 6.11: Comparison of continuous and droplet flow regimes upon dispersion
over a 1 m tubing using diﬀerent analysis techniques
A: Optical detection of a change in colour in droplet flow (blue) and continuous flow (red). Flow
rate 4 µLmin−1. B: Electrochemical measurement using a 50 µm platinum electrode detecting a
change in concentration of Fc in droplet and continuous flow regimes. Flow rate 2 µLmin−1. C: A
glucose biosensor, fabricated on a 50 µm combined electrode, detects a change in concentration of
glucose in both flow regimes. Flow rate 1 µLmin−1.
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Table 6.1 summarises the results from all three experiments, in terms of flow
rate, and the 90% response times. The response times vary with flow rate and are
comparable. As the flow rate is halved, the relative response time approximately
doubles. The glucose biosensor has a slightly longer response time because diﬀusion
to the electrode surface is reduced due to the poly(phenol) film used to entrap the
enzyme.
Table 6.1: Dispersion over 1 m connection tubing: continuous and droplet flows
Method Flow rate / µLmin−1 T90 Continuous / s T90 Droplet / s
Optical 4 19 0.2
Fc + bare electrode 2 32 0.5
Glucose + sensor 1 69 1.4
It is very apparent that digital microfluidics has the great eﬀect of eliminating
Taylor dispersion. This is due to the compartmentalisation of solutions into discrete
droplets, which do not interact with each other until they reach the analysis chamber.
Applied to microdialysis systems, this will have a large eﬀect, as a long connection
tubing from the probe to analysis is a necessary component in both animal and
clinical procedures.
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6.4 Placement of Electrodes Along the Length of
the Chamber
This section will describe a detailed analysis of the chamber to find the optimal
position of the electrode within the chamber to maximise the sensitivity and reli-
ability of the recordings. Optical methods were used to compare flow dynamics in
the chamber to a mathematical model.
6.4.1 Optical Analysis
Optical analysis was used to assess the droplets merging in the chamber and hence
find the optimal positioning of the electrodes. This involved creating a sequence
of alternating droplets, four dark (water with a dye moiety) and four light (water),
using a robotic head. These droplets were then introduced to the analysis chamber
where a CCD camera (Phantom V) recorded the chamber as the droplets passed
through. The setup is shown in figure 5.4 (minus the laser setup). The videos were
analysed in ImageJ, as shown in figure 6.12.
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Figure 6.12: Processing of high speed videos
A: A single frame of a high speed video of the microfluidic chamber where droplets coalesce. An
analysis line was drawn with ImageJ and the greyscale values measured (using 8-bit conversion).
Distance measured from 0 µm to 1360 µm, left to right. B: Plot profile of the grayscale values
measured along the line. C: For some images the grayscale was converted to false colour images
(generated by ImageJ).
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A line was drawn through the centre of the chamber within ImageJ, along which
the grayscale was analysed at every pixel. The complete length of the chamber was
analysed (1360 µm). The midline of the chamber was analysed to avoid the eﬀects
of flow complexities (such as corner flow), which occur due to the oil wetting the
PDMS surface. The midline was analysed at diﬀerent time points, which allowed
the same change in concentration to be observed as it moved through the chamber.
Figure 6.13 shows frames (in false colour) from a video (Video 7 on the associated
DVD) of a dark droplet entering a white filled chamber.
Figure 6.14 displays the change from a light filled chamber to a dark filled cham-
ber, with the midline analysed every 50 ms. The change is clearly seen at the
entrance of the chamber by the decrease from 1 to 0.1 and occurs over 121 µm. 0.75
s later, the same step change in concentration occurs over 740 µm. Dispersion is
aﬀecting the time resolution by smearing out the step change in concentration, as
each new droplet enters the chamber, displayed here as the change in the gradient of
the rising slope. Before the arrival of the next droplet, the oil is being removed and
the solution in the chamber is stationary. This is seen as overlapping traces. Here,
the gradient does not change indicating that there is no mixing whilst the solution
is stationary.
6.4.2 Mathematical Model of the Chamber
A mathematical model of the chamber was designed by Professor Kim Parker, to
help determine the best position to place analysis electrodes. In developing a model,
it was assumed that the chamber is rectangular and that the concentration of the dye
inside the inlet droplet was uniform at the entrance of the chamber (where x = 0).
It was also assumed that inertial eﬀects are so small that the velocity profile within
the chamber was either zero when the oil was being removed or instantaneously fully
developed when the approaching droplet first coalesced. It also assumed that the
pattern of dark and light droplets is symmetrical. The Reynolds (Re) number of the
aqueous solution in the microfluidic channels was calculated, using equation 6.1, to
be 0.4, placing the fluid flow in the laminar regime.
Re =
vL
ν
(6.1)
where v is the velocity, L is the length travelled and ν is the viscosity.
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Figure 6.13: Frames of a video of the aqueous solution entering the analysis chamber
The frames are in false colour for eﬀect and show a progression of a dark droplet joining the light
coloured aqueous solution held in the chamber.
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Direction of Flow
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Figure 6.14: Experimental data of dark and light droplets in the chamber
Initially the chamber was filled with light drops, giving the horizontal lines at C/C0 = 1. At 0 s,
a dark droplet starts to enter the chamber. 50 ms later, C/C0 was evaluated at all points along
the midline giving the curve on the left hand side of the figure. This was repeated every 50 ms to
give the complete figure. Thicker curves are due to the flow being stationary before the next dark
droplet enters the chamber. Note that the coalescence of incoming droplets is not synchronised to
the data collection rate, hence the spacing is not always even.
This also allows us to estimate the entrance length, xL, for the establishment of
a steady-state flow profile using equation 6.2 (200, 212).
xL/2h = 0.04Re + 0.5 (6.2)
where h = height. For our system xL is 100 µm, which can be compared with
the droplet length of 600 µm in figure 6.13. The analysis uses the general solution
for Poiseuille flow in a rectangular chamber given by Mortensen et al. (2005) (213).
The channel has a width w with y = [−w2 , w2 ] and height h with z = [0, h].
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The distance along the channel is x. The velocity distribution across the (y, z)
cross-section is given in equation 6.3.
u(y, z) =
4h2∆p
π3L
∞￿
n=1,3,...
1
n3
￿
1− cosh
￿
nπx
2
￿
cosh
￿
nπw
2h
￿￿ sin￿nπy
h
￿
(6.3)
where ∆pL is the pressure gradient along the channel and η is the coeﬃcient of
viscosity of the fluid. The velocity distribution is expressed either in terms of the
maximum velocity, u0, which occurs in the centre of the channel and is shown in
equation 6.4,
u0 = u(0,
h
2
) =
4h2∆p
π3L
∞￿
n=1,3,...
(−1)n−12
n3
￿
1− 1
cosh
￿
nπw
2h
￿￿ (6.4)
or the mean velocity U , which is shown in equation 6.5.
U =
1
wh
w/2￿
−w/2
h￿
0
u(y, z)dzdy
=
4h2∆p
π3L
2
π
∞￿
n=1,3,...
1
n4
￿
1− 2h
nπw
tanh
￿nπw
2h
￿￿ (6.5)
The ratio of the maximum velocity and the mean velocity is given by equation 6.6.
u0
U
=
π
∞￿
n=1,3,...
(−1)n−12
n3
￿
1− 1
cosh(nπw2h )
￿
2
∞￿
n=1,3,...
1
n4
￿
1− 2hnπw tanh
￿
nπw
2h
￿￿ (6.6)
This is shown in Figure 6.15 as a function of the aspect ratio of the cross-sectional
area γ = wh . For Poiseuille flow in a circular tube, this ratio is 2 and in 2D channel
flow (γ → ∞), the ratio is 3/2. For the aspect ratio of the microfluidic channels
used, γ = 2, the ratio is very close to 2. This is a factor which should be considered
when connecting square channels to circular tubing to achieve a smooth connection.
The velocity profile for Poiseuille flow in a channel is parabolic and comparison
of the centre line profiles for finite aspect ratios shows that the centre line velocity
profile is very close to parabolic for γ as small as 2, figure 6.16. The eﬀect of the
aspect ratio is predominantly on u0, not the shape of the centre-line profile.
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Figure 6.15: Velocity ratio
The ratio of centre-line velocity u0 to mean velocity U as a function of the aspect ratio of the
rectangular channel γ.
6.4.3 Flow Dynamics in the Droplets and the Chamber
The main diﬀerence between the flow in a droplet approaching the chamber and the
flow in the chamber, is the eﬀect of surface tension in the meniscus at the front and
back of the droplet. At the interfaces between the oil, water and wall, the surface
tension dominates the viscous forces that lead to the no-slip condition in single phase
flow. Within the droplet, the no-slip condition holds at the walls whereas at the
interfaces, the velocity at the wall is equal to the convective velocity of the droplet.
This diﬀerence in boundary conditions results in a flux of fluid away from the wall at
the back of the droplet and towards the wall at the front. This establishes a strong
circulatory, secondary flow within the droplet which results in rapid mixing within
the drop and homogeneous concentration profiles. Once the front meniscus of a
drop coalesces with the meniscus at the front of the chamber, the no-slip condition
requires that the velocity at the top and the bottom of the chamber is zero. The
resulting velocity profile causes convective dispersion. The vertical dispersion on the
centre line of the chamber is illustrated in Figure 6.17.
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Figure 6.16: Velocity distribution
The velocity distribution u/u0 in a rectangular channel with γ = 2. The black line indicates the
velocity profile in the centre of the channel across which the concentration of tracer was measured.
The concentration measured in these optical experiments is the average concen-
tration across the depth of the chamber. It is clear that the average concentration
will vary with time along the length of the chamber in a way that is rather com-
plex. Close to the inlet of the chamber, the concentration will change rapidly as the
bands of tracer are predominantly vertical. Further from the inlet the bands become
more angled and the fronts of tracer become more diﬀuse. Close to the ceiling and
the floor of the chamber, the bands are nearly horizontal and the contribution of
these bands to the average concentration provides a history eﬀect. Close to the wall
there is some tracer from all of the droplets that have preceded the current droplet.
Over time, this leads to Taylor dispersion where the concentration gradients in the
vertical direction due to the nearly horizontal bands becomes important leading to
diﬀusive dispersion in the vertical direction. In the limit this dispersion, coupled
with the parabolic velocity profile, leads to an axial concentration gradient that is
approximately Gaussian.
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Figure 6.17: Simulated dispersion within the chamber
This figure shows a simulation of the dispersion along the centreline of the coalescence chamber as
a function of z, the vertical axis, due to the parabolic flow profile. It is assumed that the droplets
are well mixed due to the meniscus at the back of the droplet until it merges with the meniscus at
the origin of the chamber, x = 0. When there is convection in the chamber, the no-slip condition
at the top and bottom walls applies and the flow profile is parabolic. The sequence of droplets
alternates between four dark and four light.
In a microfluidic device, the easiest and the most common place to fabricate
an integrated electrode, is on the wall of the channel. We also discuss in section
6.13, that the wall is best for needle electrode on simple diﬀusion field arguments.
Figure 6.17 shows that wall placement is not ideal due to the build up of previous
droplets creating a history eﬀect.
Therefore in this analysis chamber, the optimal position of the needle electrodes
is as close as possible to the point of coalescence, where the bands are vertical. This
is at the entrance of the chamber, and figure 6.18 displays this clearly. A high speed
video, with a frame rate of 2 ms, of the joining of a droplet in false colour can be
found on the associated DVD (Video 8).
Further away from the point of coalescence, the bands (seen in figure 6.17) be-
come increasingly horizontal, lowering the sensitivity of the assay. This is shown in
figure 6.19. Diﬀerent coloured droplets were recorded as they passed through the
chamber. The change from a light to dark was analysed in ImageJ. Figure 6.19A
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Figure 6.18: Coalescence at the entrance of the chamber
The chamber is filled with light solution. The interface when a dark droplet enters has been
investigated using a high speed camera. The frames are 2 ms apart and are false colour. The
graphs show the grayscale analysis of each frame.
shows the whole chamber. There is a shadow over the chip but the solution within
the chamber is clear. The black indicates the dark droplets and the yellow indicates
the light coloured droplet. The beginning of the chamber the change between the
two coloured solutions is much sharper than towards the end. This is seen more
clearly in figure 6.19B, which is a cut-out of the solution within the chamber. Fig-
ure 6.19C analyses the change from light to dark at the beginning of the chamber
and a sharp cliﬀ is seen. Whereas figure 6.19D shows the change at the end of the
chamber where the change occurs over a longer distance indicating the smearing
eﬀect.
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6.4 Placement of Electrodes Along the Length of the Chamber
In summary, the microelectrodes should be located in the middle of the chamber,
away from the walls, as here the bands are vertical and less of the history eﬀect is
seen. The electrode should also be placed close to the point of coalescence of the
incoming droplet to take full advantage of the cliﬀ-like change in concentration. Also
here, the bands are more vertical and so the position of the electrode in the channel
(in terms of position floor to ceiling) is less crucial. If, however, the no-slip condition
at the wall was broken or baﬄes were introduced to the walls, convective mixing
within the chamber would occur and stop the bands from forming. Positioning the
needle electrode in the middle of the channel would also potentially disrupt the flow,
resulting in the same eﬀect.
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Figure 6.19: False colour frames of diﬀerent coloured droplets within the chamber
A: The chamber is filled with dark solution. Four light colour droplets have entered the chamber
followed by one dark coloured droplet. B: displays a closer look at the solution within the chamber.
C: Analysis conducted in ImageJ of the change in grayscale at the entrance of the chamber. D:
Analysis of the change from light to dark droplets in grayscale at the end of the chamber.
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6.5 Dual Electrode Orientation
The dual electrodes were developed for use either as a sensor and sentinel combi-
nation or for multi-analyte analysis. It has previously been discussed that the dual
electrodes exhibit a degree of cross-talk when placed in a beaker of Fc (chapter
3). The dual electrodes were also investigated under flow conditions in a similar
experiment. One electrode of the pair was held at a constant potential of 0 V, as
the other had the applied potential scanned. As the potential increased, the classic
cyclic voltammogram is seen as Fc is oxidised to Fc+. Cross-talk is seen if the dif-
fusion fields overlap and the constant potential electrode reduces this product back
to Fc. This is seen as a negative peak. The collection eﬃciency is the percentage of
product seen at the other electrode.
The orientation of the two working electrodes when placed on-chip will aﬀect
the collection eﬃciency as now there is a directional flow of solution introducing
convection. Figure 6.20 shows schematics of the two extreme scenarios in which the
electrodes can be placed.
!
"
Figure 6.20: Schematic of dual electrodes under flow conditions
Flow direction is indicated by the arrows. The dual electrodes are shown within a chamber. A: the
electrodes are positioned across the direction of flow. The dotted lines indicate the cross section
taken to view the diﬀusion fields (schematic on the right) B: The electrodes are positioned in-line
with the direction of flow.
On the right of each orientation a schematic indicates the likely geometry of
the diﬀusion fields. When placed across the flow, figure 6.20A, the diﬀusion fields
overlap, depending on the relative spacing of the electrodes within the hypodermic
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needle. However, when placed in-line with the flow, figure 6.20B, there is now
an added factor of convection. This distorts the diﬀusion fields by flattening and
elongating them. Hence, more products formed at the upstream electrode will now
be detected at the downstream electrode than vice versa.
The orientation of the dual electrodes was assessed by marking the relative posi-
tions of the electrodes on the needles using a microscope and placing them on-chip,
both across and in-line with the flow. As an example, CVs produced at electrode
D4 are shown in figure 6.21.
A summary of the results from all dual electrodes is shown in table 6.2. Note
that D1 was broken and therefore no longer included. The collection eﬃciencies are
shown as a percentage and were calculated from the limiting currents of the CVs.
The electrodes used here correspond to the photographs shown in figure 3.16.
Table 6.2: Collection eﬃciencies on-chip
Electrode Across In Line
AScan:BCollect BScan:ACollect AScan:BCollect BScan:ACollect
D2 1.13 1.03 2.11 9.33
D3 0.95 0.96 0.69 15.9
D4 13.75 15.02 17.12 8.93
D5 0.71 0.57 1.64 0.64
D6 7.55 5.87 23.62 3.04
D7 9.06 9.03 1.53 11.59
When placed across the direction of flow, the collection eﬃciencies of the dual
electrodes are very similar at both electrodes. The cross-talk on-chip is much smaller
than the cross-talk of the same dual needle electrode in a beaker (Table 3.8). This
is due to the convection created by the flow carrying some products away from the
collection electrode.
However, when the dual electrodes are placed in-line with the flow, the collection
eﬃciency depends upon whether the collection electrode is upstream or downstream
of the generating electrode. The downstream electrode will detect more products
that are produced at the upstream electrode than vice versa, again due to the
convection added by the flow.
The majority of dual electrodes are close together and display high levels of
cross-talk. Electrode D5 has the most inter-distance between electrodes and under
flow, it produces the smallest amount of cross-talk. The fabrication of electrodes to
produce dual electrodes, which exhibit zero cross-talk should be developed.
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Figure 6.21: CVs showing the collection eﬃciencies of electrode D4 when placed in
diﬀerent orientations on-chip
1.5 mM Fc. Continuous flow 2 µLmin−1. Scan rate 10 mVs−1. 30G integrated needle. 2 x 25 µm
platinum working electrode. The percentages indicate the collection eﬃciency. A and B show the
response in line with the flow where the red electrode is upstream. C and D show the responses
perpendicular to the flow. Positive CVs are scanning whereas negative traces are produced from
the electrodes held at 0 V.
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Due to the cross-talk, two diﬀerent analytes cannot be measured. However,
the chamber is large enough to house two separate hypodermic needles. In this
arrangement, one electrode will be upstream of the other, and the cross talk between
working electrodes was tested using the same experimental protocol. Figure 6.22
shows the CVs produced and cross talk was found to be 0.1 % between separate
needles. Here, there is an approximate distance of 500 µm between electrodes.
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Figure 6.22: CVs of separate needle electrodes in the chamber
Continuous flow of 1.5 mM Fc perfused at 2 µLmin−1. Scan rate 50 mVs−1. 2 x 50 µm platinum
working electrode. Electrodes are in line with the flow with the red electrode upstream. Red CV
is scanning whereas negative the purple trace is held at 0 V. Collection eﬃciency is 0.1 %.
In summary, the amount of cross-talk on the dual electrodes, on-chip, depends
upon the orientation of the two electrodes compared to the direction of flow. There-
fore, dual electrodes in this format cannot be used to create a multi-analyte sensor.
Two needle electrodes can be placed in the same chamber and run simultaneously
with no crosstalk between the sensors. However, the response of the down stream
electrode is compromised by being further away from the point of coalescence. An
alternative solution may be smaller detection chambers placed in series, rather than
expanding one chamber to house multiple sensors, as each microelectrode can be
positioned at the optimal location at the point of coalescence within each chamber
to achieve the highest time resolution and sensitivity.
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6.6 Biosensors On-Chip
The glucose and lactate biosensors described in chapter 4 were placed on-chip for
assessment. They were placed within the analysis chamber and initially tested in
continuous flow. Solutions of varying concentrations of glucose and lactate were
introduced on-chip and the responses characterised. The sensors were then assessed
in droplet flow. Both glucose and lactate are considered hydrophilic and have parti-
tion coeﬃcients (LogP values) of -2.84 and -0.62 respectively (214, 215). The glucose
will not partition into the oil and will stay within the aqueous droplet ensuring an
accurate measurement. The partition coeﬃcient of lactate suggests that it may par-
tition into the oil. However, lactate has a pKa value of 3.86 (216), meaning that
less than 0.1 % will be in the correct state to partition into the oil. Finally the two
diﬀerent sensors were placed on-chip together, within the same analysis chamber,
and solutions alternated between glucose and lactate.
The main problem of calibrating the sensors on-chip was found to be the alterna-
tion of solutions to produce a reproducible step change in concentration. A syringe
switcher was initially tested but the change in pressure caused by the switching
caused the solutions to jump. This was especially apparent in droplet flow and the
droplet generation was greatly aﬀected. Syringe pumps were then employed and
the solutions alternated by stopping and starting the pumps. The solutions were
fed into diﬀerent channels on-chip. Whilst this was more reproducible the pumps
were very slow in stopping and starting causing a variable flow rate, which aﬀected
the signal recorded at the flow-rate sensitive sensors. Figure 6.23 shows the speed
of the pumps stopping and starting by use of integrated flow sensors. The time to
change from 7 µLmin−1 to the flow in the system to stop moving is approximately
40 seconds. Finally, syringe taps were tested to divert the flow directly from the
syringe. In this setup the pumps were continuously running. The diversion of fluids
using syringe taps proved to be the most reliable method; however sometimes the
switching did cause a change in flow rate, which can sometimes be seen as peaks.
6.6.1 Glucose
Continuous Flow
The glucose biosensors were placed on-chip within the analysis chamber. So-
lutions of varying concentrations were perfused through the chip. Solutions were
controlled using a syringe pump (Harvard) and syringe taps were used to divert
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Figure 6.23: Syringe pump flow rate measured with flow sensors
Flow sensors, in-line with the flow from a syringe pump, record the change in flow rate as the
syringe pump is turned from on at 7 µLmin−1 to oﬀ. It takes approximately 40 s for the flow rate
to reach zero.
flows when required. The flow rate through the microfluidic chip was 2 µLmin−1
for all solutions. The solutions were switched between PBS, 1 mM and 0.25 mM
glucose and the change in current at the electrode recorded. The results for a 50
µm disc glucose biosensor is shown in figure 6.24. The sensor responds clearly to
changes in the glucose level and the majority of noise comes from changes in the
flow rate as the syringe taps are turned and the solutions are alternated.
Two diﬀerent sizes of glucose biosensors were placed on-chip, 50 µm and 25 µm.
This was due to the 125 µm electrodes being housed in a larger syringe electrode,
which did not easily fit in the analysis chamber. Table 6.3 summarises the results
found. Comparing this to the glucose biosensors characterised in a beaker (Table 4.7)
the sensitivity seems to be enhanced. This is due to mass transport of the analyte
to the biosensors created by the flow. Overall, the response times are slower, but
this is probably due to the placement of the sensors on-chip in relation to the ceiling
height. Recessed electrodes will have a longer response time and the approximately
3-5 times larger standard deviations seen in the on-chip response times are probably
due to positioning of the sensors on-chip.
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Figure 6.24: A glucose biosensor on-chip: calibration
Glucose biosensor: 50 µm diameter. Electrode held at a constant potential of 0.75 V. Solutions
were alternated between PBS and 1 mM glucose at a flow rate of 2 µLmin−1. The solutions then
alternated between PBS and 250 µM glucose at a flow rate of 2 µLmin−1. Grey dotted lines
indicated when the solutions were switched.
This process needs further work to make it more accurate and reproducible. The
LOD of the sensors is still within the same range as that seen in a beaker (a few
µM).
Table 6.3: Continuous flow on-chip glucose biosensors at 2 µLmin−1
Electrode size Sensitivity T90
(µm) (nAmM−1cm−2) (s)
50 (n=13) 8.9 ± 0.9 x 103 14.3 ± 5.5
25 (n=7) 8.4 ± 2 x 103 15.4 ± 12.9
Droplet Flow
The sensors were placed on-chip and droplets of PBS and 1 mM glucose were
alternated. Figure 6.25 shows the importance of correct positioning on-chip. Here
the sensor is pushing on the PDMS design and distorting the geometry of the chip
and the chamber is not catching the aqueous droplets but letting them pass straight
through. Both the oil and the aqueous droplets are passing straight through the
chamber, which is clearly seen as noise when 1 mM glucose droplets are running.
The T90 of this sensor is 28.1 s.
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Figure 6.25: A glucose biosensor on-chip in droplet flow: chamber not working
Glucose biosensor: 50 µm diameter. Electrode held at a constant potential of 0.75 V. Solutions
were alternated between PBS and 1 mM glucose at a flow rate of 2 µLmin−1 aqueous and 5
µLmin−1 oil.
Figure 6.26 shows a glucose biosensor in droplet flow, when it is correctly placed
on-chip. Here the chamber is working correctly and is catching the aqueous droplets
and filtering the oil through the side channels. The aqueous solutions were switched
as before and the change in signal is much easier to see due to lower noise. The
LOD is 12 µM glucose and the T90 of this sensor is 0.6 s. This shows the potential
of the on-chip glucose sensors for monitoring online microdialysate in the intensive
care ward.
However, table 6.4 displays the average sensitivity and response time of 50 and 25
µm glucose biosensors placed on-chip under the droplet flow regime. These figures
are only for particular aqueous and oil flow rate (2 and 5 µLmin−1 respectively). The
characteristics were investigated using these flow rates as it was found in section 5.8.1
that this was the optimal flow rate for functioning of the analysis chamber. We put
the variability down to the electrode position within the length of the channel (not
a problem for continuous flow) and with respect to the ceiling. Also problems with
correct punching of electrode holes so that the chamber functions with electrodes in
place.
210
6.6 Biosensors On-Chip
[G
lu
c
o
s
e
] 
/ 
m
M
Time / minutes
Figure 6.26: A glucose biosensor on-chip in droplet flow
Glucose biosensor: 50 µm diameter. Electrode held at a constant potential of 0.75 V. Solutions
were alternated between PBS to 1 mM glucose and PBS to 0.5 mM glucose, at a flow rate of 2
µLmin−1 aqueous and 5 µLmin−1 oil.
Table 6.4: Droplet flow on-chip glucose biosensors at 2 and 5 µLmin−1
Electrode size Sensitivity T90
(µm) (nAmM−1cm−2) (s)
50 (n=3) 5.7 ± 1.7 x 103 34.3 ± 39.7
25 (n=7) 8.4 ± 2 x 103 13.2 ± 10.6
Overview
The glucose biosensors have been assessed in a beaker and on-chip in both con-
tinuous and droplet flow regimes. Table 6.5 assesses the sensors in terms of electrode
size. The key factors are investigated and awarded ticks. Overall the 50 µm had a
good sensitivity, LOD, T90 and it is the easiest to work on-chip. Therefore a 50 µm
glucose biosensor will be validated in an in vivo study discussed in chapter 7.
Table 6.5: Assessment of glucose biosensors on-chip
Electrode size Sensitivity LOD T90 Feasibility on-chip
50 ￿￿￿ ￿￿ ￿￿ ￿￿￿
25 ￿￿￿ ￿ ￿￿ ￿￿
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6.6.2 Lactate
Continuous Flow
Lactate sensors were also placed on-chip and characterised in the same way as
the glucose sensors. Figure 6.27 shows the response from a 125 µm disc electrode
fabricated as a lactate biosensor. The flow rate is 2 µLmin−1 and solutions were
alternated between PBS and 1mM lactate. The large spike, as the solutions are
changed back to PBS, is likely to be due to a change in flow rate.
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Figure 6.27: A lactate biosensor on-chip: calibration
Lactate biosensor: 125 µm diameter. Electrode held at a constant potential of 0.75 V. Solutions
were alternated between PBS and 1 mM lactate at a flow rate of 2 µLmin−1. Grey dotted lines
indicated when the solutions were switched.
Table 6.6 gives a summary of the sensitivity and the 90 % response time for
various sizes of electrodes, on-chip at a flow rate of 2 µLmin−1. A few 25 µm
diameter disc electrodes were fabricated into lactate sensors and placed directly on-
chip. These too are included in table 6.6. The sensitivity of the 50 µm sensor is
lower to that of the 50 µm glucose sensor (see table 6.3), likely due to the activity
per gram as previously discussed. There seems to be more variation between sensors.
This could be due to the low number of repeats. The response time is much longer
on-chip, but when in a beaker the sensors responded in under 10 seconds. Therefore
the placement on the chip was not correct and more repeats would possibly show a
faster response time.
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Table 6.6: Continuous flow on-chip lactate biosensors at 2 µLmin−1
Electrode size Sensitivity T90
(µm) (nAmM−1cm−2) (s)
125 (n=7) 1.3 ± 0.4 x 103 15.2 ± 8.2
50 (n=3) 6.5 ± 4.5 x 103 32.7 ± 13.2
25 (n=6) 3.9 ± 2.5 x 103 30.5 ± 11.7
Two diﬀerent lactate sensors on-chip were placed in the same analysis chamber
and their responses recorded simultaneously. A 50 µm lactate biosensor was placed
upstream of a 125 µm lactate biosensor within the same analysis chamber. The
solutions were changed between PBS and 500 µM lactate. Both sensors respond to
the change in lactate and the downstream electrode responds 2.4 seconds later than
the upstream sensor. This is due to the time delay for the solution to move between
the sensors within the analysis chamber.
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Figure 6.28: Two lactate biosensors on-chip: calibration
Electrodes were held at a constant potential of 0.75 V. Light green trace: 50 µm glucose biosensor.
Dark green trace: 125 µm glucose biosensor. Solutions were alternated between PBS and 0.5 mM
lactate at a flow rate of 2 µLmin−1. The 50 µm lactate biosensor is upstream in the analysis
chamber of the 125 µm biosensor. The time between the responses is 2.4 seconds.
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Droplet Flow
The 25 µm diameter disc electrode were fabricated into lactate biosensors and
tested in droplet flow on-chip. Figure 6.29 shows an example of the trace seen
during this period. The on-chip flow rates were 2 µLmin−1 aqueous and 4 µLmin−1
oil. Droplets were alternated between 1 mM lactate and PBS. The T90 of this on-
chip lactate sensor was 96 seconds. Whilst this seems very slow, it was since found
that the positioning of the electrode within the PDMS chip is very important and
so may be an limiting factor. The LOD (found by calculating 3 standard deviations
of the baseline) was 62 µM and the sensitivity was 4.41 x 103 nAmM−1cm−2. The
average sensitivity and T90 using 25 µm electrodes, on-chip in droplet flow, was 3.3
± 1.5 x 103 and 20.8 ± 3.1 respectively (n=3). Due to further work investigating
the properties of lactate sensors previously discussed, they were not tried again in
droplet flow.
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Figure 6.29: A lactate biosensor on-chip: calibration in droplet flow
Lactate biosensor: 25 µm diameter. Electrode held at a constant potential of 0.75 V. Solutions
were alternated between PBS and 1 mM lactate at a flow rate of 2 µLmin−1. Oil flow rate was 4
µLmin−1.
Overview
The lactate biosensors have been assessed in a beaker and on-chip in continuous
and droplet flow regimes. Due to the need for further optimisation only one size
was used in droplet flow and so no comparison between sizes can be made in the
droplet flow regime. However, the results from the beaker and continuous flow look
promising and with further optimisation would be ready for use in droplet flow.
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6.6.3 Multi-Analyte
A glucose and a lactate sensor were tested on-chip. They were made on two separate
needle electrodes due to the cross talk previously discussed. The glucose biosensor
was fabricated on a 50 µm disc electrode and the lactate on a 125 µm disc electrode.
The analysis chip was connected to a syringe pump, which alternated solutions of
1 mM glucose and 1 mM lactate at 2 µLmin−1 via syringe taps. The results of
the initial experiments are shown in figure 6.30. Initially it seems as though both
sensors are a glucose sensor. The change in current at the larger lactate sensor is
approximately 20 pA and at the smaller glucose sensor, approximately 65 pA. The
syringe containing 1 mM glucose was removed from the pump and replaced with
one containing PBS. The solutions were alternated between PBS and 1 mM lactate.
Now only the lactate sensor responds. The response to a change of 1 mM lactate is
17 pA.
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Figure 6.30: A glucose and lactate biosensor on-chip: contamination
Glucose (red) biosensor: 50 µm diameter. Lactate (green) biosensor: 125 µm diameter. Electrodes
were held at a constant potential of 0.75 V. Solutions were initially alternated between 1 mM
glucose (G) and 1 mM lactate (L) at a flow rate of 2 µLmin−1. The 1 mM glucose syringe was
then changed to one containing PBS and the solutions alternated between PBS and 1 mM lactate
(L).
It was concluded that the lactate biosensor was somehow contaminated with
glucose oxidase. New integrated electrodes should be fabricated and used only as
lactate biosensors. A further study should look at whether the sensitivity of the
lactate sensors change as a result and both a glucose and a lactate sensor should be
tested together on-chip.
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6.7 Conclusion
This chapter discussed the integration of electrodes onto the microfluidic platform.
It was shown optically and electrochemically, that digital microfluidics eliminates
Taylor dispersion, a phenomena seen in continuous flows that acts to smear out fast
concentration changes. Within the microfluidic analysis chamber, a step change in
concentration at the point of coalescence, had a T90 of < 2 ms, which is the time
taken for the interfaces to join together. Further into the analysis chamber, the
response time increased, indicating that the electrode must be as close as possible
to the coalescence point to take full advantage of this eﬀect. All measurements
gave a huge increase in the time resolution, dramatically improving the potential of
microdialysis to measure small, fast changes.
It was found that the punching of electrode hole was crucial to the functioning
of the analysis chamber. The PDMS wall was easily lost if the hole was incorrectly
punched and if too close to the walls or positioned at an angle, the large and rigid
electrode could deform the chamber design, rendering the chamber useless. However,
needle electrodes were successfully incorporated on-chip, and the electrodes were first
tested using redox couples and electrochemistry. Glucose and lactate sensors were
then fabricated and placed on-chip and the responses compared to that seen in a
beaker. There were large variations in the response of the sensors, even in continuous
flow. By simple diﬀusion field arguments, it was thought that the optimal position
of the electrode was flush to the ceiling of the chamber. However, analysis of the flow
dynamics within the chamber suggests that this is not the case, due to a memory
eﬀect caused by the build up of previous droplets horizontally along the chamber
wall. The electrode should therefore be positioned in the middle of the chamber,
where the bands are vertical. The needle electrode in this position would also disrupt
the flow inducing convective mixing and stop the bands from forming. Introducing
baﬄes on the wall of the chamber would also have the same eﬀect. Positioning the
electrode close to the point of coalescence has the added advantage that the bands
here are more vertical, making the positioning of the electrode in the middle less
crucial (an advantage as currently this is very diﬃcult). Parts of the work discussed
in this chapter has been published in the journal, Physical Chemistry Chemical
Physics.
Dual electrodes were also assessed on-chip, and it was shown that the flow added
a convective component to the diﬀusion field geometry. As expected, cross-talk
occurred within the dual electrode, however two separate needle electrodes held
within the same chamber eliminated the eﬀect. This will compromise the response
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of the downstream electrode by being further away from the point of coalescence
but it does allow for multi-analyte detection. An alternative solution for multiple
sensors could be to have several smaller detection chambers placed in series. In this
way, each microelectrode can be positioned at the optimal location, the chamber size
can be reduced to house only one electrode and as the droplet stream is re-formed
after each chamber, the inherent time resolution of digital microfluidics is conserved
between each analysis.
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Chapter 7
On-Line Analysis of
Microdialysate, in vivo
7.1 Introduction
7.1.1 Clinical Background
Traumatic brain injury (TBI) has been described by The Lancet Neurology as a
silent epidemic (29) as around the world, TBI is a major cause of death and disability.
Alarmingly, the UK incidence of TBI (238 - 458 / 100,000 population) is higher
than that of breast cancer (120 / 100,000 population) (217). Public awareness of
TBI remains low, and no new treatment has been approved in the past 30 years.
The primary injury often causes a focal injury site, such as a haemorrhage. This
causes local ischemia. This lack of blood flow starves the local region of oxygen
and glucose, leading to changes in metabolism. Over several days, the injured area
may increase in size, called secondary injury. Secondary injury is a subject of much
clinical research. Patient outcome is hugely variable, as the occurrence of secondary
injury is very unpredictable and a conservative wait-and-see approach is taken whilst
the patient is being monitored in intensive care. Here, the patient is put in a drug
induced coma to switch of brain activity and decrease the energy requirements in
the injured areas. The classical covariates used to determine the outcome of TBI are
age, motor score, pupil abnormalities, hypoxia, hypotension and the Marshall CT
scale. However, the IMPACT study by Murray et al showed that these commonly
used covariates only explain 30% of the variance in TBI outcome (52).
Spreading depolarisations (SDs) were first observed in the human brain by the
Boutelle/Strong collaboration (40) and have subsequently been shown to occur fre-
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quently in the injured brain (41). The mass depolarisation of cells, first described
by Leao in 1944 (36), propagates like a wave over the cortex, leading to failure of
ion homeostasis and disruption of cortical function. The depression of the electrical
signal coincides with a large increase in extracellular potassium as the neuronal cells
depolarise, an increase in blood flow and changes in metabolism due to the high
demand of energy presumably to re-polarise the cells (37, 38).
These waves have been characterised using rapid sampling microdialysis, to give
a chemical signature of an SD waves in patients (53). Notably, glucose levels are
seen to decrease and lactate levels increase as the waves pass (57). It has previously
been shown using microdialysis that SD waves are potentially harmful and may
cycle around the site of injury, explaining the repetition at regular intervals seen in
some patients (218). This repetition can drive down the local glucose concentration,
possibly to a level where the tissue is no longer viable (53).
7.1.2 Translational Studies
Ischemia leads to a decreased energy production, which results in neuron depolari-
sation. Animal models of ischemia tend to reduce the levels of oxygen and glucose
in the brain (56, 57). The pathophysiological outcomes are dependent upon the
severity, location and duration of the ischemia within the brain (219).
Animal models have used a wide range of species, initially with gyrencephalic
brains (folded cortex like a human brain) but more recently rats and mice. Rats
have a small brain size allowing ease of fixation for sections and histology, commonly
used after brain infarction. However, the brain of a rat is not folded and has less
supporting glial cells than a human brain.
A successful study of SD waves, needs to have a method of initiating the wave,
either an injury model leading to spontaneous SD waves, or a means acutely stim-
ulating them. Both require a method to detect and monitor the wave progression.
There are several models used in the literature and in this thesis, which are now
discussed.
Acute Stimulation: Middle Cerebral Artery Occlusion
Middle cerebral artery occlusion (MCAO) is a technique used to model the ef-
fects of stroke. There are several variations of this technique but all produce a
heterogeneous tissue state. A necrotic core is at the centre, surrounded by a penum-
bral, at-risk, area. This stroke model provides a highly useful approximation of
ischemia in humans (220). The SD waves are spontaneous and one variation used
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with microdialysis is where the artery is clipped, shutting oﬀ blood flow (56). Other
variations involve the injection of an artificial sphere (or blood clots) into the cere-
bral circulation. Spheres that are approximately 300 µm tend to cause blockages in
the proximal middle cerebral artery (MCA), whereas spheres approximately 50 µm
in diameter causes blockages in distal regions.
Acute Stimulation: Spreading Depolarisations
There are several methods of evoking a depolarisation event. The micro injection
of potassium chloride into the cortex was used by Hashemi et al (57). Cotton
buds infused with KCl can also be placed on the cortex, triggering SD’s. Similarly,
pricking the cortex with a needle tip or pin, will elicit the same response. Both the
cotton bud and needle prick methods are used in this thesis.
Imagining Techniques
There are many ways of imaging the propagation of SD waves. Optically intrinsic
imaging was used to measure depolarisation’s (221, 222) and with the use of voltage
sensitive dyes (223, 224). Depolarisation’s are associated with an increased light
reflectance and was used to record changes in the extracellular space.
Fluorescence imaging was used by Hopwood et al (56) to monitor changes asso-
ciated with the reduction of the NAD/H couple, as described by Strong et al (225),
and monitor the propagation of depolarisation’s over the cortex.
Another technique, laser speckle flowmetry (LSF), is a time-varying imaging
technique that is used in biological applications to measure moving objects, such as
red blood cells. Speckle is a phenomena, which is observed when a highly coherent
light beam is diﬀusively reflected from a rough surface, producing a random inter-
ference pattern. It only came into prominence with the invention of the laser in the
1960s as it is can easily be observed when a laser beam hits a rough surface such
as white paper. Speckle patterns result from the interference of many wavefronts of
the same frequency but each have diﬀerent magnitudes and phases. When added
together, the intensity of the light seems to vary at random, however it was soon
discovered that these patterns carry information about the surface deformations.
When the particle moves, a time-varying speckle pattern is produced at each pixel
of the captured image and when the fluctuations are rapid the pattern becomes
blurred (226). Quantifying the blurring of the speckles allows a two dimensional
map of blood flow to be formed.
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Real time measurement of cerebral blood flow (CBF) using LSF, has been used
to study SD propagation under both normal (57) and ischemic (49, 57) conditions. It
has been shown to be a good tracker of depolarisation waves (49, 226) and is a semi-
quantitative measure of dynamic CBF (227). LSF has high spatial and temporal
resolution (10 to 25 µm and 10 to 50 ms respectively) providing a high resolution
map of the evolution of cerebral blood flow (226).
7.1.3 Testing of the Microfluidic System for the Clinic
Before the new microfluidic system can be incorporated onto a clinical ward, it must
be thoroughly tested. During my PhD I had the opportunity to spend two weeks
at the Max Plank Institute (MPI) for Neurological Research in Cologne. Animal
studies using rats, tested the microfluidic system. The dialysate was analysed using
microelectrodes fabricated into glucose biosensors and was validated by rsMD (our
gold standard). A potassium ion selective electrode (ISE) was also included (devel-
oped by Ms Chi Leng Leong) to give a clear chemical time point for the beginning
of the depolarisation wave.
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7.2 Animal Studies
To assess the microelectrodes in a flow system, before clinical use, a pilot study was
conducted in rats comparing the performance to rsMD analysis. The microfluidic
lab equipment and the sensors were transferred to the Max Plank Institute for
Neurological Research in Cologne, Germany for two weeks. During this time, several
models of ischemia were tested in collaboration with Dr Delphine Feuerstein and Dr
Rudolf Graf.
7.2.1 Methods and Setup
The procedure for all animal studies is set out below, followed by the methods for
the models used in this study.
Anaesthesia
All animal procedures were carried out in accordance with the German Laws
for Animal Protection and institutional guidelines. For all experiments, rats (Male,
Wistar) were anaesthetised with 5 % isoflurane delivered in air at 3.0 Lmin−1 for 2
minutes. Anaesthesia was maintained between 2 and 3 % isoflurane delivered in air
at 0.5 Lmin−1. Throughout the procedures, rectal temperature was maintained at
37.5 ◦C with a thermostatically controlled heating pad. Exclusion criteria include
normality of blood gases, glucose, potassium levels and blood pressure, normality of
MD basal levels of glucose and potassium, consistent basal value of cerebral blood
flow and normality of SD propagation rate.
Imaging
In all experiments, the skull was thinned and the cortex illuminated with a laser
diode (DL7140-201, 785 nm, 70 mW, Sanyo, Japan) to produce a speckle pattern.
The speckle was captured using a CCD camera (A602f-2 BASLER, Ahrensburg,
Germany) using Speckle Contrast Imaging Software. The region of interest (ROI) 1
is defined as 1 mm from the probe towards bregma, and ROI2 is 1 mm away from
bregma.
Probe and sensor placement
An animal microdialysis probe (MAB 6.14.2) was implanted 4.5 mm posterior
and 3.5 mm lateral from Bregma through a small durectomy, at a rate of 5 µms−1
using a piezoelectric motor, whilst perfusing with aCSF at 1.6 µLmin−1. The probe
was inserted acutely to the full membrane length (2 mm). A parenchymal potassium
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electrode was also implanted into the brain (4 mm posterior and 3.5 mm lateral from
Bregma), which was fabricated by Dr Delphine Feuerstein.
Droplet flow
A microfluidic T junction was connected to the MD probe outlet. Oil could then
be pushed through the system when required, by turning on the syringe pump to
create droplets of microdialysate. The droplets were transferred to an analysis chip
containing a glucose biosensor and a potassium ISE, fabricated by Ms Chi Leng
Leong.
Continuous flow
The MD probe outlet was connected directly to a microfluidic analysis chip
containing a glucose biosensor and a potassium ISE. The dialysate stream was then
fed to the rsMD valve for FIA measurements of glucose and lactate. A photograph
of the full setup is shown in figure 7.1. A close up of the probes positioned in the
brain is shown in figure 7.2.
Equipment and Sensors
The glucose biosensors used in this chapter are combined needle electrodes of
either 25 µm or 50 µm in diameter. The fabrication and characterisation is described
in chapter 4 and on-chip in chapter 6. This chapter also refers to a potassium
ISE, which was developed and fabricated by PhD student Ms Chi Leng Leong.
A photograph of the sensors on-chip within an in-house faraday box is shown in
figure 7.3. The rsMD system used in the animal procedures, is described in chapter
2. It is a system, which resides in Cologne for neurochemical analysis of brain injury
and stroke patients in the hospital.
Euthanasia
By law, euthanasia is the end point of all procedures used in this study. Euthana-
sia was induced by the intravenous injection of a high concentration of potassium
chloride (3M KCl).
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Figure 7.1: Setup for animal experiments in MPI, Cologne
The rat is facing top left. The skull has been exposed and thinned. A MD probe and a K+ electrode,
has been positioned into the cortex and the outlet is connected to the microfluidic chip containing
diﬀerent sensors. The microfluidic chip and sensors are housed in a purpose built faraday box.
The outlet of the chip is connected to rsMD.
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Figure 7.2: Close view of setup of probes in the rat in MPI, Cologne
The rat is facing top left. The skull has been exposed and thinned. A MD probe and a K+
electrode, has been positioned into the cortex and the outlet is connected to the microfluidic chip
containing diﬀerent sensors. The skull is covered with protective oil. The microfluidic chip and
sensors are housed in an in-house faraday box. The outlet of the chip is connected to rsMD.
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Figure 7.3: Close view of the sensors in an analysis chip in a faraday box
The fluid inlets and outlets are on the sides and the electrical connections are on the top face. A
combined electrode has been fabricated into a glucose biosensor. A potassium ISE has a separate
reference electrode in a side arm of the microfluidic chip.
227
7. ON-LINE ANALYSIS OF MICRODIALYSATE, IN VIVO
Middle Cerebral Artery Occlusion
A TiO2 macrosphere (diameter 0.315 - 0.355 mm, BRACE, Alzenau, Germany)
was injected in to the circulatory system with the intention to block the MCA and
emulate a stroke. One macrosphere was slowly injected with ∼0.2 mL of heparinised
saline into the internal carotid artery (ICA) via a catheter (PE-50). The macro-
sphere location was determined by post-mortem examination, where the brains are
removed from the skull and the cerebral arteries visually inspected.
SD Stimulation
SDs were induced via the application of a KCl (3M) infused cotton bud to the
thinned skull. The cotton bud was in place for 30 minutes after which it was
removed. The application of the cotton bud can evoke SDs, which circle over the
dura. The circling of SD waves is sometimes seen in human patients where it can
drive down the local glucose concentration if the tissue does not have enough time
to fully recover before the next wave hits (53).
The needle prick (NP) model causes focal ischemia by stimulating a precise area
of the cortex. A single needle prick on the cortex reliably induces a SD (228).
The needle prick model has been successfully used to investigate SDs (229) and has
been used in this thesis to study the potassium, glucose and blood flow changes
during an event. The needle prick model was used to provide a larger stimulus than
the cotton buds, which will hopefully be recorded on the rsMD glucose. Then the
on-chip biosensor can be properly assessed.
In this model two diﬀerent locations were stimulated and it was found that an
ischemic event could be induced each time. The rat was given time to rest in between
subsequent needle pricks so that a baseline of normal state could be recorded before
each stimulus. Figure 7.4 indicates the relative locations of the probes and stimuli
used in this thesis. The first trauma location was approximately 0.5 mm anterior
and 3.5 mm lateral and the second location was approximately 3.5 mm posterior
and 6 mm lateral from Bregma.
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Figure 7.4: Depiction of relative positions of probes and stimuli on the rat cortex
The blue circle and purple circle indicates the position of the MD probe and the parenchymal
electrode (if used) respectively. The orange circles indicate trauma sites. The cotton bud and
needle prick were stimulated in position one. A second needle prick was also conducted at position
two. In this diagram, the nose of the rat is towards the left and the tail towards the right.
Data presentation
All data shown in this thesis has been time aligned so that the events are syn-
chronised between analysis techniques. Figure 7.5 shows the overall setup for the
animal procedures. At t0 the microdialysis samples the ECF during the event. It
then takes time t1 for the sample to reach the on-chip sensors. This is approximately
1 minute in droplet and 3 to 4 minutes in continuous flow. There is then a time,
t2, which is the delay of transferring the same sample to the rsMD analysis system.
This is typically 8 to 10 minutes. Initially the on-chip sensors and rsMD were cal-
ibrated individually and the time delays calculated from the lengths of connection
tubing. This made time aligning the datasets diﬃcult as the PDMS chip swelled
and the tubing connections had some dead volume. Therefore there was no clear
event to accurately calculate the time delays created by transferring the solutions.
During the second opportunity to conduct these experiments, this was addressed
and a calibration solution was passed through the chip via a side channel, also
shown in figure 7.5. The solution therefore passed through the analysis chamber
and calibrated the on-chip sensors and an accurate time delay (t2) can be found
between the sensors and rsMD. Also a recovery protocol was introduced, where
the MD probe was transferred to a solution of glucose and potassium. This not
only checked that the MD probe was working, but gave a recording of t1 and a
confirmation of t2.
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Figure 7.5: Schematic of animal set-up
Schematic shows event for a needle prick experiment in continuous flow. The needle prick initiates
a SD waves that travels over the cortex (imaged by laser speckle). At t0 the event is sampled by
the MD probe. There is then a time t1 until the sample is analysed by the on-chip sensors. The
sample is then transferred to rsMD via connection tubing creating a time delay of t2. Not to scale.
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7.2.2 Results: Droplet Flow
The digital microfluidic set-up was tested. During the experiment, the on-chip
potassium ISE failed and so the only measurements recorded on-chip was from the
glucose biosensor. The parenchymal electrode, measuring tissue potassium, EEG
and DC potential, was also used. However, due to no reliable way of removing
a continuous stream from the analysis chip, the dialysate was not passed through
rsMD for comparison. Figure 7.6 shows the events during droplet flow and all data
is time aligned.
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Figure 7.6: Needle prick and cardiac arrest in droplet flow
DC (pink), tissue K+ (purple) and EEG (blue) shown in top graph. Glucose (red) is shown in the
bottom graph. Digital microfluidics was run at a dialysate flow rate of 1.6 µLmin−1 and FC-40 oil
flow rate of 8.4 µLmin−1. Oil pump is turned on at time zero. Grey dotted lines indicate external
events. NP = needle prick SD = spreading depolarisation wave.
231
7. ON-LINE ANALYSIS OF MICRODIALYSATE, IN VIVO
A needle prick (NP) at site one was conducted as indicated by the first grey line.
This evoked a SD wave, which was in the area of the implanted tissue electrode at
a time indicated by the second grey line. At this point, the DC potential decreases
sharply, the local potassium increases suddenly and the EEG is seen to flatten.
Unfortunately the SD caused by the NP was seen to pass just below the MD probe
on the laser speckle video and the biosensor did not show any evidence of a SD. The
tissue electrode was in a slightly diﬀerent position to the MD probe and therefore
does detect the SD wave passing. After the needle prick, the glucose biosensor was
quite noisy. It is thought that perhaps the chamber was not functioning 100 % and
some oil was passing through the chamber. This would create noise in the trace seen
by the biosensor and cause the on-chip potassium ISE to fail (which indeed it did).
After 30 minutes the rat was euthanised by a 3 M intravenous KCl injection.
This is clearly seen in the parenchymal electrodes, where there is a large increase
in potassium, a permanent flattening of the EEG signal and a decrease in the DC
potential. There is some disturbance of the glucose signal seen as the rat is prepared
for injection and the glucose levels returned to higher than before the injection. In
this experiment, lots of things were not working. The level of glucose recorded by
the biosensor is higher than past levels of microdialysis brain glucose. There was
no change during the needle prick in the dialysate but there was a clear SD wave
passing the nearby tissue electrode. This could be due to the biosensor used on
that day not functioning as well as previous sensors, or it could be working well and
representing the glucose changes. Without a method of comparing the biosensor
to a gold standard no conclusion can be made about this data set. Therefore, the
experiments following were conducted in continuous flow, where the dialysate could
be passed to rsMD for confirmation of glucose levels. Also, this allows successful
recording from the on-chip potassium ISE. Connection tubing from the MD probe
to the on-chip sensors was reduced to the smallest length to reduce dispersion.
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7.2.3 Biosensor Validation
To validate the biosensor performance, continuous flow was used in the following
experiments. This allows a chemical marker of the SD in the dialysate (on-chip
potassium ISE) and further analysis of glucose and lactate levels via rsMD. To
ensure that the microelectrodes were capable of detecting biologically relevant con-
centrations of glucose, the results from the glucose biosensor within the microfluidic
chip were compared to the results from rsMD. This section will look in more detail
to the levels of glucose recorded by both analysis techniques.
A glucose biosensor was fabricated on a 50 µm Pt disc integrated electrode and
placed on-chip, where it was calibrated before being transferred to the animal room.
The rsMD system was calibrated in the usual way.
Figure 7.7 shows a time course of the experiment with recordings from both
rsMD (red) and the biosensor (orange). Time zero is the marker used to time align
the two diﬀerent analysis techniques (in this case the first needle prick). There is a
large range of concentration from approximately 0.4 mM to 1 mM over the course
of the experiment. This was one of the sets of data used to investigate how well the
two analysis techniques correlated.
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Figure 7.7: Glucose biosensor versus rsMD
A full experiment of over 200 minutes, comparing the online rsMD glucose levels in red and the
on-chip glucose biosensor in orange. Levels have been converted to concentration after individual
calibrations and the two traces have been time aligned.
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The Clarke error grid was devised in 1987 to quantify the clinical accuracy of
devices for the monitoring of blood glucose in diabetic patients (230). Figure 7.8
shows the on-chip biosensor and rsMD glucose comparison with a Clarkes grid laid
over the top. The majority of points lie within the A band. This is the 95 % accuracy
bracket. The other regions are most relevant to comparing sensor performance to
the blood glucose, and indicate the outcome of using the device (inappropriate or
unnecessary treatment, B and C, or failure to detect hypoglycemia or hyperglycemia,
D, or confusion between hyper- and hypoglycemia, E).
Figure 7.8: Glucose biosensor validation with Clarkes grid
Glucose biosensor readings versus the concentration detected by rsMD. Three biosensors individ-
ually fabricated and tested on diﬀerent days are shown. The Clarkes error grid is overlaid in grey.
The majority of points lay within the A banding.
Whilst error grids provide accuracy for paired static data, they do not account
for the timing of paired results, which in continuous glucose monitoring is an im-
portant factor (231). Therefore the mean diﬀerence provides a better estimation of
a continuous sensor performance and for the biosensor assessed here, this is shown
in figure 7.9. Looking across the spread of this data, the standard deviation of this
combined data is 40 µM. This includes error from both the biosensor and rsMD.
The estimated error in rsMD is approximately 8 - 20 µM alone (53, 91).
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Figure 7.9: Glucose biosensor validation
A more stringent test of validation, comparing the diﬀerence in the two analysis techniques to the
gold standard rsMD glucose concentrations.
Each animal model used in the pilot study, compares the glucose biosensor to
the rsMD glucose analysis. To analyse the data and assess the biosensor, the raw
data was individually calibrated and converted into concentration. The two data
sets were then time aligned and the glucose levels compared. The results from each
of these will now be discussed.
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7.2.4 Results: Insertion of the Microdialysis Probe
A novel procedure was used, to implant the microdialysis probe, which allows for
the first time to see the dynamic eﬀects of insertion upon the tissue. The MD
probe was implanted using a piezo-electric motor at a rate of 5 µms−1, whilst being
perfused with aCSF at a rate of 1.6 µLmin−1. Cerebral blood flow increases during
the implantation of the probe. This is shown in figure 7.10, which shows the laser
speckle images and in Video 9 on the associated DVD. The areas of red indicate that
there is higher blood flow in that region. This increased blood flow is easily seen in
the surrounding area of the probe and is seen to radiate from the implantation site.
This is characteristic of an SD wave.
Looking at the data of the online biosensor, during the implantation of a MD
probe, the level in glucose increases. Figure 7.11 shows the raw data from the glucose
biosensor and the corresponding data from rsMD. Again, this data has been time
aligned to take account of time delay in analysis. Before implanting the MD probe,
both analysis techniques are sampling aCSF only. For rsMD this gives zero peaks,
but in the biosensor there is some background current generated.
The act of implanting a probe or an electrode into the brain causes localised stress
to the tissue (75). In fact, the act of implanting a MD probe or tissue electrode is
not dissimilar to a needle prick. A piezo-electric motor was used to try and reduce
some of this stress by implanting the probe at a slow and constant rate. The
glucose concentration increases slowly due to the sampling length of the membrane
increasing as it is implanted. During this period the steady state is being set-up.
At the peak recording, the concentration is approximately 1 mM and 900 µM for
the rsMD and on-chip biosensor respectively. The act of implantation causes an
increase in blood flow and hence an increase in glucose delivery. The SD wave will
cause a decrease in glucose. However, the probe membrane length within the tissue
is increasing as the probe is implanted and therefore it is not clear, which one of
these factors is dominating the reading of glucose. After implantation when the full
membrane length is inserted in the cortex and steady state has been reached, the
glucose level has reached a constant concentration of approximately 500 µM and
400 µM for the rsMD and on-chip biosensor respectively. This diﬀerence between
readings does disappear during the stabilisation period, which is where the rat is
monitored for at least 30 minutes before the any stimulation.
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Figure 7.10: Laser speckle images of a MD probe insertion
Increased blood flow is seen as a change in colour from blue to red. T = 0 when the MD probe
insertion began. The position of the probe is indicated on the first image where T = 200 s. During
the course of the implantation, blood flow to the local area increases and an SD wave is induced.
The insertion of the MD probe finishes at T = 400 s.
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Figure 7.11: Biosensor and rsMD glucose raw data during a MD probe insertion
On-chip glucose biosensor in yellow, rsMD glucose in red where the peak height represents the
level of glucose. Implantation of the probe begins at T = 0. An SD is seen on the laser speckle
during implantation as indicated.
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7.2.5 Result: Euthanasia
By law, the end point of all procedures was euthanasia induced by the intravenous
injection of a high concentration of potassium chloride (3 M KCl). To ensure full
use of the procedure, this too was studied in terms of glucose concentration. Laser
speckle confirms that euthanasia has occurred by changing to a dark blue as seen in
figure 7.12 and Video 10 on the associated DVD. This happens very quickly, over a
few seconds.
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Figure 7.12: Laser speckle images of a KCl injection
The position of the MD probe is indicated in the first slide at T = -2 s. At T = 0 s the rat was
injected with 3 M KCl. The speckle image turns a dark blue within a couple of seconds, indicating
that there is no blood flow and hence no delivery of glucose or oxygen to the brain.
The changes of glucose throughout this period were recorded using both the on-
chip glucose biosensor and the gold standard, rsMD. Figure 7.13 compares the levels
of glucose as seen by the two techniques before and after an injection of KCl. Both
analysis methods were individually calibrated and were converted into concentration
before being time-aligned and compared. Out of the 8 animals, 5 procedures showed
a change in glucose similar to that seen in figure 7.13. When the injection was
administered (illustrated by the dotted line in figure 7.13) it caused noise in the
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glucose biosensor, seen as a large spike in current. This is due to the sensors being
very close to the animal and so may of been knocked during the procedure. The
level of glucose falls below zero but this is likely to be mis-representative due to
a change in baseline after the spike. Not all traces show this spike, but it is also
sometimes noticed when blood gases are taken during the procedure and therefore
is most likely to be noise. Both analysis methods are in good agreement with each
other, in terms of the concentration before and after the injection, and the change
in glucose is approximately 400 µM.
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Figure 7.13: Euthanasia induced by KCl injection
The grey dotted line indicates the time point when the injection of KCl occurred. rsMD glucose
is shown in red, and the glucose biosensor in orange.
Figure 7.14 shows another example of data, recorded over the duration of eu-
thanasia and 2 of the 8 procedures show this story over the course of euthanasia.
Blood flow is shown in the top graph, on-chip recordings of glucose and potassium in
the centre graph and rsMD glucose and lactate levels in the bottom graph. During
the course of the day the rat suﬀered from respiratory problems that resulted in
large changes in glucose and potassium concentration, seen easily on-chip. These
changes can only be seen in the chemical data, as the blood flow data is steady.
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Cardiac arrest is seen as a clear drop in blood flow and glucose rsMD levels fall
and lactate rsMD levels rise as expected. The on-chip sensors show a more detailed,
complicated story. The delayed rise in potassium and fall in glucose could reflect
consumption of astrocytic glycogen stores. Only when these stores run out, do the
cells depolarise releasing potassium. When the potassium levels begin to increase,
the glucose biosensor shows the level of glucose falling. There is a slight mismatch
in the timing of the two glucose recordings, likely to be due to the PDMS swelling
and therefore changing the volume of solution between the two analysis systems.
This delayed fall in glucose (in comparison to lactate) has been noted previously in
the literature (44).
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Figure 7.14: Changes during euthanasia
Blue lines = Blood flow changes taken from Laser Speckle data. Solid red line = On-chip glucose
biosensor. Solid purple = On-chip potassium ISE. Dotted red and green = rsMD glucose and
lactate respectively. The yellow colouring indicates the timing of the intravenous injection of KCl.
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7.2.6 Results: Stroke model
The stroke model is widely used at the Max Plank Institute, Cologne, and it was
decided to be used in this pilot study, as it induces a smaller change in glucose than
cardiac arrest and so is a harder test for the glucose biosensor to pass. The method
used to emulate a stroke in a rat, was a middle cerebral artery occlusion (MCAO).
Upon inspection of the brain post-mortem, it was found that the macrosphere
had become lodged in the posterior communicating artery as opposed to the intended
MCA. This is shown in figure 7.15. The macrosphere was contralateral to the MD
probe and the blockage resulted in only a small change in blood flow. This is due
to the macrosphere aﬀecting flow to the brain and the change is only small, due to
the ability of collateral flow to compensate for minor alterations.
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Figure 7.15: Visual inspection of the location of the injected macrosphere
On the left is a diagram of the major blood vessels taken from http://neurology-
cases.blogspot.com/2011 03 01 archive.html On the right, is a photograph of the ventral view
of the rat brain. Approximate position of MD probe on the dorsal side and the macrosphere
placement is indicated.
Figure 7.16 shows the changes in blood flow and glucose levels as recorded by
both the on-chip glucose biosensor and rsMD. The laser speckle video can be viewed
on the associated DVD (Video 11). The levels of glucose correlate very well between
the two analysis methods. Upon injection of the macrosphere, the glucose levels fall
by approximately 200 µM and blood flow transiently decreases by approximately
10 %. Also contributing to the small change in blood flow is the positioning of the
probe, relative to the connecting artery blockage.
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The probe is in the penumbral region of the occlusion. The decrease in the level
of glucose is likely to be due to the reduced blood flow causing a lower deliverance
of glucose. The good agreement of rsMD and the on-chip biosensor indicate that
the sensor is a viable option for measuring neurochemical changes in brain injury
patients.
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Figure 7.16: Changes upon injection of a macrosphere into the connecting artery.
Blood flow changes taken from Laser Speckle data and shown in the top graph in blue. The solid
red line indicates the glucose biosensor on chip and the dotted red line indicates the level of rsMD
glucose.
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7.2.7 Results: Spreading Depolarisation’s
SD waves have been shown to occur in the injured human brain with possible detri-
mental eﬀects. Within the animal brain, the events provide a tough test for the
sensors to pass as often the concentration changes are small. SD waves can be
caused by a variety of models. Here two such models are discussed, the cotton bud
stimulation and the needle prick model.
1: Cotton Bud Stimulation
Figure 7.17 shows a section of laser speckle images during a cotton bud stimula-
tion. The MD probe and cotton bud location is indicated on the first image. This
figure only shows one SD wave (shown as areas of red) moving from the area where
the cotton bud is placed towards the MD probe, as indicated by the small black
arrows. In fact, during this particular stimulation, five SD waves were seen, which
can be seen in Video 12 on the associated DVD. This is a feature of cotton bud
model that repeated waves occur.
Figure 7.18 shows the chemical data collected during a cotton bud stimulation.
SDs are seen as transient hyperaemia’s in the speckle data (shown in blue) and
coincident with these, the 25 µm disc electrode glucose biosensor (red trace) and
the K+ ISE (shown in purple) show opposing changes. Looking more closely at the
raw data of rsMD (the bottom trace), the glucose decreases can also been seen,
however with much more diﬃculty due to a sample rate of once a minute. The
changes in glucose concentration are approximately 15 µM. These changes are very
small, which is a very hard test for glucose biosensor. Although you can see the
downward perturbations more clearly in the biosensor than the rsMD. If the blood
flow or potassium data were absent, it would be very diﬃcult to distinguish from
noise.
Overall, the glucose biosensor has performed well, indicating the clear advantage
of continuous analysis. Whilst the sensor is sensitive enough to see SDs, the small
magnitude and rapid repetition of the waves in the cotton bud model, make it
diﬃcult to use a biosensor alone. A multi-analyte system is therefore the best
option. To get an ambiguous of the biosensor during an SD wave, a second model
of SDs was used, which is reported to give a bigger single SD wave, that can be seen
on rsMD.
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Figure 7.17: Laser speckle images of a cotton bud induced SD
An SD wave is seen as a red patch (area of increased blood flow) moving past the MD probe.
Arrows help to indicate the wave and show the direction in which the wave is moving. During the
placement of this cotton bud 5 SD waves were produced although only one is shown here.
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Figure 7.18: Changes upon application of a cotton bud.
Blood flow changes taken from Laser Speckle data shown in blue. The raw data of glucose biosensor
(red), potassium ISE (purple) are displayed in the middle graph. The raw data of rsMD glucose
is shown in the bottom graph and the height of the peaks indicates the concentration level.
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2: Needle Prick Model
Figure 7.19 shows an overview of the measurements recorded from the probes
in the brain tissue, during a needle prick. All the recordings were individually cali-
brated and time aligned, where time zero is the time that the needle prick occurred.
The speckle video can be found on the associated DVD (Video 13).
The top graph displays the recordings from the DC electrode and the EEG.
During an SD, there is a sudden and large decrease in the DC potential and a
narrowing of the EEG trace, characteristic of cellular depolarisation.
The second graph compares the tissue potassium electrode and the on-chip MD
potassium ISE. Potassium levels are much higher in the tissue than in the dialysate
due to the dialysis sampling of the extracellular space. The shape of the transient
measured at the on-chip sensor is stretched over time and this is due to Taylor
dispersion in the connection tubing. The mismatch in timing of the beginning of
the increase between the two recordings is due to slightly diﬀerent positions of the
tissue potassium electrode and the MD probe. During an SD a clear increase in
the potassium levels is seen at both electrodes. The height of the peak at both
electrodes is diﬀerent, due to the tissue electrode sensing the full potassium signal.
The MD probe however is a sampling technique dependent upon diﬀusion across
the probe membrane, and the recovery of the probe is not 100%. Therefore, the full
concentration will not be collected in the time it takes for the event to pass.
The glucose levels are compared in the third graph in figure 7.19 and show rsMD
in red and the biosensor in orange. The concentrations correlate very well before and
during the SD and there is a slight discrepancy after the SD has occurred. However,
the two data sets do return to matching very closely not long after. During the SD,
the concentration of glucose decreases by 12 µM in both data sets.
The rsMD data is shown in the bottom graph, where glucose is shown again in
red for easy comparison to the lactate levels (shown in green), which increase during
the SD. Both metabolites return to baseline after the event.
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Figure 7.19: Needle prick: probe measurements
From top to bottom: DC potential (light blue) and EEG (dark blue) show transients character-
istic of cellular depolarisation; Comparing tissue potassium (purple) and on-chip potassium (dark
purple); The on-chip glucose biosensor (orange) and rsMD glucose measurement (red) show good
correlation; rsMD data: glucose in red and lactate in green.
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Figure 7.20 shows four NPs data sets, which show clear potassium and glucose
changes, with the associated blood flow changes. Figure 7.20A is a laser speckle
image, which indicates the position of the MD probe, approximate sites for the NP
and the location of the ROI’s used to analyse the blood flow. The colour of the
circle indicates the trace seen in the blood flow graphs. Figure 7.20B-E show the
four NP data sets.
Analysis from laser speckle reveals that the hyperaemia, during an SD wave,
coincides with the increase in extracellular potassium. Once the hyperaemia has
passed, the cells are re-polarising as indicated by the fall in potassium levels. For
this, the cells require more energy, and therefore the local demand for glucose in-
creases. However at this point, there is no longer an increase in blood flow and
hence no increase in the supply of energy resources. A decrease in the local glucose
concentration is then observed. It can be concluded that the energy demand of the
tissue was not being met due to a lack of supply of glucose from the blood. This is
true for all four NP data sets.
Table 7.1 gives a summary of the glucose changes, recorded from the micro-
dialysate, during a needle prick and compares the glucose response of the 50 µm
disc electrode biosensor to that of the rsMD system. The changes in the glucose
concentration, observed as the SD wave passes the MD probe, are very similar in
both analytical techniques. The average diﬀerence between the two recordings, was
-6.5 ± 10 µM (n=6). The biosensor, therefore gives reliable recordings of the glucose
level at low levels and during small changes. Whilst the two measurements were in
agreement, the needle prick did not necessarily give a larger change in glucose than
the cotton buds. Half of the successful needle pricks gave a change in glucose similar
to that seen during the cotton bud stimulation, whereas the other half were indeed
larger changes.
Table 7.1: Changes in glucose concentration caused by needle pricks
Biosensor / µM rsMD / µM (Biosensor - rsMD) / µM
-12 -12 0
-38 -52 14
-77 -85 8
-10 -3 -7
-40 -61 21
-10 -13 3
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Figure 7.20: Needle prick: on-chip glucose, potassium and blood flow
A: Speckle image indicates the positions of the MD probe and approximate locations of NP sites.
The coloured circles indicate the three ROI used to generate the blood flow data. The blood flow
data is shown in corresponding colours in the data graphs. B to E show the results of the laser
speckle analysis and the on-chip glucose biosensor (orange) and potassium ISE (purple) data. The
dotted lines indicates the increase of potassium and the decrease in glucose.
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The on-chip data from the needle pricks were analysed more closely. This is
shown in figure 7.21. All changes in potassium and glucose concentration were
aligned by allocating the point of change in potassium as 0,0. Therefore, the back-
ground is removed and the relative changes and timings can be closer assessed. In
shades of purple, all of the potassium changes are overlaid. Clearly there is an in-
crease as the cells depolarise. The potassium levels all return back to baseline and
the release and uptake rates of all needle pricks are very similar. In variations of red,
are the glucose concentration changes for the same four needle pricks. The changes
are all small, all negative from the baseline and all delayed from time zero. Mea-
suring potassium gives a chemical time point for the onset of depolarisation within
the microdialysate, as any dispersion that occurs, aﬀects both the potassium and
the glucose. Previously, the glucose was aligned to other data (such as ECoG) by
approximation.
All four needle pricks show some delay in the decrease of local concentration
compared to potassium. Note, that the glucose biosensor is always upstream of
the potassium sensor and in calibrations, the biosensor responded to the change in
concentrations first. Therefore we can rule out this delay being due to mass trans-
port eﬀects. Table 7.2 shows the timings of the glucose and potassium responses.
There seems to be no correlation between the duration of the glucose or potassium
concentration changes and the delay in the glucose onset.
Table 7.2: Glucose and potassium changes during a NP
NP Delay in response / s Duration of K change / s Duration of G change / s
1 68 150 216
2 60 174 197
3 30 175 192
4 90 267 320
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Figure 7.21: Assessment of glucose and potassium changes after a needle prick
Traces are aligned by allocating the point of potassium change as 0,0. In variations of blue and
purple are an overview of the potassium changes as recorded by the on-chip potassium ISE. In
variations of red and orange are an overview of the glucose changes as recorded from the on-chip
glucose biosensor. The inset shows a reminder of the probe locations and NP sites.
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7.3 Human Studies in the Intensive Care Ward
I had the opportunity to incorporate the microfluidic platform into the clinical mon-
itoring system in two hospitals: at King College Hospital in London and in the MPI
in Cologne. This section will now discuss the results from both locations.
7.3.1 Equipment Setup
The microfluidic analysis chip was tested in two hospitals and in two flow regimes. At
both locations a glucose biosensor and potassium ion selective electrode were placed
within the analysis chamber as previously done with the animal procedures. Initially,
the microfluidic platform was run in continuous flow to reduce complications. Digital
microfluidics was tested on one patient at the Max Plank Institute in Cologne. The
set-ups in the two locations will now be described.
Kings College Hospital, London
The microfluidic set-up was transferred to King College Hospital (KCH) in Lon-
don. Here, rsMD monitors brain injury patients. Once surgery has been conducted
and the MD probe and ECoG strip electrodes implanted, the patient was moved
onto the intensive care ward. The MD probe was perfused with sterile aCSF at 2
µLmin−1 and the rsMD is usually attached to the MD probe outlet via 1 m low vol-
ume FEP connection tubing. When applying the microfluidic platform and on-chip
sensors, the microfluidic box (identical to the one used in the animal experiments,
see figure 7.3) is placed in between the MD probe outlet and the inlet of rsMD. A
25 µm disc electrode glucose biosensor and a potassium ISE can be placed within
the microfluidic analysis chip, which was contained within the microfluidic box that
acts as a faraday cage. A photograph of the equipment at Kings College Hospital
whilst monitoring a patient is shown in figure 7.22.
Max Plank Institute, Cologne
Whilst at the MPI in Cologne, conducting the pilot study in rats as previously
discussed, a stroke patient was admitted who presented a case for rsMD monitoring.
Therefore, the rsMD system (which was being used in the animal study) was trans-
ferred back to the clinic for patient monitoring. The staﬀ allowed the microfluidic
system to be tested on the patient and the sensor box was inserted between the
MD probe outlet and the rsMD system as described above. Whilst monitoring the
patient in Cologne, droplet flow was also tested. This involved placing a microflu-
idic T junction chip, at the outlet of the MD probe, which was connected to an
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Figure 7.22: rsMD and microfluidic setup on the intensive care ward at KCH
Flow from the MD probe (patient out of shot bottom left) travels to the faraday box containing
an analysis chip and on-chip sensors. The outlet of the microfluidic box is connected to the rsMD
valve for glucose and lactate measurements.
open bottle of oil. When droplets were required a syringe pump was turned on that
pushed the oil through the system at a flow rate of 8 µLmin−1. A suction pump
was also attached to the outlet of the system to pull the fluid through at a flow
rate of 10 µLmin−1. The droplets were transported to the analysis chip containing
a 50 µm disc electrode glucose biosensor and the rsMD was disconnected to avoid
oil contamination.
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7.3.2 Patient Data
KCH Patient
The microfluidic platform was connected to the patient for 15 hours and data
was collected from the on-chip glucose biosensor and rsMD. The levels of the glucose
readings from both analysis techniques were individually calibrated, time aligned
and compared. A 25 µm platinum disc electrode in a combined needle was used
and fabricated into a biosensor the previous day prior to use on the clinical ward.
Figure 7.23 shows the glucose biosensor and the rsMD glucose levels. Whilst they
are both within the same concentration region, the rsMD shows more and larger
fluctuations. It is possible that the biosensor was not sensitive enough to see these
changes, as a 25 µm disc electrode was used. The apparent large dip in glucose
concentration at about 2 hours, is due to nursing activity and the patient was turned
to the left. The apparent change in rsMD glucose level is much larger, with a longer
duration. The rsMD level then returns to a level approximately 200 µm higher than
the microfluidic glucose biosensor. This is likely to be due to a kink in the connection
tubing, aﬀecting the flow. The eﬀect of this kink on rsMD measurements, is that
no sample is injected. However, the sensor is still held within the previous sample.
Therefore it will continue to deplete the analyte. The change in current seen by the
25 µm disc diameter glucose biosensor, is only 7pA.
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Figure 7.23: On-line glucose recordings from patient at KCH
The microdialysate was fed to the analysis chip in continuous flow. A 25 µm glucose biosensor
(orange) and rsMD (red) analysed the glucose in the microdialysate.
256
7.3 Human Studies in the Intensive Care Ward
MPI Patient
Figure 7.24A shows a period of almost 5 hours where the glucose biosensor and
rsMD glucose were analysed simultaneously. The raw data is shown and the glucose
biosensor had a negative oﬀset that has been removed (adjusted by comparison of
levels to rsMD and aCSF oﬀ-line levels). This negative oﬀset was only seen when
the sensor was connected to the microfluidic set-up on the clinical ward and ground-
ing more equipment did not get rid of this oﬀset. The apparent large changes seen
after 3 hours is due to flow problems, associated with the microdialysis perfusion
pump. These drops are analogous to the decrease seen in the Kings College patient.
However, here they are more pronounced in the biosensor (approximately 20 pA),
due to a larger electrode size used. Therefore when the flow stops, the larger elec-
trode consumes more analyte in a given time. The glucose biosensor shows good
correlation with rsMD with the levels fluctuating together. When converted into
concentration the levels at the beginning of this monitoring period for the on-chip
biosensor and rsMD were approximately 550 and 720 µM respectively. Both showed
the glucose level increasing through the monitoring period, and levels at the end
were approximately 700 and 1000 µM respectively. No events were recorded by the
ECoG electrodes during this monitoring period.
Two days later, droplet flow was tested on the same patient. Oil was pumped at
8 µLmin−1 and a suction was applied to the end of the system at the total flow rate
of 10 µLmin−1. This was to reduce the pressure in the system and try to reduce
flow problems created by the microdialysis perfusion pump. The result is shown in
figure 7.24B and it is the world-first time digital microfluidics has been used on a
patient. The trace is noisy as many people came to look at the system working in
droplet flow, again indicating that there is a problem with grounding the system.
The setup requires further improvement to reduce this noise. The levels of glucose
are lower than that seen two days ago in continuous flow, which is normal for online
microdialysis. The rsMD was recording a glucose level of approximately 600 µM
before the droplet flow analysis had commenced and approximately 560 µM once
the rsMD was reconnected after the droplet analysis. Again this is lower than the
levels recorded in continuous flow but there is still a diﬀerence of a few 100 µM
between analysis techniques.
In events of cause unknown, at approximately 16, 25 and 40 minutes in fig-
ure 7.24B, there are decreases in the glucose level over periods of 20 to 30 seconds,
all corresponding to approximately 50 µM. This is after the dialysate has been trans-
ferred over 1m of tubing. In the continuous flow data (figure 7.24A), the changes
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Figure 7.24: On-line glucose recordings from a stroke patient at MPI
A: MD probe was connected to the on-chip glucose biosensor (dark red) and the dialysate was then
fed into rsMD (Light red). Raw data shown and the two traces are time-aligned. Peak height in
the rsMD data corresponds to concentration. Note: large decreases are due to flow issues from
the microdialysis perfusion pump. B: The dialysate was segmented into droplet flow at the probe
outlet and fed to the analysis chip containing the glucose biosensor only. The oil flow rate was 8
µLmin−1 and suction was applied at the end of the system at 10 µLmin−1 to reduce pressure.
approximately 15 to 30 minutes into recording are approximately 50 to 90 µM and
occur over approximately 120 seconds. These are of the same magnitude as that
seen in droplet flow but possibly due to dispersion occur over a longer time period.
Whilst the glucose changes in both sets of clinical data are not associated with SD
events, it does show the possibility of measuring glucose levels in droplet flow.
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All three opportunities to incorporate the microfluidic platform onto the clinical
system has given great insight into the problems that need addressing. First, there is
a problem with grounding as the sensors are more sensitive to noise and sometimes
show an oﬀset that is not seen oﬀ-line. Also all three cases have given a lower
recording of the glucose level compared to the rsMD. This was not seen during the
animal studies and is likely to be a background current, which we cannot control.
One way of addressing this problem could be to introduce standard additions and
therefore the background current can be taken into account. Despite this, the sensors
show similar fluctuations with the rsMD and therefore with further optimisation,
are suitable for monitoring on the intensive care ward.
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7.4 Conclusion
The glucose biosensor and microfluidic platform was combined and tested in vivo.
A pilot study was conducted in the Max-Plank Institute, Cologne, where several
models of ischemia were used. The study was a multi-modal analysis of several focal
ischemia models. Droplet flow was initially tested in the pilot rat study. Due to the
lack of comparable glucose data (the rsMD could not be used), no on-chip potassium
recording (due to oil incompatibility issues) and insuﬃcient time to optimise the
set-up in Cologne for droplet flow, the remaining procedures were carried out in the
continuous flow regime. In continuous flow, the on-chip potassium ISE was used to
detect the onset of depolarisation at the MD probe, and the glucose biosensor was
assessed by comparison to rsMD glucose levels. It was concluded that the on-chip
glucose biosensor is suﬃcient in sensitivity, time response and stability to analyse
brain dialysate and assess the changes in glucose levels associated with ischemia.
During diﬀerent stimuli, the local glucose levels in the dialysate were recorded
by both a glucose biosensor and rsMD. During implantation of the microdialysis
probe, an increase in glucose levels was seen by both. The glucose levels here are
comparable with both seeing a change of approximately 400 µM. During euthanasia,
glucose levels fell and were again comparable at both the on-chip glucose biosensor
and rsMD. The concentration decreased for 5 out of 8 procedures.
A stroke model (MCAO) saw a change in glucose of approximately 200 µM.
The two methods of glucose analysis again showed good correlation. The change
in glucose levels was not as large as first expected. However, visual inspection
of the macrosphere location showed that the occlusion occurred in the posterior
communicating artery, as opposed to the intended middle cerebral artery. The
occlusion also occurred on the opposite side of the brain to the sensors. This resulted
in collateral flow compensating for blockage and therefore only a small change in
blood flow and glucose levels were seen.
Spreading depolarisation’s have been recorded in the injured human brain and
these changes have been previously characterised by rsMD. It has been shown that
SD waves are potentially harmful and can drive down the local glucose concentra-
tion by frequent repetition. This can harm and potentially kill the local tissue.
Measuring the SD events using a glucose biosensor within the microfluidic platform
was therefore investigated in the pilot study. The first method of initiating an SD
event was a cotton bud stimulation. Here, multiple SD waves were produced from
one application of the cotton bud. The changes produced in both the glucose and
potassium levels were small and the on-chip glucose biosensor performance could
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not be assessed using rsMD due to inadequate resolution of a sample a minute.
Due to the repeatable nature of the SDs stimulated using this method, it was hard
to distinguish the responses from noise. The use of multi-modal recording allowed
the identification of the small glucose changes. Hence a second model, the needle
prick, was used, to induce larger changes in glucose concentration and typically one
single SD wave. Half of the changes in local glucose concentration were larger than
those seen using the cotton bud model, however the rest were similar in magnitude.
Again, the on-chip glucose biosensor performed well showing the same concentration
of glucose as the rsMD. The needle pricks gave an insight, for the first time, into the
relationship between glucose, potassium and blood flow during an SD event. The
glucose concentration decrease is delayed from the onset of cellular depolarisation
and coincides with the return of blood flow to baseline levels, i.e. the hyperaemia
has passed but the cells are still re-polarising. Therefore, there is a high energy
demand but no increase in supply and local glucose levels decrease.
The microfluidic analysis chip and glucose biosensors were preliminarily tested in
the intensive care unit. Fifteen hours of monitoring in continuous flow was recorded
at Kings College Hospital. Whilst in Cologne, there was the opportunity to assess
the microfluidic system on a stoke patient. Five hours were recorded in continuous
flow and droplet flow was also tested on this patient two days later. The glucose
levels recorded, had a discrepancy of approximately 200 µM, between the biosensor
and rsMD reading. Whilst no SD events were monitored, the data highlights the
feasibility of implementing the digital microfluidic system at the bedside to monitor
human patients.
Overall, the microfluidic platform with integrated glucose biosensor was highly
successful. In continuous flow it was easily incorporated between the patient and
rsMD analysis. Biosensor performance in all the ischemia models used in the pilot rat
study was comparable to that of rsMD. In the clinic , for the first time, a microfluidic
analysis system with integrated electrochemical biosensors, was incorporated at the
bedside. This was conducted in both continuous and droplet based flows. The
glucose biosensor was also more sensitive to noise and on occasion there was an
oﬀset that is not seen when run oﬀ-line. Further work to ground the equipment
properly and optimise microfluidic system when incorporated into the intensive care
unit is required. The next step is to test the system in the droplet flow regime.
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Chapter 8
Discussion
8.1 Overview
The aim of this thesis was to develop a system capable of monitoring brain dialysate
at the bedside in an intensive care unit. A microdialysis probe was used as a sampling
method, as it is FDA approved and can therefore be placed within the human body,
during surgery. Specifically, the concentrations of glucose and lactate within the
dialysate, were desired using analysis in real-time, to give an insight into the health
of injured brain tissue. I proposed the use of electrochemical biosensors, placed
within a microfluidic manifold, to analyse the microdialysate continuously. The
sensors needed to be highly sensitive and fast responding, as the events of interest
(spreading depolarisations), are small concentration changes that occur relatively
quickly. It has been suggested in the literature that a large number of SD waves,
which occur frequently, can cause the deterioration of the brain tissue surrounding
the focal injury site that is seen in 40% of patients.
The current rsMD system used at the clinic, dramatically improves upon the
time resolution of traditional microdialysis. However, the system requires a long
connection tubing (approximately 1 m) from patient to analysis, during both surgery
and whilst monitoring at the bedside on the intensive care ward. At the typical
microdialysis flow rate used during clinical monitoring (2 µLmin−1), transport of
the sample over 1 m of connection tubing takes approximately 10 minutes. If a
real-time assessment of the health of the tissue was required (for example, if the
system was used to alert clinicians of deterioration) then even a delay of 10 minutes
may be too late for therapeutic action. In continuous flow, Taylor dispersion occurs.
This smears out sharp concentration changes making it harder to analyse. Also,
the clinical trolley on which the rsMD system is placed, is large and bulky, and
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diﬃcult to position close to the patient. Therefore a digital microfluidic system
was proposed. Dispersion was eliminated due to the segmentation of flow and the
microfabrication of devices dramatically reduces the size of the analysis system.
The first step was to microfabricate a PDMS T junction using soft lithography and
droplets of reproducible size were reliably formed.
The application of digital microfluidics, particularly the use of two phases, led
to problems of analysis. A combined needle electrode was developed to house the
working, reference and auxiliary electrodes, for placement within a microfabricated
flow cell. The biosensors were successfully miniaturised and gave good results, with
response times of a few seconds and a limit of detection in the low µM, but the
placement in a two phase system was problematic. Firstly, the entire electrochemical
cell must be contained within a single droplet for suﬃcient time for analysis of the
droplets contents. Secondly, the oil fouled the electrode surface and blocked the
aqueous signal from being recorded. An analysis chip was therefore designed to
remove the oil and re-join the droplets together. This created an continually aqueous
solution where the electrode could be placed without any interaction with the oil.
Two designs were discussed in this thesis, both removing the oil using the geometry
of the channels, with the separation occurring spontaneously via passive coalescence.
To assess the viability of the electrodes on-chip under a droplet flow regime,
initially electrochemistry on bare electrodes was conducted with standard redox
solutions. Cyclic voltammograms showed the sensors performing exceptionally well
in the analysis chamber in both continuous and droplet flow. Dispersion in both
flow regimes was assessed using optical and electrochemical methods. The T90 was
reduced from 19 s in continuous flow to less than 16 ms in droplet flow. This 1000-
fold increase in time resolution highlights the potential of using digital microfluidics
for all microdialysis users, not only clinical monitoring on the intensive care ward
as intended here, but in all microdialysis studies.
A translational study, conducted at the Max Plank Institute, Cologne, tested the
microfluidic platform in a microdialysis study of SD waves. Here, the glucose biosen-
sor, placed on-chip, was validated against rsMD glucose with excellent results. A
potassium sensor, fabricated by Ms Chi Leng Leong, was also placed on-chip within
the analysis chamber. This provided, for the first time, a chemical start point of the
depolarisation in the microdialysate. Previously, the start of the depolarisation in
the chemical data was estimated from the electrical signals seen on the ECoG. For
the first time, this study has allowed an insight into the timing of events that occur
during an SD wave. It was found that the characteristic hyperaemia was tightly
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associated with the release of potassium as the cells depolarise. The decrease in
glucose only occurred once the increased blood flow had returned to normal levels,
and the cells were re-polarising, as indicated by the fall in potassium. Therefore the
glucose signature was delayed by approximately one minute from the potassium and
blood flow. It was concluded that whilst the cells were depolarising, the hyperaemia
provided oxygen and glucose. However, once the hyperaemia passes and the cells
begin to re-polarise, there is no additional supply of metabolic substrates by the
blood and the local glucose concentration is seen to fall.
This study was conducted in continuous flow for several reasons. However, would
the use of droplet flow help show more detail in the relationship between potassium
and glucose? I would expect the transients to be sharper and quicker, due to the
reduction of dispersion inherent in droplet flows. For example the potassium trace to
be closer in shape to that seen by the tissue electrode (and presumably the glucose
would be faster by the same extent). This is illustrated in figure 8.1. The empty
boxes indicates the time period over which the transient occurred in continuous
flow and the filled in boxes indicate the potential time period in droplet flow. This
was based on the responses seen by the potassium tissue electrode and the on-chip
potassium electrode in figure 7.19. In droplet flow, the time periods of the transients
is likely to be approximately one minute. The time responses of the sensors therefore
need to be fast enough and be able to distinguish the sharp transients from noise.
The signal seen in droplet flow would not necessarily be greater in magnitude than
that seen here in continuous flow, as this is dependent upon the recovery of the MD
probe. However, digital microfluidics would allow the dialysate perfusion rate to be
lowered, without compromising the transit time to analysis, and this would increase
the recovery of analytes over the membrane and therefore give larger signal, which
is easier to record.
This thesis also presented data conducted at the bedside, on a patient in the
intensive care unit, using the microfluidic based analysis system. This is a first for the
group and possibly world-wide. Continuous flow was initially used and over 15 hours
were recorded at Kings College Hospital, using the glucose biosensor. Continuous
and droplet flow were also tested on one patient at the Max Plank Institute in
Cologne, which highlights the areas of improvements and shows the potential of
combining digital microfluidics, electrochemical biosensors and microdialysis.
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Figure 8.1: Glucose and potassium changes
Potassium changes shown in the top graph, Glucose on the bottom. The empty box shows the
time responses seen (potassium purple, glucose red) and the filled boxes indicate the possible time
responses if droplet flow was used.
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8.2 Future Work
This section will discuss the future work required.
Electrodes and Sensors
The accurate placement of electrodes on-chip in relation to the chamber ceiling
needs further work. This is the source of much variation in the biosensor performance
and improvement in the method will greatly improve the success of the on-chip
sensors. If it is not possible to accurately place the electrodes away from the walls,
where the chemical history eﬀect from previous droplets is less and the electrode
will disrupt the formation of bands, then baﬄes could be introduced to enhance
mixing and ensure accurate analysis of droplets. For multi-analyte analysis, the
production of dual electrodes with better placement within the needle to eliminate
cross talk would be desired. The second electrode could also be used as a sentinel
electrode, which will help eliminate any questions about possible failings of the sensor
overtime when run within the chamber. However, the size of the needle constricts the
possibilities of eliminating crosstalk. Therefore, in my opinion, further optimisation
of the design is required, with more than one analysis chamber. Optimisation of the
geometry of the chamber, to house a single electrode, will allow multiple chambers
to be placed concomitantly. As the droplet flow is reformed after each chamber, the
high time resolution is retained. This will eliminate the cross talk seen in the system
presently with the dual electrodes and does not compromise the time resolution by
placing one electrode further from the point of coalescence.
Whilst the biosensors were shown to work well, the stability of stored glucose
sensors is an area that could be improved. Whilst making fresh sensors for each
experiment gives good results, it is not always practicable when dealing with pa-
tients. As brain injury patients are emergency cases, it is unknown when the next
patient will be and therefore planning is very diﬃcult. Sensors that are stable in
storage will allow more flexibility. A higher enzyme loading to the electrode sur-
face will help the biosensors fare better in storage. The lactate sensors also require
further optimisation, the main objective being to be improve the sensitivity. This
too will involve optimising the fabrication process to increase enzyme loading onto
the electrode surface. The best way to increase enzyme loading would be using an
electropolymerisation solution, which is low in volume and high in concentration.
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Microfluidic Toolkit
The preliminary data from implementing digital microfluidics and microdialy-
sis showed a possible enhancement of recoveries when the T junction was placed
very close to the microdialysis membrane. Although very interesting, this was not
investigated further due to the clinical microdialysis probes having a long outlet
tubing. However, if there was the opportunity to redesign the microdialysis probe,
incorporation of a T junction will allow segmentation of the dialysate as close as
possible to the membrane. This could take advantage of the increased recovery rates
(presumably due to the stop-start motion of the dialysate), which the preliminary
data showed, but further investigations would be required. The incorporation of the
T junction into the microdialysis probe will also increase the time resolution further,
as it eliminates all continuous flow. The analysis of the flow through the chamber
indicated that Poiseuille flow is established over a short distance and therefore dis-
persion would be reduced the closer the T junction was placed to the microdialysis
membrane.
The first design of the microfluidic analysis chip separated the two phases into
two channels. The second design was an improvement upon the first, by allowing
symmetrical separation, about an analysis chamber. Whilst the second design of
the analysis chip performs better than the first, it does not produce a continuous
aqueous flow. This is desired for validation of the glucose biosensor in droplet
flow. Initial studies show that the aqueous solution held within the chamber could
be slowly drawn out without depleting the chamber for biosensor analysis. The
solution could then be injected into rsMD for analysis and comparison. However,
problems of suction through the valve, even when hard wired, disrupted the droplet
flow and caused air to be drawn through the system. Further work to optimise this
process would be extremely valuable.
The dosing of droplets holds much potential. Enzymes could be dosed in to
eliminate high concentrations of interfering electro-active species (such as ascorbate
oxidase) as well as enzymes for detection of analytes. Further investigations into the
properties of the enzyme, the PDMS surface and use of oil surfactants need to be
thoroughly investigated and optimised. A second advantage of dosing droplets, is to
add standards at set intervals for auto-calibration. Auto-calibration is required for
all hospital instrumentation and will be extremely beneficial, as the sensitivity of the
sensors can be tracked throughout the course of monitoring, allowing for accurate
interpretation of the recordings.
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Implementation on the Intensive Care Ward
For successful implementation onto the intensive care ward, the system must
first be validated in droplet flow. For this to happen, successful formation of a
continuous aqueous flow of dialysate from the analysis chip to rsMD is required.
Preliminary studies has shown that whilst in the intensive care unit, both at Kings
College Hospital and the Max Plank Institute, the microfluidic system is subject to
more noise and electrical oﬀsets than seen either oﬀ-line in the lab or in the pilot
animal studies. This needs to be address to reliably analyse the data.
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